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ABSTRACT 
 
 
The three dimensional structure of the human genome is known to play a critical 
role in gene function and expression. I used chromosome conformation capture 
(3C) and 3C-carbon copy (5C) techniques to investigate the three-dimensional 
structure of the cystic fibrosis transmembrane conductance regulator (CFTR) 
locus.  This is an important disease gene that, when mutated, causes cystic 
fibrosis. 3C experiments identified four distinct looping elements that contact the 
CFTR gene promoter only in CFTR-expressing cells. Using 5C, I expanded the 
region of study to a 2.8 Mb region surrounding the CFTR gene. The 5C study 
shows 7 clear topologically associating domains (TADs) present at the locus, 
identical in all five cell lines tested, regardless of gene expression status. CFTR 
and all its known regulatory elements are contained within one TAD, suggesting 
TADs play a role in constraining promoters to a local search space. The four 
looping elements identified in the 3C experiment and confirmed in the 5C 
experiment were then tested for enhancer activity using a luciferase assay, which 
showed that elements III and IV could act as enhancers. These elements were 
tested against a library of human transcription factors in a yeast one-hybrid assay 
to identify potential binding proteins. Element III gave two strong candidates, 
TCF4 and LEF1. A literature search supported these transcription factors as 
playing a role in CFTR gene expression. Overall, this work represents a model 
locus that can be used to test important questions regarding the role of three 
dimensional looping on gene expression. 
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INTRODUCTION 
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Cystic Fibrosis – An Uncommonly Common Recessive Disease 
“Wehe dem Kind, das beim Kuß auf die Stirn salzig schmekt, er ist verhext 
und muss bald sterbe“– Beware of the child who tastes salty from a kiss on the 
brow, for it is cursed and soon must die. This medieval German quote refers to 
the disease Cystic Fibrosis (CF). Thought to be first accurately described in 1595 
by Pieter Pauw of the Netherlands, CF is a recessive genetic disorder that 
disproportionately affects those of European descent (Quinton, 1999). Although 
the disease itself has been recognized in some form for centuries, only recently 
have major advances in treatment significantly extended patient life-span. The 
CFTR gene, responsible for causing CF when mutated, was the first human gene 
to be cloned (Riordan et al., 1989). Upon its discovery, many believed it was only 
a matter of time until scientists could use gene therapy to insert a healthy copy of 
the CFTR gene into diseased tissues. This goal proved elusive. There is still no 
cure. 
Cystic fibrosis is characterized by a number of clinical phenotypes (listed 
at the Cystic Fibrosis Foundation, www.cff.org). The most noticeable symptom, 
as referenced by the quote above, is an increased level of sweat chloride, 
leading to a salty taste of patient sweat (Kumar et al., 2012). A major symptom is 
mucus buildup in the airway of an affected individual, leading to difficulty 
breathing and chronic lung infections. These infections are caused by the 
pathogens Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas 
aeruginosa (Saiman, 2004). Biofilm formation of P. aeruginosa is the most 
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common infection. Many CF patients continually take antibiotics to fight bacterial 
infections prophylactically. Eventually patients may require a lung transplant from 
a healthy, non CF individual (Belkin et al., 2006). The condition also produces 
problems in the gastrointestinal tract. Analogous to mucus buildup in the airway, 
pancreatic secretions also accumulate, causing a barrier to digestive enzymes 
entering the gut. This leads to pancreatic insufficiency and a lessened ability to 
properly digest food (Kumar et al., 2012). Enzymatic supplements are used to 
treat this problem. In the reproductive tract, congenital absence of the vas 
deferens is present in many male cases of CF (Chen et al., 2012). Indeed in 
many infertility cases, including congenital absence of the vas deferens, the 
patient is found to harbor a mild CF mutation (Du et al., 2014; Jiang et al., 2013; 
Sharma et al., 2014; Yu et al., 2012). However CF patients can have children 
using in vitro fertilization methods (McCallum et al., 2000).  
 
The Genetic Basis of Cystic Fibrosis 
 Cystic fibrosis is a single gene recessive disorder. The CFTR gene is 
highly expressed in the epithelial cells of the airway and pancreas, as well as in 
the colon, sweat glands, liver, and reproductive tissues (Riordan et al., 1989; 
Trezise and Buchwald, 1991). About 1/25 to 1/30 people of European descent 
are carriers of a CFTR mutant allele, which is a strikingly high number for a 
recessive disease (Cystic Fibrosis Foundation, 2014). There is a hypothesis that 
this high carrier frequency is tolerated because of some type of heterozygote 
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advantage, perhaps similar to the advantage given to heterozygote carriers of the 
sickle cell anemia allele against malaria (Allison, 1954). Some studies have 
shown links between mutant CFTR and the incidence of cholera, typhoid fever, 
and lactose tolerance (Gabriel et al., 1994; Modiano et al., 2006; Pier et al., 
1998). However, cholera is not limited to Europe, and further work into this theory 
has not shown any link to cholera resistance (Cuthbert et al., 1995; Högenauer et 
al., 2000). Additionally, the idea that CFTR mutant alleles provide resistance to 
typhoid fever is also refuted by the prevalence of typhoid fever across the world, 
while CF is limited to Europe (and by extension the Americas). An increase to 
lactose tolerance does correlate with the high European prevalence of CF, but 
further research must be done to prove any correlation. A fourth idea, that CF 
heterozygosity confers resistance to heavy metal poisoning, coincides with 
research showing that mutant CFTR protein changes the redox potential inside 
cells, leading to a greater ability to sequester toxic lead used from the time of the 
Roman empire (Childers et al., 2007). None of these theories have yet been 
confirmed.    
The location of CFTR  was discovered to be in a 30 Mb window on 
chromosome 7 in 1985 by Lap-Chee Tsui (Tsui et al., 1985). Tsui then 
collaborated with Francis Collins, who came up with a chromosome jumping 
technique, to more precisely identify where the gene was located (Collins et al., 
1987). In 1989, three papers published in Science showed not only the exact 
location and length of CFTR, but identified the length of the CFTR protein and in 
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which tissues it was expressed, predicted its function, and pinpointed the now 
famous phenylalanine deletion at position 508 (ΔF508) as the key mutation in 
over 70% of CF patients (Kerem et al., 1989; Riordan et al., 1989; Rommens et 
al., 1989). This groundbreaking work was met with excitement about potential 
treatments, including gene therapy, as a total cure for this disease.  
 
A Defect in CFTR Results in a Multitude of Complications 
The CFTR gene produces the CFTR protein, which is an ABC family 
transmembrane chloride ion (Cl-) channel activated by cyclic AMP (cAMP) (Bear 
et al., 1992; Rich et al., 1990). Normal CFTR allows Cl- to flow down its 
electrochemical gradient, moving Cl- and thiocyanate (SCN-) ions out of the cell. 
Sodium (Na+) ions follow, creating an increase in electrolytes in the mucosal 
layer of the airway and digestive tract. “A number of other cellular functions have 
been ascribed to CFTR: it down-regulates transepithelial sodium transport, in 
particular the epithelial sodium channel; it also regulates calcium-activated 
chloride channels and potassium channels and may serve important functions in 
exocytosis and the formation molecular complexes in the plasma membrane 
(Rowe et al., 2005).” When this pump is impaired or missing, the symptoms of 
CF appear, though there is debate about how exactly the many symptoms of CF 
are caused by absence of the CFTR transporter. The salty-tasting sweat may be 
the easiest symptom to explain. Human sweat contains some salt (NaCl) but a 
majority of it is re-absorbed in the sweat gland duct. In the sweat glands of a CF 
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patient, there is an imbalance of Cl- and Na+ in the ductal lumen of the gland due 
to the defect in CFTR. Na+ can be taken into the cell, but Cl- cannot, increasing 
the negative charge, and thus the amount of NaCl, in the lumen and 
consequently in the excreted sweat of the patient (Rowe et al., 2005). The heavy 
mucous coating the airways is thought to be the result of a dehydration of the 
mucosal layer, resulting in a thicker, sticky mucus that is harder to clear 
(Brennan, 2008). In the respiratory tract, it has been shown that airway epithelial 
cells homozygous for the ΔF508 deletion failed to produce thiocyanate, a 
component of an antimicrobial pathway, contributing to the growth of S. aureus 
and P. aeruginosa (Moskwa et al., 2007). There is also evidence that CFTR is 
responsible for the transport of glutathione, which affects the redox state of the 
cell. If this redox state is imbalanced, a multitude of downstream effects are 
observed, including mis-regulation of zinc-dependent enzymes, improper gene 
regulation, hyper inflammation, altered pH, and imbalance of fatty acids (Childers 
et al., 2007). Additionally, mutations in CFTR can result in congenital bilateral 
absence of the vas deferens and male infertility, even if CF has not been 
clinically diagnosed (Yu et al., 2012). The influence of losing one transport 
channel in the cell is far reaching, with many negative consequences, leading to 
the complex CF phenotype. 
 
Cystic Fibrosis and the Promise of Gene Therapy 
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 The study of molecular biology holds great promise for the potential 
treatment of genetic disorders. Notably, cystic fibrosis has been at the forefront of 
this type of groundbreaking research. CFTR is an ideal candidate, since only one 
good gene copy is needed for a fully functional protein to reach the cell 
membrane. Over 1500 mutations have been found in the CFTR gene (Bobadilla 
et al., 2002). The most severe mutation, ΔF508, occurs in over 70% of CF cases 
(Riordan et al., 1989). This mutation causes incorrect folding and subsequent 
degradation of the CF protein, so it never reaches the cell membrane. 
Intriguingly, overexpression of this allele causes overloading of the protein 
degradation pathway, and does allow some of the mutated protein to arrive at the 
cell membrane, where it is a functional transporter (Cheng et al., 1995). It has 
also been shown that the ΔF508 mutation can be rescued via 
transcomplementation of only a fragment of wild-type CFTR, producing a 
functional channel at the cell membrane (Cormet-Boyaka et al., 2004). This hints 
at potential therapy – if one can rescue the native allele, even though it is 
mutated, one can rescue the CF phenotype. Since CF is a single-gene recessive 
disorder, it has been at the forefront of potential gene therapy treatments for 
decades. Simply replacing the mutated gene with a normal copy, or 
overexpressing the commonly mutated version, would cure this disease. This 
approach was taken on human cell lines, and it was found that inserting CFTR 
cDNA into cells with mutated CFTR created a functional CFTR protein (Drumm et 
al., 1990; Krauss et al., 1992; Rich et al., 1990). A recent study published in late 
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2013 used CRISPR/Cas9 technology to “correct the CFTR locus by homologous 
recombination in cultured intestinal stem cells of CF patients (Schwank et al., 
2013).” CRISPR/Cas9 repaired both mutant alleles in the majority of clones in 
this study and created functional CFTR protein. The authors were able to grow 
primary intestinal organoids from the corrected cells in which CFTR function was 
normal. Though the 2013 paper used modern technology in clonal cells that can 
grow into an organ ready for transplant, the dream of CF gene therapy is still that 
– a dream. Correctly targeting all the cells necessary for a cure to work is a huge 
barrier for gene therapy. Although in theory reaching the airway cells by a nasal 
spray is relatively simple, getting the corrected gene into cells of the gut and 
reproductive system is a much larger hurdle. The challenge of creating this type 
of cure in vivo, and not just in the petri dish, remains.  
 
Animal Models for Cystic Fibrosis 
 Three years after the Cystic Fibrosis gene was cloned, a mouse model 
was created containing a truncated form of the CFTR gene (stopping at exon 10) 
(Snouwaert et al., 1992). This mouse produced similar symptoms to CF patients 
including failure to thrive and alteration of mucous glands, however most mice 
died within 40 days of birth, making long-term studies unfeasible. Since then, 11 
different CF mice models have been created (reviewed in Guilbault et al., 2007). 
Though these mice all represent the CF phenotype to some degree, none of 
them completely recapitulate the human symptoms, especially in the airway. 
9 
 
Researchers then turned to the pig, an animal that more closely represents 
human physiology. In 2008 a CFTR-/- pig was reported (Rogers et al., 2008) 
which closely recapitulated the symptoms seen in human CF patients (Stoltz et 
al., 2010). More recently a homozygous pig for the ΔF508 mutation was 
produced, and four pigs with this mutation developed lung disease as they aged 
(Ostedgaard et al., 2011). It has also been shown that transgenically expressing 
porcine CFTR in the intestine of CFTR-/- animals partially restored and improved 
intestinal function, but did not improve pancreatic function or prevent lung 
disease (Stoltz et al., 2013). Though mouse models have advantages such as 
low cost and years of data collected, the pig model seems very promising for 
development and treatment of new CF therapies.  
 
Regulation of the CFTR Gene 
If gene therapy is to be attempted, proper CFTR regulation needs to be 
understood. The gene is expressed in a tissue-specific manner, yet the promoter 
region appears to contain no tissue-specific elements and looks like a 
housekeeping gene (Koh, et al., 1993; Yoshimura et al., 1991). Studies focused 
on the CFTR promoter were done in the early 90s. Binding sites were identified 
for proteins such as SP1, AP-1, CRE, NF-κB, HNF1α and C/EBP (reviewed in 
McCarthy and Harris, 2005). Multiple transcription start sites have been identified 
in different human tissues (reviewed in McCarthy and Harris, 2005). Alternate 
transcripts may include either exon1a or exon-1a which splice directly to exon2 
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(Koh et al., 1993; Lewandowska et al., 2010). Additionally, the CFTR gene shows 
some hormonal regulation by both progesterone and estrogen, though the main 
studies showing this have been done in rats (de Andrade Pinto, Ana C.O. et al., 
2007; Gholami et al., 2012; He et al., 2010; McCarthy and Harris, 2005). 
DNase 1 hypersensitive sites (DHS) are interesting to investigate in terms 
of gene regulation. DHS are indicative of open chromatin regions, areas where 
protein can easily bind to DNA and cause activation or repression of 
transcription. The Harris lab has done extensive work characterizing DHSs within 
and around the CFTR gene, with much of this work reviewed in McCarthy and 
Harris (2005). Of important note are the studies examining DHSs in introns 1 and 
11 of CFTR, one located about 202 kb downstream of the CFTR promoter, and 
two located 80 and 20 kb upstream of the CFTR transcription start site (TSS) 
(Kerschner and Harris, 2012). The upstream DHS at -20 kb was shown to 
contain CTCF binding sites (Blackledge et al., 2007). The DHS in intron 1 has 
been shown to increase luciferase expression driven by the CFTR promoter and 
shown to decrease CFTR expression in the intestine up to 60% when removed 
from a YAC reporter (Mogayzel Jr. and Ashlock, 2000; Ott et al., 2009a; 
Rowntree et al., 2001; Smith et al., 1996). Nucleosome positioning studies have 
shown a depletion at DHSs in intron 1, 11 and at the downstream 202 kb site in 
CFTR expressing cells (Yigit et al., 2013). The DHSs in introns 1, 11 and 202kb 
downstream of the gene have been shown to act as CFTR enhancer elements 
(Gheldof et al., 2010; Ott et al., 2009b; Rowntree et al., 2001, chapter 5 of this 
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thesis). More recently, Zhang et al. described an upstream enhancer located 35 
kb from the TSS active only in airway cells that drove luciferase expression of 
CFTR (Zhang et al., 2013). Thus there are a number of known CFTR regulatory 
elements in the 400 kb region of the locus. 
We are still working to understand the cell type specific regulation of the 
CFTR gene, to identify the role of enhancer elements located hundreds of kb 
from the promoter, and to discover transcription factors involved in CFTR 
expression. Though the gene has been known for over 20 years, its precise 
function and regulation remain unclear. There are still debates as to how the lack 
of CFTR protein function causes the multiple symptoms of CF. Although 
treatment options for patients have improved, a complete cure for the disease 
remains elusive. Many different attempts at gene therapy cures have been 
attempted, but success remained constrained to the lab. Though extensive work 
has been done to characterize CFTR regulatory elements, the full picture has yet 
to emerge. This thesis aims to address questions relating to the regulation of 
CFTR with the hope that the knowledge contained herein may one day contribute 
to treatments and perhaps a total cure for CF.  
 
The Human Genome in Three Dimensions 
 Now we must change focus, away from an in-depth analysis of CF and the 
CFTR gene to an entirely different topic, the organization of the human genome 
in three dimensions. There are two popular ways to measure genome 
12 
 
organization: microscopy methods (especially fluorescence in situ hybridization 
(FISH)), and molecular methods (“C” based methods). Each of these methods 
has their pros and cons. 
FISH microscopy is a powerful tool for investigating the position of 
genomic loci in three dimensions (3D) (Langer-Safer et al., 1982). FISH uses 
molecular probes that hybridize to target genomic sequences.  These probes can 
be labeled with a variety of fluorescent labels, allowing for identification of 
multiple targets in one experiment. Multicolor FISH has been used to paint entire 
chromosomes, identifying chromosome territories within the nucleus and 
translocations implicated in disease (Bolzer et al., 2005; Speicher et al., 1996). In 
terms of genome architecture, FISH was used to show that when the HoxB 
cluster becomes active it loops out of its chromosome territory (Chambeyron and 
Bickmore, 2004). Recently it was shown that the β-globin locus decreased in 
volume by approximately 40% upon gene activation, presumably because of an 
increase in chromatin looping within that locus (Corput et al., 2012). The 
technology to image finer and finer structure is rapidly progressing; however 
there are still limitations to the amount of detail one can gain through this method 
(Markaki et al., 2012). Additionally, FISH is challenging to multiplex because of a 
limited number of color options.  
Another way to identify the 3D structure of chromatin in the nucleus is to 
use “C”-based methodology. Chromosome Conformation Capture (3C) was first 
described by Dekker et al. in 2002. This technique uses formaldehyde to 
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crosslink DNA in its 3D nuclear structure. Once chromatin is crosslinked, it is 
digested with a restriction enzyme. The digested ends are ligated together to 
form a library of genomic interactions in 3D. Pieces of DNA that may have been 
far apart in the linear genome can be close together in 3D space, and these 
fragments become ligated in the 3C library. These new DNA fragments can be 
analyzed using PCR-based methods. Many other methods based on this 
approach have been described, including chromosome conformation capture on 
chip (4C), chromosome conformation capture carbon copy (5C), ChIA-PET, and 
the genome-wide Hi-C technique (Dostie et al., 2006; Fullwood et al., 2009; 
Lieberman-Aiden et al., 2009; Simonis et al., 2006). All of these techniques 
identify which parts of the genome are close together in 3D space with a higher 
resolution and much higher throughput than current microscopy methods allow. 
 
There are Many Levels of Chromatin Organization 
 Human DNA can stretch to 2 meters in length, yet it is packaged into a 
small cell nucleus that averages 10 microns in diameter. Although the genome 
could be randomly packaged within that 3D space, it is organized within the 
nucleus on many different levels. The highest level of nuclear organization is the 
chromosome. Humans have 23 pairs of chromosomes, which have been shown 
to occupy individual territories in the nucleus (Bolzer et al., 2005; Cremer and 
Cremer, 2001). Chromosomes of the same size tend to be near each other, with 
larger and gene-poor chromosomes near the periphery of the nucleus and 
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smaller and gene-rich chromosomes near the center (Bolzer et al., 2005; Boyle 
et al., 2001; Croft et al., 1999; Tanabe et al., 2002; Zhang et al., 2012). Regions 
of chromosomes have been shown to interact with the inner nuclear membrane 
via lamin-associated domains (LADs) (Guelen et al., 2008). These loci are 
between 0.1-10 Mb in size and associate with the protein lamin B1 at the inner 
nuclear membrane. LADs tend to be transcriptionally inactive, consistent with the 
idea that active genes tend to be located in the middle of the nucleus, not the 
periphery (Guelen et al., 2008). Indeed, this is the case for the CFTR gene. In 
cell lines that do not express CFTR, the gene is preferentially located at the 
periphery of the nucleus, while in cell lines that do express CFTR the gene is 
localized more to the center of the nucleus (Zink et al., 2004). Another interesting 
organizational phenomenon seen with the microscope is the presence of sub-
nuclear foci. Labeling nascent RNA transcripts with 5-bromouridine 5'-
triphosphate (BrUTP) revealed that transcription from RNA polymerase II takes 
place in punctate speckles throughout the nucleus (Wansink et al., 1993). This 
observation, and others, led to the idea that polymerases are gathered into 
particular transcription stations in the nucleus, and actively transcribed genes are 
brought to these stations (Cook, 1999; Iborra et al., 1996; Osborne et al., 2004). 
Within each chromosome, active and inactive genes are organized into separate 
compartments (Lieberman-Aiden et al., 2009; Zhang et al., 2012) referred to as A 
and B compartments, respectively. These compartments stretch for megabases. 
A compartments tend to contact other A compartments in 3D, while B 
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compartments prefer to contact other B compartments (Lieberman-Aiden et al., 
2009) (Figure 1.1). The A compartment is defined by containing gene-rich, 
transcriptionally active chromatin, while the B compartment is defined by 
containing mostly gene-poor, inactive chromatin (Lieberman-Aiden et al., 2009). 
It is possible that the detection of A and B compartments by Hi-C mirrors 
microscopy data of nuclear speckles and other types of sub-nuclear foci. 
Zooming into the A and B compartments, one finds Topologically Associating 
Domains (TADs) (Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012) 
(Figure 1.1). These structures are usually hundreds of kbs to a few Mbs in length. 
Looking within a TAD, one will see specific looping interactions, such as those 
between an enhancer and a promoter, which is the finest resolution we can 
currently obtain (Figure 1.1). These interactions are less than 1 Mb in distance. 
Thus, the human genome is organized into a variety of structures, beginning with 
the largest chromosomal domain and shrinking to the smallest looping domain 
(Reviewed in Gibcus and Dekker, 2013).      
 The composition of the human genome into the compartments 
described above could be random, or it could have important biological meaning. 
Evidence supports the latter claim. It has been shown that A and B 
compartments as well as TADs exist in a variety of human cell types, and that 
TADs are, for the most part, unchanging between the different cell lines tested  
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Figure 1.1: A Simplified Model of Levels of Genome Organization (adapted 
from Job Dekker). From “C” based studies, we know that chromosomes are 
organized into multiple Mb-sized compartments of active and inactive chromatin, 
which we refer to as A and B compartments, respectively. Within these 
compartments, TADs exist at a length scale of a few 100 kbs to about 1 Mb. 
Within TADs, individual looping structures exist such as enhancer-promoter 
contacts. 
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(Dixon et al., 2012; Lieberman-Aiden et al., 2009; Naumova et al., 2013; Phillips-
Cremins et al., 2013). TAD boundaries do not change upon the addition of 
hormones estradiol and progestin, but genes within TADs seem to respond to 
hormone treatment in a correlated fashion (Dily et al., 2014). TADs have been 
seen to correlate with large blocks of histone marks (Dily et al., 2014; Nora et al., 
2012). TAD boundaries may act as a barrier to histone marks, keeping them from 
spreading into neighboring TADs. Therefore it seems that the TAD structure may 
play an important role in gene regulation. Indeed, it has been shown that while 
TAD boundaries do not shift, interactions within those boundaries do change 
between mouse embryonic stem cells and differentiated cell types (Nora et al., 
2012; Phillips-Cremins et al., 2013).  Additionally, random insertions of a lacZ 
reporter throughout the mouse genome showed that the influence of enhancers 
seems to be constrained to genes within their own TAD (Symmons et al., 2014). 
There has been a lot of speculation as to what might cause a TAD, particularly 
what might create a TAD boundary (reviewed in Gibcus and Dekker, 2013; 
Gorkin et al., 2014). Although CTCF is found to be enriched at TAD boundaries, 
this mark is widespread throughout the genome and cannot be used to identify a 
boundary location (Dixon et al., 2012). Additionally, TAD boundaries are enriched 
for gene promoters, but Dily et al. note that despite this enrichment, gene 
promoters were in median located >299 kb from TAD boundaries, indicating that 
this measurement does not clearly mark TAD boundaries either (Dily et al., 2014; 
Dixon et al., 2012). Some have proposed that looping within the TAD creates the 
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boundary. However, deleting a boundary causes the neighboring TADs to 
partially blend together and creates new loops (Nora et al., 2012). Therefore it is 
more likely that TAD boundaries constrain looping contacts within the TAD; thus 
TAD boundaries are likely not caused by their internal loop structure. How the 
boundary regions perform this task, and what molecular structures take part, is 
still an area of investigation.  
 
3D Looping is a Common Strategy for Gene Regulation 
One region that has been well-studied via “C” methods is the β-globin 
locus, home to 5 globin genes that are regulated based on developmental stages 
(reviewed in Levings and Bungert, 2002). Gene expression in the locus is 
controlled by a region called the locus control center (LCR). As cells pass 
through development, the genes are turned on and off as follows: first the ε-
globin gene is expressed in the embryo. Once the liver develops, the two γ-globin 
genes are turned on, and ε-globin is repressed. After birth, the β-globin (or adult 
globin) gene is expressed, along with α-globin at a much lower level. It has been 
shown using 3C that the LCR contacts the different gene promoters at the correct 
developmental stage to induce expression (Palstra et al., 2003; Tolhuis et al., 
2002). When these genes are not expressed, their promoters do not contact the 
LCR. These 3C experiments match microscopy data of the same locus (Carter et 
al., 2002). Thus, 3D genome looping plays a critical role in developmental 
regulation of the globin locus. Another example is Sonic hedgehog gene 
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expression in mouse limb buds (Shh). Shh expression is regulated by an 
enhancer located 1 Mb upstream of its promoter (Lettice et al., 2003). Shh loops 
out of its chromosome territory only when Shh expression is active (Amano et al., 
2009). When this enhancer is deleted, the mutant mice have no feet (Sagai et al., 
2005). Other loci that show similar expression-specific looping interactions are 
the CFTR gene (Gheldof et al., 2010; Ott et al., 2009a, Chapter 3 of this thesis), 
the c-MYC locus (Wright et al., 2010), the α-globin locus (Baù et al., 2011; 
Vernimmen et al., 2007) and key developmentally regulated genes (Oct4, Nanog, 
Nestin, Sox2, Klf4, and Olig1-Olig2) (Phillips-Cremins et al., 2013). These studies 
show that 3D looping between promoters and gene regulatory elements is a 
common strategy to control gene expression in eukaryotic cells.  
 
Goals of this Thesis 
 In order to discover regulatory DNA elements of the CFTR gene, I have 
used molecular biology techniques that examine the 3D conformation of 
chromatin inside the cell nucleus. These techniques include chromosome 
conformation capture (3C) and chromosome conformation capture carbon copy 
(5C) (Dekker et al., 2002; Dostie et al., 2006). In this thesis I describe the 
experimental methods of 3C and 5C. Then I describe the 3C experiments which 
show that the CFTR locus contains looping interactions specific to cell lines 
expressing the gene. Next I introduce an expanded experiment which 
interrogates a 2.8 Mb region surrounding the CFTR gene using 5C to search for 
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more promoter-specific interactions, examine differences in looping between cell 
types, and investigate the role of TADs in the region. Finally I present evidence 
that the elements discovered in the previous experiments act as CFTR-specific 
enhancers, and show that they bind to transcription factors that have been 
implicated in CFTR expression. 
 I find that the CFTR locus contacts four main regulatory elements in cells 
that express the gene. Two of these elements also contact each other in 3D 
space (elements III and IV). I show that these two of these elements act as 
enhancers in a luciferase assay. Using the yeast one-hybrid assay, I then identify 
sets of human transcription factors that may act in forming and maintaining the 
looping structure and/or regulating CFTR gene expression. When I looked at a 
larger region using 5C, I identified 6 TAD boundaries consistent across a panel of 
5 diverse cell types. These TAD boundaries are not dependent on gene 
expression or the interactions within or between the TADs. All CFTR enhancers 
are contained within one TAD. It appears that TAD boundaries may function to 
limit search space of gene promoters looking for their appropriate genomic 
regulatory elements.   
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CHAPTER II 
 
CHROMOSOME CONFORMATION CAPTURE METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was partially adapted from Natalia Naumova, Emily M. Smith, Ye 
Zhan, and Job Dekker. “Analysis of Long-range Chromatin Interactions Using 
Chromosome Conformation Capture.” Methods 58, no. 3 (November 2012): 192–
203. doi:10.1016/j.ymeth.2012.07.022. 
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Contributions 
 
This paper presents an update to the original chromosome conformation capture 
method and describes not only the protocol but important analysis and 
troubleshooting steps. N.N., E.M.S. and Y.Z. are co-first authors. N.N. wrote the 
troubleshooting section, E.M.S. wrote the analysis section, and Y.Z. wrote the 
materials and methods section. E.M.S. and N.N. together wrote the introduction, 
technical overview, and experimental design considerations. E.M.S. and N.N. 
created the figures. Y.Z. provided help with the figures and advice on all sections 
of the manuscript. J.D. gave guidance throughout the writing and editing process. 
All 5C sections were added by E.M.S. 
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Abstract 
 
Chromosome Conformation Capture, or 3C, is a pioneering method for 
investigating the three-dimensional structure of chromatin. 3C is used to analyze 
long-range looping interactions between any pair of selected genomic loci.  Most 
3C studies focus on defined genomic regions of interest that can be up to several 
hundred kilobases (kb) in size. 5C, or chromosome conformation capture carbon 
copy, is a method based on 3C technology. 5C utilizes deep sequencing 
technology to investigate a larger genomic region (up to a few Megabases (Mb) 
in size) in depth. The methods have become widely adopted and have been 
modified to increase throughput to allow unbiased genome-wide analysis.  Here 
we describe the 3C and 5C procedures in detail, including the appropriate use of 
the technology, the experimental set-up, an optimized protocol and 
troubleshooting guide, and considerations for data analysis. 
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Introduction 
 
Chromosomes form intricate three-dimensional structures inside the 
confined cell nucleus. This organization is thought to play roles in many, if not all, 
aspects of genome regulation, including gene expression, DNA replication, 
chromosome transmission and maintenance of genome stability (Cremer and 
Cremer, 2001; Miele and Dekker, 2008; Misteli and Soutoglou, 2009). Gene 
expression in particular is profoundly dependent on chromatin folding, where 
looping interactions facilitate long-range control by distant gene regulatory 
elements (Dean, 2011; Dekker, 2008a; Miele and Dekker, 2008).  Furthermore, 
at the nuclear level, groups of active genes are found clustered around sub-
nuclear structures enriched in transcription and splicing machineries (Fraser and 
Bickmore, 2007). Similarly, inactive regions of the genome are found in clusters, 
e.g. around polycomb bodies (Bantignies et al., 2011) and at the nuclear lamina 
(Guelen et al., 2008).  
Chromosome structure and nuclear organization have been studied 
extensively for over a century, using an expanding array of technologies that 
allow observation of chromosome folding at increasing resolution. Currently, two 
types of approaches are being used. First, microscopic studies allow study of 
chromosome structure and chromatin dynamics in single cells.  Recent 
technologies using GFP-tagged DNA binding proteins allow the visualization of 
the positions and movements of defined loci inside living cells (Belmont, 2001). 
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Recent developments in optics and image analysis have increased the resolution 
with which the relative sub-nuclear positions of loci can be determined. A second 
category of technologies employs molecular and genomic approaches to obtain 
information on average chromatin folding for large populations of cells (van 
Steensel and Dekker, 2010). This set of approaches is based on the 
Chromosome Conformation Capture technology (3C), developed over a decade 
ago (Dekker et al., 2002). 3C-based technologies allow the detection of the 
relative frequency of interaction between any pair of loci in the genome. From 
these interaction frequencies the folding of chromatin can be inferred. For 
instance, frequent interactions between two distant genomic loci point to the 
presence of a chromatin loop (Dekker, 2006). The resolution of 3C is determined 
by the choice of restriction enzyme, but is usually in the range of several kb, 
significantly higher than achievable by light microscopy. Resolution of other C-
based methods is limited only by deep-sequencing capabilities. 
Application of 3C has identified direct and non-random looping interactions 
between distant parts of the linear genome, including physical contacts between 
enhancers and their distal target genes (Miele and Dekker, 2008). Further 
application of 5C has led to the notion that genomes are organized in complex 
spatial networks via looping interactions that often are cell-type and condition-
dependent and directly related to long-range gene control (Nora et al., 2012; 
Phillips-Cremins et al., 2013; Sanyal et al., 2012). 
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3C and its offspring of variants including 4C (circular chromosome 
conformation capture) (Simonis et al., 2006; Zhao et al., 2006), 5C (chromosome 
conformation capture carbon copy) (Dostie et al., 2006), ChIA-PET (Fullwood et 
al., 2009) and Hi-C (Lieberman-Aiden et al., 2009), are all based on the same 
basic principle of capturing and detecting long-range chromatin interactions and 
have 4 common steps (Figure 2.1A): 1) Chemical cross-linking of chromosomes 
to covalently link chromatin segments that are in close spatial proximity; 2) 
Fragmenting the solubilized  genome into small pieces, usually by digesting it 
with a restriction enzyme; 3) ligation of linked DNA fragments under diluted 
conditions where intra-molecular ligation is strongly favored over inter-molecular 
events; and 4) detection and quantification of ligation products. The various 3C-
based methods differ mostly in how ligation products are detected.  In the case of 
3C, ligation products are detected one at a time by PCR using locus specific 
primers (Figure 2.1B).  5C uses a multiplexing approach to increase the number 
of interactions (ligation products) that are detected in parallel, thereby increasing 
the throughput of the assay (Figure 2.2) (Hakim and Misteli, 2012; Sanyal et al., 
2011, 2012; van Steensel and Dekker, 2010). 
 The 3C procedure produces a comprehensive library of ligation products 
representing chromatin interactions throughout the entire genome.  However, 
because interactions in standard 3C experiments are detected one at a time, a 
typical 3C analysis is usually limited to interrogation of at most hundreds of pair-
wise interactions and is focused on the detection of looping interactions in 
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relatively small regions - from 10kb up to 1Mb (Gheldof et al., 2006, 2010; 
Tolhuis et al., 2002). 5C expands upon 3C by using multiple probes to detect an 
increased number of pair-wise interactions in one experiment. 3C and 5C are 
mainly used in hypothesis-driven experiments, designed based on some prior 
knowledge such as the genomic locations of functional elements of interest. 5C is 
more amenable to experiments where less is known about a particular locus, 
since the design of multiple probes throughout the region allows more of a 
search mode than 3C. 
Whereas subsequent 3C-based methods (4C, 5C and Hi-C) were 
designed to increase the throughput of interaction detection, 3C has remained a 
critical technique that is commonly used for fine scale analysis of genomic 
regions of interest. 3C has been used to study chromatin folding in a range of 
organisms, ranging from bacteria, yeast and plant to human. In the original study 
performed on S. cerevisiae, 3C was used to measure changes of inter-
chromosomal contacts between centromeres and homologous chromosomes 
during meiosis, and to determine the overall population average three-
dimensional conformation of chromosome III (Dekker et al., 2002). Since then, 
3C has been applied mostly to study the interactions between genes and distal 
regulatory elements such as enhancers. The first such study demonstrated 
physical contacts between the β-globin genes and the Locus Control Region 
(LCR), which is known to strongly activate these genes (Tolhuis et al., 2002). 
Many more examples of such looping interactions have now been described, 
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indicating that chromatin looping is a general mechanism of gene control in 
higher eukaryotes (Miele and Dekker, 2008; Sanyal et al., 2012). 3C was also 
used to discover that looping interactions between the LCR and the globin genes 
require several transcription factors, including GATA1 and EKLF1, and some 
require the CTCF protein (Drissen et al., 2004; Splinter et al., 2006; Vakoc et al., 
2005).  
Currently, 3C is mostly used for targeted analysis of loci of interest, to 
identify long-range interaction between candidate genes and regulatory 
elements, and to probe how these interactions change upon perturbations such 
as knockdown of specific chromatin factors thought to mediate chromatin folding.  
Another emerging application is to link regions identified as playing a role in 
disease by genome-wide association studies (GWAS) to other genomic loci.  
GWAS studies often identify regions devoid of genes, but containing putative 
gene regulatory elements. 3C is now being used to identify potential target genes 
located around the GWAS region that physically interact with the GWAS regions, 
or the regulatory elements located within it (Ahmadiyeh et al., 2010; Davison et 
al., 2012; Wright et al., 2010).  
5C is used to gain high-resolution data of a large genomic region that is 
not yet obtainable by HiC or other deep sequencing methods. The 5C technique 
allows high-resolution analysis of larger genomic regions on the scale of a few 
megabases to entire chromosomes (Dostie et al., 2006). 5C has been used to 
analyze the interactions of transcription start sites with potential regulatory 
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elements in 14 genomic regions of the ENCODE project (Sanyal et al., 2012). 5C 
was done on the entire X chromosome in mouse and revealed the presence of 
Topologically Associating Domains (TADs) along the entire chromosome, and 
also showed that the boundaries between two of these domains changed when 
the XIST locus was removed (Nora et al., 2012). It was recently shown that, 
though TAD structures seem invariant between cell lines, sub-TAD looping 
interactions are cell-type specific and change during cell differentiation (Phillips-
Cremins et al., 2013). The 5C method is currently the ideal technique to look at 
large genomic regions (or many different regions at the same time) with a 
resolution of tens of kb. In the future, it is likely that deep sequencing costs will 
no longer be restrictive and 3C libraries can be directly sequenced. Until that 
time, 5C remains the go-to technique for directed 3D looping studies.  
Here we discuss in detail the principles of the 3C and 5C methods, paying 
special attention to experiment design and data analysis. We present an updated 
protocol for performing 3C analysis in mammalian cells and discuss potential 
pitfalls. The presented protocol can be easily adapted for many other organisms. 
Further, we build on our years of experience to describe troubleshooting 
solutions and to identify critical issues related to the planning, execution, and 
interpretation of the experiments. 
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Figure 2.1: Method Overview with Details of Ligation. A) An illustration of the 
3C method. Genomic DNA is crosslinked (1), capturing three-dimensional 
interactions inside the cell. After cell lysis and removal of cell membranes, the 
captured chromatin is solubilized and digested (2), isolating protein-DNA 
complexes from the chromatin network. The free DNA ends are then ligated 
together (3) in dilute conditions favoring intra-molecular ligation, creating new 
DNA junctions representing the proximity of restriction fragments in the fixed 
sample. After ligation, the crosslinks are reversed (4) and 3C template is purified 
to eliminate cellular debris. Finally, the ligation products are detected (5) using 
PCR-based methods.  After quantification (6) the results are plotted as a 3C 
profile (7), revealing interactions between anchor (labeled “A”) and all other 
fragments in the genomic regions, which mirrors 3D spacing in the nucleus. 
B) Possible outcome of ligation reaction between two restriction fragments. As 
seen in part A, there are many restriction fragments contained within one 
complex. To further understand the ligation step, we have simplified the reality 
and show a view where one complex contains only two restriction fragments - red 
and blue. The 5’ and 3’ ends are indicated for each strand. Each digested end 
has been numbered 1-4. Also indicated are the locations where 3C primers have 
been designed. Note that all the primers are on the “forward” strand, located near 
the restriction site. There are six possible ligation products that result from this 
molecule. Two of these produce self circles, which are not of interest. Only one of 
the remaining four ligation products results in a detectable product - that is when 
end 2 and end 4 are ligated to each other. This ligation event will bring the 
primers into the proper orientation to produce a PCR product. None of the other 
ligation products will be detected.   
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Figure 2.2: Preparation of the 5C Library. A) Method describing the steps 
creating a 5C library. 1. 5C probes are annealed to a 3C template exactly at the 
restriction site of the 3C template. 2. 5C probes are nick ligated and the purified 
from the 3C template. 3. The 5C library is prepared for sequencing by addition of 
specific sequencing primers. B) Sample 3C template used to create a 5C library. 
Two replicates (reps) of the cell line Capan1 are shown. C) 5C libraries created 
using the Capan1 3C templates. Note the increase in product upon increase in 
probe concentration. Equally important is the absence of a band in the control 
lanes, indicating the 5C library is not contaminated. D) Snapshot from the USCS 
genome browser showing the 5C probe design. Blue indicates the presence of a 
forward-facing probe, and red indicates the presence of a reverse-facing probe. 
The probe design incorporates the ENCODE region Enm001 with an additional 1 
Mb downstream. There are 12 genes contained in this region.  
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Technical Overview of the Methods 
 
 In this section we provide a discussion of the steps of 3C and 5C, paying 
particular attention to the molecular biology behind the method. The basic steps 
of 3C are: 1) formaldehyde crosslinking, 2) digestion with a restriction enzyme, 3) 
intra-molecular ligation, and 4) ligation product detection via PCR-based methods 
(Figure 2.1A). 5C builds off the 3C template by 1) annealing probes to the 3C 
template, 2) ligating and purifying the probes, and 3) prepping the 5C library for 
deep sequencing (Figure 2.2A).  
 
Formaldehyde concentration and fixation time 
Formaldehyde concentration and time of fixation affect 3C-based 
experiments and need to be standardized to facilitate accurate comparison 
between samples. Fixation conditions can be different for different species and 
are defined by chromatin properties, presence of a cell wall etc. We crosslink 
mammalian cells with 1% formaldehyde for 10 minutes at room temperature. 
Other groups have reported using 2% formaldehyde for 10 minutes (Tolhuis et 
al., 2002).  3C experiments in Drosophila embryos were successfully performed 
with fixation with 3% formaldehyde for 30 minutes at 25oC (Comet et al., 2011). 
Intact yeast cells should be fixed with 3% formaldehyde for 10 minutes (Belton, J-
M. and Dekker, J., unpublished), but yeast spheroplasts are fixed with 1% 
formaldehyde for 10 minutes (Dekker et al., 2002). 
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Changing fixation conditions affects the amount and density of protein-
DNA cross-links, which in turn affects the efficiency of restriction digestion and 
thus the size of DNA-protein complexes. Inefficient formaldehyde cross-linking, 
caused by using a low concentration of formaldehyde or a too short of an 
incubation time, may lead to a failure to capture looping interactions. Over-fixed 
chromatin will make digestion very inefficient, leading to large DNA fragments 
and low PCR signals. Optimal conditions can be determined experimentally by 
performing 3C using a range of formaldehyde concentrations. An appropriate 
formaldehyde concentration will lead to readily detectable and abundant ligation 
products for fragments separated only a few kb.  When analyzing cells in tissues 
or organs, it is recommended to first dissociate these materials, e.g. with 
collagenase, into single cells prior to fixation (e.g. (Montavon et al., 2011)). 
 
Digestion with Restriction Enzymes 
 The second step of 3C involves digesting the crosslinked chromatin with a 
restriction enzyme. We recommend using restriction enzymes that recognize and 
cut 6 bp sites when possible (“6-cutter”) for overnight digestion. The amount of 
enzyme in the reaction can be increased if higher digestion efficiency is required 
(at least up to 5-fold). 
Protein complexes crosslinked to DNA may block restriction sites and 
reduce efficiency of restriction digestion. For instance, efficiency of yeast and 
mammalian chromatin digestion is around 70-75% on average as was measured 
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by PCR with primers located across restriction sites (Gheldof et al., 2006, 2010; 
Sanyal et al., 2012; Tolhuis et al., 2002). 
Inactive and condensed chromatin is generally less accessible to 
nucleases than active and open chromatin, and this might confound 3C studies. 
Importantly, 3C analyses have been found to be not, or only to a very limited 
extent, affected by this intrinsic difference in chromatin compaction. Several 
studies directly determined the digestion efficiency in the context of a 3C 
experiment of actively transcribed accessible loci and of repressed, methylated 
and condensed loci. Digestion efficiency was found to be unaffected (Gheldof et 
al., 2006; Kim et al., 2009; Tolhuis et al., 2002), as chromatin digestion in 3C is 
performed after chromatin is partly denatured in the presence of 0.1% SDS and 
brief incubation at 37°C, which removes proteins that are not cross-linked from 
DNA and partly denatures cross-linked proteins. This dramatically increases 
accessibility of DNA. Efficiency of restriction digestion can be easily determined 
by PCR using primers on either side of restriction sites (Figure 2.3). We 
recommend saving a small aliquot of chromatin directly after digestion (and 
before ligation) for this analysis if desired.  
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Figure 2.3:  Analysis of Restriction Efficiency of the Chromatin Sample. 
Restriction efficiency in a given site is estimated by PCR as a ratio between a 
PCR product obtained with internal primers 1 and 2 versus primers across the 
restriction junction 1 and 3. Note that both PCR products should be of similar 
length to be synthesized simultaneously by the same program.  The ratio 
obtained from digested unligated sample should be corrected by the PCR with 
the same pairs of primers performed on naked uncut genomic (or BAC) DNA. 
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Ligation and Reversal of Crosslinking 
 The third step involves DNA ligation. This step is performed at low DNA 
concentrations to strongly favor intra-molecular ligation of cross-linked chromatin 
fragments over background inter-molecular ligation between fragments that are 
not cross-linked. Intra-molecular ligation is kinetically fast, obviating the need for 
prolonged ligation times. The ligation time should be kept at a minimum, to avoid 
increasing the level of background ligations. After ligation, the cross-links are 
reversed by heating at 65°C in the presence of proteinase K. The 3C ligation 
product library is then purified and is ready for analysis. The library can also be 
used as a template for 5C experiments at this stage.  
 
Detection of Ligation Products 
The final step of 3C is the detection and quantification of ligation products, 
representing long-range chromatin interactions. For this step, locus-specific 
primers are designed to specifically amplify ligation junctions. PCR amplicons are 
typically around 200 bp in size to facilitate efficient amplification. Both end-point 
PCR and quantitative real-time PCR (qPCR) have been employed to quantify the 
abundance of 3C ligation products, with very comparable results (e.g compare 
regular 3C data for the beta-globin locus described in Tolhuis et al. (Tolhuis et 
al., 2002) with 3C-qPCR data for the same region described in Splinter et al. 
(Splinter et al., 2006). In both cases one needs to carefully titrate the amount of 
3C ligation product library to ensure amplification and quantification is in the 
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linear range. In addition, controls should be included to correct for any biases in 
PCR primer efficiency. These controls are described below. 
 
Annealing 5C probes to the 3C template 
 The first step in creating a good 5C library is to start with a good 3C 
template (described above). The 3C template is the basis of the 5C library. Once 
a good 3C template is obtained, the 5C probes are annealed to the 3C template. 
5C probes are designed to anneal exactly at the restriction sites of the ligated 3C 
template (Figure 2.2A). The 3C template and 5C probes are mixed together and 
heated to 95˚C for 9 minutes. The temperature is then dropped to 55˚C by 1˚C 
per minute and maintained overnight.  
 
Ligating and purifying the 5C library 
 Once the 5C probes are annealed to the 3C template, they are ligated to 
each other via a nick ligase (Figure 2.2A). The 5C library now consists of ligated 
probes annealed to the 3C template. This ligated library is amplified via universal 
PCR. Finally, the 5C library is separated from the 3C template via gel purification.  
 
Preparing the 5C library for sequencing 
 Specific tails must be added to the 5C library to prepare it for sequencing. 
First, “A” bases are added to the 5C probes to allow for the attachment of 
sequencing tails. Second, the sequencing adapters are added (in our case, we 
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use paired end (PE) adapters for sequencing with the Illumina platform) (Figure 
2.2A). The 5C library is gel purified and then amplified before finally being sent 
for sequencing.  
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Experimental Design Considerations 
 
 When embarking on a 3C or 5C analysis, one needs to carefully plan the 
design of the experiment. Here we describe important considerations related to 
selection of the genomic regions for analysis, the inclusion of a control region, 
the choice of restriction enzyme and the design of PCR primers and 5C probes. 
 
Choosing the region of interest and a control region  
The first step in setting up a “C” experiment is to identify a unique 
region(s) to investigate. For 3C, the size of a region is limited firstly by the 
desired resolution, determined by the restriction enzyme, and secondly by the 
amount of PCR reactions one can perform, which is related to the amount of 3C 
library one can obtain for the cells of interest. The typical size of a region that can 
be comprehensively studied by 3C ranges from tens to hundreds of kb, although 
longer-range interactions have been studied (Amano et al., 2009; Wright et al., 
2010), as well as interactions between chromosomes (Bacher et al., 2006; 
Spilianakis et al., 2005; Xu et al., 2007).1 5C experimental regions can be much 
larger, extending from a few megabases to entire chromosomes (such as X and 
                                               
1Signal to Noise:  3C signals typically decay with genomic distance.  As a result the signal to 
noise ratio decreases with increased distance between two interrogated loci, which usually limits 
3C analysis to regions up to 1Mb. Other 3C-based techniques do not have this limitation because 
they employ binned data, where the signal is determined by all interactions within the bin and not 
by a single point, as in 3C. 
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chromosome 21 (Nora et al., 2012; Sanyal et al., 2012) and unpublished data, 
Dekker Lab).  
When one intends to compare the folding of a locus of interest in different 
cell types, or under different conditions, it is important to choose a separate 
control region.  This region needs to be selected based on prior knowledge that 
suggests that the region is similarly organized in the selected cell types or 
conditions. 3C interactions determined throughout this region are assumed to be 
the same and thus can be used as an internal data set to quantitatively normalize 
the 3C data obtained for the region of interest in the different cell types or 
conditions. We advise the use of gene-poor regions (or so called gene deserts), 
although a locus with house-keeping genes has also been successfully used 
(Gheldof et al., 2006). 5C analysis benefits from the inclusion of a “gene desert” 
region as well, though it is not always necessary.  
 
Choosing an appropriate restriction enzyme 
Restriction enzymes are used to digest crosslinked chromatin. Once the 
chromatin is digested, it is ligated to create a 3C template. The choice of 
restriction enzyme to use in a “C” experiment is highly dependent on the goal of 
the experiment and the region selected for analysis. Several points should be 
kept in mind when selecting a restriction enzyme. 
 
Desired Resolution 
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The resolution at which interactions can be mapped is primarily 
determined by the size of the restriction fragments and thus the choice of the 
restriction enzyme. We recommend using a restriction enzyme that recognizes a 
6 base-pair sequence cut site, such as EcoRI or HindIII. Such enzymes will cut 
the genome approximately once every 4 kb (although a wide variety of fragment 
sizes ranging from 100s of base pairs to 10s of kb will be obtained), resulting in 
around 1 million restriction fragments in the human genome. In some cases, 
higher resolution is desired. For instance, after initial 3C analysis with a “6-cutter” 
enzyme, one might want to map the location of an interacting element more 
precisely. “Fine-mapping” can be achieved by using a “4-cutter” restriction 
enzyme, which cuts on average every 256 base pairs, giving approximately 
16,000,000 fragments of the human genome.2 
 
Proper Position of Cut Sites 
It is desirable to choose a restriction enzyme which has a more or less 
equal spacing of cut sites across the analyzed region. Fragments that are too 
short or too long should be excluded from the primer design, as they can 
introduce biases to the data.3 Thus, fragments less than 1 kb or greater than 10 
                                               
2Desired Resolution of Restriction Enzymes. The complexity of the 3C library (i.e. number of 
potentially formed ligation products) is determined by the restriction enzyme, and can impact the 
reliability of PCR detection and quantification of individual ligation product.  The complexity of the 
library obtained with a “4-cutter” restriction enzyme will be greatly increased as compared to a 
library generated with a “6-cutter”. 
 
3Exclusion of Restriction Fragments:  We have found that very large, and very small fragments 
can sometime yield aberrant interaction frequencies.  This might be due to differences in intra-
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kb should be excluded when using a “6-cutter.” In addition, when prior knowledge 
of positions of putative interacting elements is available, e.g. by the presence of 
histone modifications indicative of the presence of an enhancer or promoter, one 
can select a restriction enzyme that cuts the region in appropriate fragments that 
separate these elements from flanking regions, thus leaving elements of interest 
intact.  
 
Digestion Efficiency 
Not all restriction enzymes perform equally well in 3C. The reason for this 
is that digestion is performed in sub-optimal buffer conditions containing 
considerable concentrations of detergents. We have found that EcoRI, HindIII, 
BglII, XhoI, AciI, and BsrGI digest cross-linked chromatin efficiently, typically 
reaching 70% of digestion of each restriction site (although the region selected 
for analysis can change the digestion efficiency).  Enzymes that produce 
staggered ends are recommended, as these ends are more efficiently ligated. 
Enzymes that generate blunt ends can be used as well, but ligation efficiency is 
somewhat reduced.  
 
3C Primer Design 
                                                                                                                                            
molecular ligation efficiency for very long DNA fragments.  Therefore, we recommend avoiding, if 
at all possible, very long (>10Kb) restriction fragments. 
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In a 3C experiment any pair of interacting loci can lead to formation of six 
different ligation products (Figure 2.1B). Two of the resulting products are self-
circles, which occur when a restriction fragment is ligated to itself. The other four 
combinations occur when two different restriction fragments are ligated to each 
other in various orientations. In a typical 3C experiment primers are designed to 
detect only one of the four ligation products between the two fragments. In order 
to detect a ligation product between two different fragments, PCR primers should 
be placed in an orientation indicated by the asterisk in Figure 2.1B. In this section 
we describe primer design and common physical properties of 3C primers. 
 
Primer design in the region of interest 
3C primers are designed for all restriction fragments of interest. For 
correct interpretation of the data it is important to not only interrogate interactions 
between pairs of loci of interest, but to obtain a more comprehensive interaction 
profile throughout the region. In general this profile will show an inverse 
relationship between interaction frequency and genomic distance (Figure 2.4). A 
looping interaction is then inferred when a peak on top of this overall profile is 
observed (Dekker, 2006; Sanyal et al., 2012). 
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Figure 2.4: Representation of Final 3C Data. Figure adapted from Gheldof et 
al. Figure 1 (Gheldof et al., 2010). Plotted here is sample 3C data from Gheldof 
et al., 2010 for two cell lines. Above the graph is a schematic of the two genes 
covered in this data set. Each data point represents the average of three 
technical replicates and three normalized biological replicates. The cell lines 
were normalized to each other before they were plotted on the same graph. The 
data is plotted as relative interaction frequency versus genomic distance. The 
grey bar represents the anchor fragment. Note that as the genomic distance 
increases, the interaction frequency of both cell lines generally decreases. In cell 
line B, for example, this relationship is clear throughout the whole profile. Note 
four areas of high interaction frequency in cell line A. These four regions stand 
out as peaks, and represent locations in the genome that are close to the anchor 
point in three-dimensional space. 
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An example of a 3C experiment determines whether a given genomic 
element, for instance a gene promoter, is engaged in a long-range interaction 
with one or more distally located elements, such as enhancers. When the 
positions of these distal elements are not known, one designs 3C primers for the 
promoter and all restriction fragments throughout the region under study. If the 
location of putative distal elements is known, one designs primers for the 
corresponding fragments, but also for a number of flanking fragments located in 
between the promoter and the distal elements to obtain a larger interaction 
profile. If flanking regions are excluded, one cannot conclude which fragment 
contains the actual point of looping contact. 
 
Primer design in the control region 
As described above a control region is included in 3C studies to allow for 
comparison of 3C data obtained in different cell types or conditions. We 
recommend designing several primers throughout the region, so a control 3C 
interaction profile can be obtained that covers a similar genomic distance as that 
obtained in the region of interest. 3C primers are designed for at least 10 
different restriction fragments spaced at various distances.  
 
Direction of the primers 
We strongly encourage researchers to use a unidirectional 3C primer 
design. In such a design all primers are oriented in the same direction, on the 
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same DNA strand, along the chromosomal region of interest. All pairs of primers 
will amplify ligation products that are the result of head-to-head ligation of the 
corresponding restriction fragments. A unidirectional primer design is important 
because it avoids amplification of non-informative ligation products (Figure 2.5). 
First, when primers are used that point away from each other in the linear 
genome one runs the risk of accidentally amplifying a self-ligated partial digestion 
product. Second, primers for two directly adjacent restriction fragments that point 
towards each other in the linear genome sequence will produce a PCR product 
even when the restriction site between them was never cut in the 3C experiment. 
 
Physical properties of the primers 
To increase specificity of the primers we recommend designing long primers with 
high melting temperature (on average the Tm is 90°C); the length of 3C primers 
is 28-30bp with a GC content of ~50%, preferably carrying a single G or C 
nucleotide on the 3’ end. We have found that the use of rather long primers is 
especially important for complex genomes, where short 20bp primers do not 
provide necessary specificity and efficiency. Primers are designed ~80-150bp 
away from the restriction cut site so that the predicted amplicon will be between 
160 and 300bp in size.  We recommend checking the uniqueness of each 
primer.4  
                                               
4Checking Primer Uniqueness:  We recommend using both BLAST and BLAT for checking 
uniqueness of 3C primers as those programs have different algorithms of searching for a match 
in a genome. BLAT works much quicker, however BLAST gives more comprehensive results. It is 
also possible to check if primers have strong secondary structures (hairpins) and form stable 
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5C Probe Design 
 Once the region(s) of interest are selected, one must design probes. 
There are two general types of probe design: an alternating scheme, where the 
investigator is not searching for particular interactions but is interested in the 
general properties of the region, and a targeted scheme, where the investigator 
is looking for specific interactions in the region. An alternating scheme places 
forward and reverse probes throughout the region in an alternating pattern. This 
scheme produces a data set with complete coverage of the region and is useful 
for identifying unknown looping interactions. An example of a targeted scheme is 
shown in Figure 2.2D . Here, reverse (anchor) probes are located on every 
transcription start site (TSS) in the region, with forwards situated throughout. This 
probe scheme is attempting to discover which genomic elements loop to gene 
promoters and act as regulators.  
 
Probe design in the control region 
We suggest the use of an alternating scheme for probes located in the 
control region. An alternating probe design placed forward probes and reverse 
probes in alternating restriction fragments. This produces an unbiased view of 
the region and provides plenty of reads to use during normalization procedures.  
                                                                                                                                            
homodimers. Primers should also be checked for formation of heterodimers with anchor primer. 
Free online tools such as IDT oligo analyzer 
(http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/) can be used for this analysis. 
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Figure 2.5: Unidirectional vs Mixed 3C Primer Design and Types of 
Interactions Detected in 3C Library. A) Unidirectional primer design: all 3C 
primers are designed to the same strand of DNA; B) Mixed primer design: some 
primers in the set are designed to the opposite strand of DNA. Unidirectional 3C 
primers will only detect real looping interactions when distant regions of the linear 
genome are brought together by protein complexes C). In the shown example 3C 
molecules resulted from cut and ligation between end 2 of the anchor fragment A 
and end 4 of restriction fragment 4 will be detected by PCR. Note that such a 
ligation product can be formed only when anchor A and fragment 4 are 
crosslinked together. In the case when digestion is inefficient, undigested loops 
D) or long multi restriction fragment self-circles E) can be formed. These 
structures will be detected only when using a mixed primer design when 3C 
primers in the anchor (A) and a fragment on the other end of the DNA molecule 
(here restriction fragment 4) are designed to the opposite strands. Both 
structures will not be detected with unidirectional 3C primers.   
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However, an alternating scheme can eat up reads, so instead of placing a 
forward and reverse prove on every restriction fragment, we suggest skipping 
one or two fragments in between probes to reduce the amount of reads in this 
region. 
 
Physical properties of the probes 
5C probes can be designed at the My5C website 
(http://my5C.umassmed.edu) (Lajoie et al., 2009). Probes are 40 bp in length. If a 
shorter sequence is sufficient to obtain a predicted annealing temperature of 
65 °C, random sequences can be added to make a total of 40 bases. All of the 
5C probes have an extension of universal tail sequences at the 5′ end for forward 
5C probes and at the 3′ end for reverse 5C probes. DNA sequence of the 
universal tails of forward probes is 5′-CCTCTCTATGGGCAGTCGGTGAT-3′; 
DNA sequence for the universal tails of reverse probes is 5′-
AGAGAATGAGGAACCCGGGGCAG-3′.  
 
Creating a Control Library for 3C  
3C employs PCR with locus-specific primers, which may amplify their 
target ligation product with different efficiencies, even when great care is taken to 
design primers. It is therefore critical to correct for this differential primer 
efficiency. This can be done by PCR analysis of a control library that contains all 
interrogated ligation products in equimolar amounts. Any differences in PCR 
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product formation obtained by pairs of 3C primers with this control library as 
template can then be used to estimate primer pair efficiency.   
A control library is prepared by digesting and randomly ligating non-
crosslinked purified DNA. For small genomes (yeast, bacteria, fly) the control 
library can be generated using purified genomic DNA. For larger genomes, such 
as mouse or human, a genome-wide random control library is too complex to 
allow reliable detection of individual ligation products. For these organisms the 
control library can be made from one or more bacterial artificial chromosomes 
(BACs) that span the genomic region(s) investigated by 3C, including the control 
region (e.g. (Dostie et al., 2006)). When multiple BACs are used they should be 
selected so that they display minimal overlap while simultaneously keeping the 
number and size of gaps to a minimum. This ensures minimal over- or under- 
representation of genomic regions in the control library. If BACs are unavailable 
for a genomic region, they might be substituted with fosmids, cosmids or even 
plasmids. The control library is then generated by mixing the clones in equimolar 
amounts and digesting the DNA followed by random intermolecular ligation.  
 
Determination of Interaction Frequencies 
It is important to first determine the optimal amount of 3C library to use in 
each PCR reaction. This amount has to be found experimentally for each 3C 
library in a titration experiment (Figure 2.6). To build a titration curve, a series of 
PCR reactions with a single pair of 3C primers and different amounts of input 3C 
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template must be done. Table 1.1 gives examples of pairs of 3C primers which 
were successfully used in our lab for the titration of human and mouse libraries. 
We recommend selecting the library concentration from the middle of a linear 
region of an amplification curve in order to avoid both saturation of a signal (at 
high library concentrations) and loss of a signal (at low library concentration).    
Next PCR reactions are performed with each primer pair, using both the 3C 
ligation product library and the control ligation product library as a template. The 
relative interaction frequency of a pair of loci is then calculated by dividing the 
amount of PCR product obtained with the 3C ligation product library by the 
amount of PCR product obtained with the control library (see data analysis). By 
calculating this ratio one effectively normalizes for differences in primer 
efficiency. Since the control library is used to normalize for primer efficiency, 
reactions for each primer pair should be performed in both templates 
simultaneously, to reduce PCR variation as much as possible. Given that the 
control library contains all ligation products in equimolar amounts, all primer pairs 
should yield similar, though not identical, amounts of PCR products. When a pair 
of primers fails to amplify any product, or a product with the wrong size, these 
primers should be discarded and new primers should be designed (Figure 2.7). 
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Figure 2.6: Examples of Final 3C Library and Titrations. A) An example of a 
completed 3C template run on a 0.8% agarose gel in increasing concentration. 
The main band of the template should run above 10 kb. There should be a 
minimal amount of smear underneath the band. If no band is seen, the template 
cannot be used for downstream analysis. B, C) Titrations of a control template 
(BAC) and an experimental template (mammalian cell line). Each band is present 
in duplicate. The upper gel represents ligation products from neighboring 
restriction fragments. These fragments are close together in both linear and 
three-dimensional distance, thus giving a strong signal in both the control and 
experimental templates, even at low template concentration. The lower gel 
represents ligation products from distal restriction fragments. These fragments 
are far apart in the linear genome and far apart in three-dimensional distance as 
well. The control template shows no difference between the neighboring and 
distal fragments, indicating there is no distance bias. In contrast, the 
experimental library shows a marked decrease of interaction frequency using the 
distance primers, which indicates that those fragments are indeed far apart in 
both linear and three-dimensional space. D,E) Graphs showing the quantification 
of gel bands from B and C. As described above, there is no difference in gel 
band intensity in the control template, while there is a difference in the 
experimental template. The dashed red lines indicate the shoulder of the graphs. 
When conducting the final 3C experiment, the working concentration in each 
PCR reaction should be chosen based on the concentrations in this area of the 
graph. Using too high or too low of a concentration will skew results. 
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Human 
EcoRI Distant 57 kb Runx1-14 AAAGTTCTCACGCACCGACTGAA
CACTCCA 
Runx1-18 GCCTGGGGTGTACCCACTTTCTA
TGGATAT 
Distant 37 Kb GD8 GCAGCAAAGCAAACCAAAAGAAC
AACAGG 
GD14 GTCGCCGTTGCCTTTGCAGTTTA
CAGTG 
Neighbors - GD6 GTTTAAGACCCTCAGTATACTAGT
CATAGAAGG 
GD7 GATGCCATTTCTTATCTTGTCTTG
GCAGGTC 
HindIII Neighbors - AHF64 GCATGCATTAGCCTCTGCTGTTC
TCTGAAATC 
AHF66 CTGTCCAAGTACATTCCTGTTCAC
AAACCC 
Mouse 
HindIII Neighbors - mGAPDH
_3 
TATCAAGGGTGCCCGTCACCTTC
AGCTTTC 
mGAPDH
_4 
GGGCTTTTATAGCACGGTTATAA
AGTGG 
 
Table 2.1: List of Example 3C Primers for Library Titrations.  
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Figure 2.7: Examples of Common 3C Problems. A) Quality of 3C template. 
Typically, an excellent 3C template runs as one tight band above 10kb in size on 
0.8% agarose gel (Lane 1).  A mediocre 3C template (Lane 2) looks like a tight 
band with a noticeable smear running down the gel. Usually smeary templates 
like this are successfully used in 3C experiments. Lane 3 shows a completely 
degraded template, which should be excluded from downstream analysis.  A 1kb 
ladder is shown in Lane L. B-E): Multiple bands problem and possible solutions. 
B) – Different pairs of 3C primers amplify several bands from a 3C template. 
There might be several reasons for that, which should be checked one by one.  
The first possibility is incomplete digestion of the chromatin (C). The figure 
represents the titration of a 3C template with same pair of primers (see the 
diagram on the left). The incomplete digestion results in two ligation products, 
with and without the blue restriction fragment, which are both detected by the 
same pair of 3C primers. If the size of the blue restriction fragment is relatively 
small, both ligation products could be amplified in the same PCR reaction. 
Usually severe incomplete digest, resulting in multiple extra bands of about same 
intensity as the “main” band (B), is seen in 3C templates made with a fine cutter 
restriction enzyme (one that recognized a 4-bp cut site). In this case one should 
consider re-making the 3C library with an increased amount of enzyme and 
elongated restriction time. The case presented in C is legitimate for further 
analysis. Next, if the size of the additional bands cannot be explained by 
incomplete digest, one should consider non-specific primer annealing. Note that 
even when a pair of primers amplifies one band of expected size from a (BAC) 
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control template, the more complex 3C template, made from the whole genome, 
might have additional sites for primer annealing. Simply increasing the annealing 
temperature in the PCR reaction can resolve the issue (D). If that’s not the case, 
the primer pair (or at least the non-anchoring 3C primer) should be re-designed 
(E). 
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3C Experimental Protocol 
 
Reagents required 
Buffers 
10X Ligation buffer 
500 mM Tris-HCl pH7.5 
100 mM MgCl2 
100 mM Dithiothreitol 
Autoclaved water 
--- Store 20ml and 1ml aliquots at -80°C 
 
1X Lysis buffer 
10 mM Tris-HCl pH8.0 
10 mM NaCl 
0.2% Igepal CA-630 (NP40) 
Autoclaved water  
--- Store at 4°C 
 
10X PCR buffer 
600 mM Tris, adjust to pH 8.9 with H2SO4, 
180 mM (NH4)2SO4 
--- Store 1ml aliquots at -20°C 
 
Reagents 
Saturated phenol, pH 6.6±0.2  *bring pH to 8.0 
Chloroform 
Formaldehyde, 37% by weight 
ATP 
Proteinase K (Fungal) 
Protease inhibitors 
T4 DNA ligase 
Amicon® Ultra – 0.5ml 30K 
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Creating a BAC control library (for use with complex genomes) 
Digestion of BAC genomic DNA: 
1. Digest the DNA in the following reaction overnight at 37°C with rotation 
10µg BAC DNA5                            
10X restriction buffer           
10 mg/ml BSA (100X)           
Restriction enzyme (up to 10% of total reaction volume) 
Water (up to 500µl) 
 
2. After digestion, add an equal volume of phenol (pH 8.0)/ chloroform (1:1), 
vortex for 30 seconds 
3.   Spin at 18,000 x g in a microfuge at room temperature for 5 minutes  
4. Transfer the upper (aqueous) phase to a new 2 ml tube and add 1/10 volume 
of 3M sodium acetate, pH 5.2, vortex briefly 
5.  Add 2.5 volume of ice-cold 100% ethanol and invert the tube gently 
6.  Incubate at -20°C for at least 15 minutes 
7.  Spin at 18,000 x g in a microfuge at 4°C for 20 minutes 
8.  Wash the pellet in 1ml of 70% ethanol 
9. Spin at 18,000 x g in a microfuge at 4°C for 15 minutes 
9.  Remove all supernatant 
10.  Briefly air-dry the pellet 
                                               
5 If using more than one BAC, combine them in equimolar amounts before digestion. 
Concentration of each BAC clone should be determined using qPCR with primers that recognize 
the common BAC vector backbone. 
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11. Resuspend the pellet in 44µl water and incubate at 37ºC for 15 minutes. 
Reserve 1µl of digestion product to run as a control on the final analytical 
gel. 
 
BAC DNA ligation 
12.  Prepare the ligation reaction as follows and incubate at 16°C overnight 
Digested BAC DNA                       43µl 
5X T4 ligase buffer                       12µl 
T4 DNA ligase      5µl 
Final total volume                         60µl 
 
13.  After overnight ligation, incubate at 65°C for 15 minutes to inactivate the 
ligase  
 
Purification of BAC genomic DNA control template 
14.  Add 140µl of water to the ligation to make the final volume 200µl 
15.  Add an equal volume of phenol (pH 8.0)/chloroform (1:1), vortex 30 seconds 
and then spin at 18,000 x g in a microfuge at room temperature for 5 minutes 
16.  Transfer the upper (aqueous) phase to a fresh 1.7 ml tube 
17.  Repeat phenol/ chloroform extraction once 
18.  Transfer the upper phase to a fresh 1.7 ml tube 
19.  Add equal volume of chloroform, vortex 30 seconds, then spin at 18,000 x g 
at room temperature for 5 minutes  
20.  Transfer the upper phase to a new 1.7 ml tube 
21.  Add 1/10 volume of 3M sodium acetate, pH 5.2, briefly vortex 
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22.  Add 2.5 volumes of ice-cold 100% ethanol and invert the tube several times 
23.  Incubate at -20ºC for at least 15 minutes 
24.  Spin at 18,000 x g in a microfuge at 4°C for 20 minutes 
25.  Wash the pellet in 1 ml of 70% ethanol, spin at 18,000 x g in a microfuge at 
4°C for 15 minutes 
26.  Briefly air-dry the pellet 
27.  Resuspend the pellet in 100µl of 1X TE, pH 8.0 
28.  Incubate at 37°C for 15 minutes 
29.  Store the 3C control template at -20°C.  This library can be stored for a few 
years. 
 
 
Creating a 3C library from mammalian cells 
Crosslinking of cells 
1. Centrifuge 1 x 10^8 cells at 300 x g for 10 minutes6 
2. Resuspend the cell pellet in 45 ml of fresh medium, mix by pipetting 
                                               
6 In cases, when primary cells [38], [39], [40] or siRNA treated cells [38] are being analyzed by 
3C, getting  10^8 cells might be very difficult. Several groups has successfully applied 3C to 2 – 
10 x 10^6 cells and in some of those studies the original protocol has been modified and we 
advice to refer to the original studies. In general, while working with primary tissues it is 
necessary to break down tissues by applying collagenase to single-cell suspension before cross-
linking [41].  Time of lysis can be increased for up to 2h  as well as treatment with SDS prior 
restriction can be more severe [39]. At last, one might want to use qPCR to quantify 3C signal 
[41].When number of cells is not an issue, we strongly recommend starting with large number of 
cells, so one would have enough material for making repeats in case it is needed.  
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3. Add 1.25 ml of 37% formaldehyde to obtain 1% final concentration and 
pipette to mix 
4. Incubate at room temperature for 10 minutes on a shaker 
5. Add 2.5 ml of 2.5M glycine to stop crosslinking 
6. Incubate at room temperature for 5 minutes and then on ice for 15 minutes 
7. Spin down at 4°C 800 x g for 10 minutes and remove as much supernatant 
as possible7 
8. Add 2 ml of cold Lysis buffer and 200 µl of 10X Protease Inhibitors to each 
pellet and resuspend it well on ice 
9. Incubate on ice for at least 15 minutes to let the cells swell 
10. Lyse the cells on ice using a Dounce homogenizer (pestle A). Use 10 slow 
strokes, then let the cells rest for 1 minute on ice. Complete lysis by applying 
10 more strokes 
11. Transfer to 2 microcentrifuge tubes, spin at 2,200 x g in a microfuge for 5 
minutes 
12. Wash each pellet with 1 ml of 1X NEB buffer 2 (or the buffer appropriate to 
your restriction enzyme, however do not use NEB4 as we have found it is not 
compatible with 3C buffers) and spin down at 2,200 x g in a microfuge for 5 
minutes 
13.  Repeat Step 12 once 
14.  Resuspend all the pellets from the same sample in 1 ml of 1X NEB buffer 
                                               
7 The experiment can stop at this point. Store the pellet at -80°C by incubating the pellet on dry 
ice for 20 minutes and then store at -80°C for up to at least two years. 
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Digestion 
15. Distribute the suspension over 20 1.7 ml microcentrifuge tubes, 50 µl per 
tube. (Optional) save 10µl of lysate for the chromatin integrity check. 
16. (Optional) Chromatin integrity control. Take 10 µl of lysed cells from the 
previous step. Add 50 μl of 1x NEB and 10 μl of Proteinase K (10mg/ml). 
Incubate for 30 min at 65°C. Purify DNA by single phenol-chloroform 
extraction without ethanol precipitation. Add 5 μl of RNAseA (10mg/ml) to the 
aqueous phase and incubate for 15 min at 37°C. Check quality of the sample 
by running it on 0.7% agarose gel. The sample is good if DNA is either stuck 
in the well or runs as a single high molecular weight band (>23 kb). 
17. Add 312 µl of corresponding 1X NEB buffer per tube.  
18. Add 38 µl of 1% SDS per tube and mix well by pipetting up and down, 
avoiding air bubbles 
19. Incubate at 65°C for exactly 10 minutes, then place on ice immediately8 
20. Add 44 µl of 10% Triton X-100 to each tube to quench SDS, mix well, 
avoiding air bubbles 
21. Add 400 U of the restriction enzyme (up to 10% total reaction volume) of 
choice to each tube, mix well 
22. Incubate at 37°C overnight with rotation 
 
Ligation and reverse crosslink 
                                               
8 This step removes proteins that are not crosslinked to the DNA. 
65 
 
23. Add 86 µl of 10% SDS to each tube, mix carefully to avoid making air 
bubbles 
24. Incubate at 65°C for 30 min to inactivate the enzyme. Place tubes on ice 
immediately after incubation 
25. Prepare the ligation cocktail master mix as follows (except ligase) and 
distribute 7.61 ml of cocktail to each of 20 pre-chilled 15 ml conical tube 
Ligation cocktail   per reaction                      
10% Triton X-100   745 µl                        
10X Ligation buffer   745 µl                        
10 mg/ ml BSA   80 µl                        
100 mM ATP   80 µl                        
Milli-Q water    5960 µl   
                     
26. Transfer each digestion product from Step 23 into each of the 15 ml conical 
tubes with ligation cocktail. Keep on ice. 
27. Add 50 U (10 uL) of T4 DNA ligase (Invitrogen) to each tube  
28. Mix by inverting the tubes several times and spin briefly  
29. Incubate at 16°C for 2 hours 
30. Add 50 µl of fresh 10 mg/ ml proteinase K solution per tube  
31. Mix by inverting the tubes several times and spin briefly 
32. Incubate at 65°C for 4 hours 
33. Add 50 µl of 10 mg/ ml fresh proteinase K per tube and continue incubating 
at 65°C overnight9.  
                                               
9 Alternatively, one can incubate overnight after the first proteinase K treatment, add the 
second proteinase K aliquot the next morning and incubate at 65°C for 2 hours 
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DNA Purification 
34. Transfer and combine reactions into 50 ml conical tubes, 20 ml per tube  
35. Add equal volume Phenol per tube, vortex for 2 minutes and spin at 3,000 x 
g for 10 minutes 
36. Transfer the aqueous phase to fresh 50 ml conical tubes 
37. Add an equal volume of Phenol (pH 8.0)/ Chloroform (1:1) to each tube, 
vortex for 1 minute and spin at 3,000 x g for 10 minutes  
38. Pool aqueous phases and distribute equally in new 50 ml conical tubes  
39. Add 1x TE buffer, pH 8.0 to a total volume of 50 ml per tube to prevent DTT 
from precipitating. 
40. Transfer each 50 ml pool to a 250-ml screw-cap centrifuge bottle that is 
suitable for high-speed spinning 
41. Add 1/10 volume of 3M sodium acetate, pH 5.2 per bottle, vortex briefly 
42. Add 2.5 volumes of ice-cold 100% ethanol per bottle, mix well by inverting 
the bottles several times 
43. Incubate at -80°C at least 60 minutes or overnight 
44. Spin at 12,000 x g for 20 minutes at 4°C (Make sure the mixture has thawed 
completely on ice before spinning down) 
45. Dissolve each pellet in 450 μl 1x TE buffer, pH 8.0 and transfer to a 15 ml 
conical tube 
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46. Wash the bottle with 450 μl of 1x TE buffer, pH 8.0 and transfer to the same 
tubes as in step 44. If dissolving is difficult, incubate samples at 65 °C no 
more than 10 minutes 
47. Add an equal volume of phenol (pH 8.0) to each tube and vortex for 1 
minute; then spin at room temperature at 3,000 x g for 5 minutes  
48. Transfer the upper aqueous phases to fresh 15 mL tubes 
49. Add equal volume of phenol (pH 8.0)/ chloroform (1:1), vortex 1 minute and 
spin at 3,000 x g for 5 minutes  
If the interfaces are clear, go to step 49; otherwise repeat step 48 once 
50. Transfer the aqueous phases into clean 1.7 ml centrifuge tubes (about 400µl 
per tube) 
51. Add 1/10 volume of 3M sodium acetate, pH 5.2, vortex briefly 
52. Add 2.5 volumes of ice-cold 100% ethanol, invert gently 
53. Incubate at -80°C at least 1 hour 
54. Spin at 4°C at full speed in a microfuge for 20 minutes 
55. Remove all supernatant and briefly air dry the pellets 
56. Dissolve each pellet in 500 µl of 1X TE buffer, pH 8.0 
57. Insert an Amicon ultra-0.5 30K device into one provided microcentrifuge tube  
58. Transfer DNA sample to the Amicon ultra filter device (up to 500 µl) and cap 
it 
59. Place the capped devices into the rotor of a microfuge, aligning the cap strap 
towards the center of the rotor 
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60. Spin at 18,000 x g for 5 minutes and discard the flow-through from the 
collecting tubes 
61. Add 450 µl of 1X TE to each filter device, spin at 18,000 x g for 5 minutes 
and discard the flow-through 
62.  Repeat wash step 3 times 
63. After the final wash, place the filter device upside down in a new provided 
collecting tube 
64. Place the tubes in centrifuge, aligning the cap strap towards the center of the 
rotor, spin at 1,000 x g for 5 minutes 
65. Transfer all collected DNA from the same sample to a 1.7ml centrifuge tube 
66. Add 1X TE to each sample to make a total volume of 1ml 
67. Add 1 µl of 10 mg/ ml of DNase-free, RNase A and incubate at 37°C for 15 
minutes 
68. Load 1 µl and 2 µl of 10X diluted template on 0.8% agarose/ 0.5X TBE gel, 
along with a sample of a 1Kb DNA ladder to check quality and quantity of the 
template 
69. Store the 3C template up to 2 years at -20°C (kept in aliquots) 
 
Determination of quantity and quality of 3C Libraries 
Before embarking on quantitative analysis of the 3C library, one first has 
to determine the amount of 3C library to use in each PCR reaction. To do this, 
one can perform a titration experiment, as shown in Figure 2.2. Both the BAC 
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control template and the experimental 3C library should be titrated using a serial 
two-fold dilution series beginning with 240 ng of 3C template and 25 -50ng of 
BAC control template.10 We routinely use two different primer pairs for the control 
region for this analysis. The first primer pair interrogates a short-range interaction 
(i.e. a pair of restriction fragments separated by only a few thousand bp in the 
genome). The second primer pair is chosen to interrogate a longer-range 
interaction (i.e. a pair of restriction fragments separated by tens of thousands of 
bp). We suggest performing each PCR reaction in duplicate. PCR products are 
run on a 2% agarose gel and quantified using a standard gel imaging set up. A 
water control should be included.  
The amount of PCR product is then quantified and plotted versus the 
amount of input DNA. The resulting titration curve should plateau to a flat 
shoulder, as shown in Figure 2.6 D and E. The concentration of 3C template to 
use in 3C experiments should be taken from the linear slope of the graph to 
ensure that one will not over-or under-saturate signals from the 3C library. The 
PCR reaction is assembled as follows: 
Titration Reaction: 
10x PCR Buffer         2.5 μl 
50 mM MgSO4         2 μl 
20 mM dNTPs   0.2 μl 
80 μM Primer1         0.125 μl 
80 μM Primer2         0.125 μl 
                                               
10BAC Dilution Series:  The starting amount of a control template depends on the BAC 
composition of the template: the more complex the control library is, i.e. the more possible 
interactions it is covering, the more DNA is needed in a PCR reaction. In our experience, using 
BAC clones covering up to a megabase of genomic DNA, starting the dilution series with 50-70 
ng of the template works well. 
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Taq Polymerase        0.2 μl 
Diluted template        4 μl 
dH2O                        15.85 μl 
Total Volume            25 μl 
 
PCR conditions: 
1. 95 C 5 minutes 
2. 95 C 30 seconds 
3. 65 C 30 seconds 
4. 72 C 30 seconds 
5. 95 C 30 seconds 
6. 65 C 30 seconds 
7. 72 C 8 minutes 
8. 10 C forever 
Repeat steps 2-4 34 times. 
 
Generating 3C Data 
After choosing the appropriate concentration of both the control and the 
experimental 3C library from the titration analysis, one can start to determine 
interaction frequencies between pairs of loci. To do so, one uses pairs of primers 
for restriction fragments of interest to perform semi-quantitative PCR on each of 
the two templates. Each PCR reaction is performed in triplicate. The PCR 
conditions are identical to the ones used to titrate the 3C and control libraries. 
PCR products are run on a 2% agarose gel and the amount of PCR product is 
quantitated using a standard gel quantification set up. 3C products can also be 
quantified using qPCR, with very similar results (Hagège et al., 2007).  
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5C Experimental Protocol 
 
 
Reagents Required 
 
Reagents 
 
10x NEB4 
 
Isopropanol  
 
1 mg/mL Salmon Sperm DNA 
Taq Ligase 
Taq Ligase Buffer 
Amplitaq Gold 
 Supplied with 25 mM Deoxyribonucleotides (dNTPs) 
   25 mM MgCl2 (Magnesuim Chloride) 
   PCR buffer 
Pfu Ultra II  
 Supplied with 25 mM Deoxyribonucleotides (dNTPs) 
   25 mM MgCl2 (Magnesuim Chloride) 
   PCR buffer 
Taq Polymerase 
10 mM Adenosine Triphosphate (ATP) 
T4 DNA Ligase 
T4 DNA Ligase buffer 
PE Adapter Oligo Mix 
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Kits 
QIAquick PCR Purification Kit (Qiagen) 
QIAquick Gel Extraction Kit (Qiagen) 
MinElute PCR Purification Kit (Qiagen)  
Library Quantification Kit, Illumina Genome Analyzer v2 (KAPA) 
 
Primers 
PE adapter oligo mix 
Phosphorylated Universal Primers (Standard Desalting): 
FWD: 5’ - /5Phos/CCTCTCTATGGGCAGTCGGTGAT – 3’ 
REV: 5’ – /5Phos/CTGCCCCGGGTTCCTCATTCTCT – 3’ 
PE Primers (HPLC Purification): 
1.0: 5’ –
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT – 3’ 
2.0: 5’ – 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCT
CTTCCGATCT – 3’ 
 
5C Library Titration 
Before beginning the 5C protocol, the 3C library must be titrated with the 
5C probes to determine the appropriate number of genome copies and primer 
73 
 
concentration to use in the downstream steps. To determine the number of 
human genome copies, we use the following numbers:   
 1 Dalton = 1.65x10-24 gram 
 1 base pair = 650 Daltons 
Thus, 1 base pair = 1.0725x10-12 gram 
And, 3 billion base pairs (1 genome copy) = 3.2x10-12 gram = 3.2 picograms 
Therefore, 100,000 genome copies = 320 nanograms  
We recommend starting the titration at 100,000 genome copies and doubling the 
amount (200,000, 400,000, etc.). We also recommend beginning the probe 
titration at 1 fmol/probe (1 nM probe). In our hands most libraries are made using 
1 or 2 fmol/probe. The following reaction is used for titration:  
 
5C Annealing Reaction11 
10x NEB4  2 uL 
1 mg/mL ssDNA filler for controls (replaces 3C library) 
3C Template  X Genome copies 
5C Probes  X fmol/probe 
dH20   up to 20 uL 
 Incubate:  95˚ for 9 minutes 
   Drop temperature to 55˚ at a rate of 0.1˚/second 
   55˚ overnight 
 
5C Ligation Reaction12 
                                               
11 It is important to include 3 controls whenever the annealing reaction is performed: no Taq 
ligase, no 3C library, and no 5C probes. The no Taq ligase control is necessary for the ligation 
reaction but must be set up at this step. 
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Taq Ligase buffer 2 uL 
Taq ligase  0.25 uL 
dH20   17.75 uL 
 
 Incubate:  55˚ 1 hour 
   75˚ 10 minutes 
   4˚ 10 minutes 
 
5C Universal PCR Reaction 
5C ligated template 6 uL 
10x PCR buffer 2.5 uL 
25 mM MgCl2 1.8 uL 
25 mM dNTP  0.2 uL 
Amplitaq Gold 0.225 uL 
80 uM Forward Primer 0.5 uL 
80 uM Reverse Primer 0.5 uL 
dH20   13.275 uL 
A water control should always be included with this reaction. 
Incubate 95˚ 9 minutes 
   95˚ 30 seconds 
   65˚ 30 seconds     Repeat 27x13 
   72˚ 30 seconds 
   72˚ 7 minutes 
   10˚ forever 
 
After this step, run the products out on a gel (Figure 2.2C). Choose the 
appropriate number of genome copies and probe concentration. In our hands 
400,000 genome copies and 2 fmol/probe are generally successful. If there are 
any bands in the control lanes, the library has been contaminated and should not 
be used in downstream steps (Figure 2.8). See the troubleshooting section for 
tips on avoiding and solving contamination issues. 
                                                                                                                                            
12 Remember to include a no Taq ligase control. This reaction is added directly to the annealing reaction. 
13 This cycle number can also be modified, though 30 cycles is the maximum we recommend.  
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Creating the 5C Library 
To create the 5C library, repeat the reactions as outlined in the Titration 
section. Performing 10 annealing reactions is enough to produce sufficient 
product for downstream steps. After the ligation step, we suggest taking at least 
4 reactions from each ligation product for the universal PCR, resulting in at least 
40 universal PCR reactions plus the water control. After the universal PCR is run, 
combine all the reactions and then run a gel to ensure there is no contamination 
in the control lanes (Figure 2.8). If the control lanes are clean, it is time to move 
on to the next part of the protocol. 
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Figure 2.8: 5C library with Contamination in the Control Lanes. Lane 1 
shows a 5C library with an expected size of 138 bp. Lanes 2-5 are controls, and 
should not show a band at 138 bp. The lower band in all lanes represents primer 
dimers. This library should be re-made.  
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Preparing the 5C Library for Sequencing 
To prepare the 5C library for sequencing, we first concentrate the library 
and then run it all out on a 1.8% agarose gel.  
 
Concentrate with QIAquick column 
1) Add 5 volumes buffer PB to 1 volume 5C library  
2) Spin for 30 seconds at 6000 rpm, then for 30 seconds at full speed 
3) Discard the flow-through, and repeat step 2 
4) Wash with 750 mL buffer PE 
5) Spin for 30 seconds at full speed, discard the flow-through, and place 
the column in a new tube 
6) Spin for 1 minute full speed and place the column in a collection tube 
7) Incubate the column with 50 uL hot buffer EB14 for 3 minutes 
8) Spin 1 minute full speed 
9) Add 100 uL EB buffer to the eluate and proceed to gel purification 
Gel Purification 
10) Pour a long 1.8% agarose gel using broad combs  
11) Load the entire 5C concentrated library alongside a low MW ladder 
12) Run the gel at 4˚ at 200 volts for 90 minutes 
Gel Extraction 
                                               
14 Heating the EB buffer at 65˚ before use enhances the amount of DNA retrieved from the 
column. 
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13) Carefully cut out the band of interest from the gel (the band will run at 
135 bp) 
14) Weigh the gel slice, then chop into fine pieces to aid in melting 
15) Add 3x the gel slice weight of buffer QG 
16) Melt the gel slice by vortexing and hand heat (DO NOT place the gel 
slice at high temperature in a heating block or water bath, this will 
lower the yield).  
17) Add 1x the gel slice weight of isopropanol 
18) Transfer the liquid to a QIAquick column and spin for 30 seconds at 
6000 rpm, then for 1 minute at full speed 
19) Discard the flow-through 
20) Wash the column with 500 mL buffer QG and spin 1 minute full speed  
21) Discard the flow-through 
22) Wash the column with 750 mL buffer PE and spin at 1 minute full 
speed 
23) Discard the flow-through 
24) Repeat step 22 and 23 once 
25) Spin 1 minute full speed in a new tube 
26) Place the column in a collection tube and incubate with 31 µL hot 
buffer EB for 3 minutes 
27) Spin for 2 minutes full speed 
Addition of “A” bases 
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28) Add directly to the eluate:  3.5 uL 10x Taq buffer 
1.2 uL Taq polymerase 
1.2 uL 10 mM ATP 
 29) Incubate the reaction for 45 minutes at 72˚ 
Purify and Concentrate with MinElute column 
29) Add 175 µL buffer PB to the above reaction 
30) Spin for 30 seconds at 6000 rpm, then 1 minute full speed 
31) Discard flow-through 
32) Wash with 750 µL buffer PE, spin for 1 minute full speed 
33) Discard flow-through 
34) Place column in new tube, spin 1 minute full speed 
35) Place column in collection tube and add 31 µL hot buffer EB 
36) Incubate for 3 minutes, then spin for 2 minutes full speed to elute the 
DNA.  
Ligation of PE Adapters 
37) Add to the above eluate: 10 µL 5x T4 DNA Ligase buffer 
4 uL T4 DNA ligase 
7 uL PE adapter oligo mix 
38) Incubate the reaction for 2 hours at room temperature 
Gel Purification 
39) Pour a long 1.8% agarose gel using broad combs  
40) Load the entire 5C concentrated library alongside a low MW ladder 
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41) Run the gel at 4˚ at 200 volts for 90 minutes 
Gel Extraction 
42) Carefully cut out the band of interest from the gel (the band will run at 
135 bp) 
43) Weigh the gel slice, then chop into fine pieces to aid in melting 
44) Add 3x the gel slice weight of buffer QG 
45) Melt the gel slice by vortexing and hand heat (DO NOT place the gel 
slice at high temperature in a heating block or water bath, this will 
lower the yield).  
46) Add 1x the gel slice weight of isopropanol 
47) Transfer the liquid to a QIAquick column and spin for 30 seconds at 
6000 rpm, then for 1 minute at full speed 
48) Discard the flow-through 
49) Wash the column with 500 mL buffer QG and spin 1 minute full speed  
50) Discard the flow-through 
51) Wash the column with 750 mL buffer PE and spin at 1 minute full 
speed 
52) Discard the flow-through 
53) Repeat step 51 and 52 once 
54) Spin 1 minute full speed in a new tube 
55) Place the column in a collection tube and incubate with 20 µL hot 
buffer EB for 3 minutes 
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56) Spin for 1 minute full speed 
57) Repeat elution 
Amplification of the 5C library 
Amplification Reaction 
 5C Library    2 µL 
10x Pfu Ultra II buffer 5 µL 
25 mM dNTP   0.5 µL 
25 µM PE Primer 1  0.7 µL 
25 µM PE Primer 2  0.7 µL 
Pfu Ultra II   1 µL 
dH20    31.8 µL 
 
 Incubate:  95˚ 2 minutes 
   95˚ 20 seconds 
   65˚ 20 seconds    Repeat 15-17x (16 cycles is 
recommended) 
   72˚ 15 seconds 
   72˚ 3 minutes 
   10˚ forever 
 
Gel Purification 
58) Pour a long 1.8% agarose gel using broad combs  
59) Load the entire 5C concentrated library alongside a low MW ladder 
60) Run the gel at 4˚ at 200 volts for 90 minutes 
Gel Extraction 
61) Carefully cut out the band of interest from the gel (the band will run 
at 135 bp) 
62) Weigh the gel slice, then chop into fine pieces to aid in melting 
63) Add 3x the gel slice weight of buffer QG 
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64) Melt the gel slice by vortexing and hand heat (DO NOT place the 
gel slice at high temperature in a heating block or water bath, this 
will lower the yield).  
65) Add 1x the gel slice weight of isopropanol 
66) Transfer the liquid to a QIAquick column and spin for 30 seconds 
at 6000 rpm, then for 1 minute at full speed 
67) Discard the flow-through 
68) Wash the column with 500 mL buffer QG and spin 1 minute full 
speed  
69) Discard the flow-through 
70) Wash the column with 750 mL buffer PE and spin at 1 minute full 
speed 
71) Discard the flow-through 
72) Repeat step 70 and 71 once 
73) Spin 1 minute full speed in a new tube 
74) Place the column in a collection tube and incubate with 15 µL hot 
buffer EB for 3 minutes 
75) Spin for 1 minute full speed 
76) Repeat elution 
77) Run a small 2% agarose gel to check the final library – it should 
now be just above 250 bp in size.  
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Library Quantification 
 We use the KAPA library quantification kit to accurately assess the 
amount of 5C library before we send the samples to be sequenced. The KAPA kit 
provides DNA standards and primers for qPCR analysis of DNA concentration in 
the 5C library.  
 
Sequencing 5C libraries 
 At this point the 5C libraries are ready to be sequenced. With the scheme 
presented here, libraries are sequenced on the Illumina GAIIx machine using 50 
bp paired end reads. To sequence 5C libraries using other platforms, simply 
change the PE adapters to fit the platform of choice. Some sequencing facilities 
will perform sample preparation for you – in this case one should send the 5C 
library before addition of PE adapters, just after the universal PCR step. 
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Analysis of 3C Data 
 
A typical 3C experiment includes the analysis of three biological replicates 
of the 3C and control library. Further, each interaction frequency of interest is 
determined by three PCR reactions (technical replicates) using each of the three 
3C and control libraries. Ideally, all 3C reactions should be prepared with the 
same PCR master mix and run simultaneously in the same PCR block, but 
practically it is not always possible if the experiment covers a large region. To 
minimize experimental noise we recommend that PCR replicates for the 3C 
library and the control library are performed in parallel and run side-by-side. We 
use LabWorks software (version 4.0, BioImaging Systems) to analyze the 
intensity of each band minus the background on an agarose gel. Then one 
calculates the average of the three technical replicates. Thus for each biological 
replicate one obtains an average value for the interaction frequency of each pair 
of loci.  Finally, the three datasets obtained with the three biological replicates 
are normalized to each other so that they are all on the same scale. This allows 
the data from different replicates and different conditions to be directly compared. 
Below we present an illustration of how 3C data can be calculated and how 3C 
datasets obtained for different cells or conditions can be quantitatively compared. 
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Example of a 3C Analysis 
We describe a 3C analysis of a gene in two cell lines, A and B. A BAC-
based control library was also generated. In this example, cell line A expresses 
the gene of interest while cell line B does not. In this analysis interactions 
between a single anchor restriction fragment, containing the gene promoter, and 
20 flanking restriction fragments were determined to generate a 3C interaction 
profile. In addition, a control region (ENCODE region Enr313) was analyzed to 
obtain a set of interactions that are assumed to be identical in cell line A and B.   
 
Calculation of Interaction Frequencies for Each Biological Replicate 
The first step in analyzing a 3C experiment is to average the technical 
replicates. Simply average the technical replicates and find the standard 
deviation for each primer pair. In order to control for primer efficiency, divide each 
averaged technical replicate by its corresponding averaged control template 
value. In this example, for each pair of primers the averaged value of three PCR 
reactions performed on a given 3C library for each cell line (A or B) is divided by 
the corresponding average of three PCR reaction performed in the BAC control 
library. For example, the interaction frequency for a given primer pair is (Equation 
1):  
 (𝐴1 +  𝐴2 + 𝐴3)(𝐶𝐶1 + 𝐶𝐶2 + 𝐶𝐶3) 
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where the values A1, A2 and A3 represent three technical replicates for that 
primer pair in cell line A, and  CL1, CL2 and CL3 represent three technical 
replicates for the same primer pair in the control library. This value is the 
interaction frequency of a pair of loci for a given biological replicate. In order to 
calculate the standard deviation of each interaction frequency, use the following 
formula (Equation 2): 
 
𝑆𝑆𝑆𝑆𝑆 =  𝑠𝑠𝑠𝑆 ��𝑆𝑆𝑆𝑆𝑆𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐿𝐿𝐿𝐶𝐿𝐶𝐿
𝐴𝑆𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐿𝐿𝐿𝐶𝐿𝐶𝐿 �
2 +  �𝑆𝑆𝑆𝑆𝑆𝐸𝐸𝐸.  𝐿𝐿𝐿𝐶𝐿𝐶𝐿
𝐴𝑆𝐴𝐸𝐸𝐸.  𝐿𝐿𝐿𝐶𝐿𝐶𝐿 �
2
�
∗ 𝐼𝐼𝑆𝑆𝑠𝐼𝐼𝑆𝐼𝐼𝐼 𝐹𝑠𝑆𝑠𝐹𝑆𝐼𝐼𝐹  
where StDev is the standard deviation, Avg is the average, Exp. Library is the 
experimental 3C library value, and Interaction Frequency is the value calculated 
using Equation 1. 
Using this approach the average interaction frequency, and the standard 
deviation, for each pair of loci is determined for each of the three biological 
replicate 3C libraries.  
 
Combining Biological Replicates 
The results from individual biological replicates can be directly compared 
in separate graphs (to determine whether the same peaks occur in each 
replicate) or the biological replicates can be averaged together. To calculate the 
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combined standard deviation of all biological replicates, use the following formula 
(Equation 3):  
𝑆𝑆𝑆𝑆𝑆 =  𝑠𝑠𝑠𝑆 ��𝑆𝑆𝑆𝑆𝑆𝐵.𝑅𝑅𝐸1
𝐴𝑆𝐴 𝐵.𝑅𝑅𝐸1 �
2 +  �𝑆𝑆𝑆𝑆𝑆𝐵.𝑅𝑅𝐸2
𝐴𝑆𝐴𝐵.𝑅𝑅𝐸2 �
2 + �𝑆𝑆𝑆𝑆𝑆𝐵.𝑅𝑅𝐸3
𝐴𝑆𝐴𝐵.𝑅𝑅𝐸3 �
2
� ∗ 𝐴𝑆𝐴𝐴𝐶𝐶 𝑅𝑅𝐸𝑅 
 
where StDev is the standard deviation, Avg is the average, B is biological, and 
Rep is replicate.15 
 
Normalizing 3C Data Obtained from Different Experiments 
In order to allow direct quantitative comparison between two 3C datasets, 
e.g. two different biological replicates and/or data obtained with two different cell 
lines, they must be first normalized to each other. This normalization is done 
using the interaction frequencies measured within the control genomic region, 
which was selected based on the assumption that it has the same conformation 
in both cell lines. In our example we have analyzed two cell lines (A and B), and 
have three biological replicates. Here we provide an example of how these 
                                               
15Standard Deviation versus Standard Error of the Mean. We suggest that when plotting the 
average of biological replicates to also display the standard deviation (SD) of each data point and 
not the standard error of the mean (SEM). The standard error of the mean reflects the certainty 
with which the average can be estimated. The SEM incorporates the number of measurements 
taken because the more measurements made, the more likely it is that the correct value has been 
found. This is a valid error to plot while examining an individual biological replicate. A large SEM 
indicates that the value of a give data point is very uncertain, and it may be necessary to perform 
additional technical replicates to increase the precision of measuring that specific value. 
However, it is more informative to indicate the SD while comparing biological replicates, since the 
SD will better reflect potentially relevant variation between samples. 
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datasets can be compared.  We will normalize the data for cell line B to the data 
for cell line A, for each of the three biological replicates separately, so that three 
independent cell line comparisons are obtained.  
First, the interaction frequencies are calculated for each biological 
replicate for cell line A and B, as described above, for each of the pairs of loci in 
the control region.  Next, a normalization factor is calculated to normalize the 
data for one experiment to the other, e.g. to normalize the data obtained with cell 
line B to the data obtained with cell line A. For this, determine the log ratio for 
each interaction frequency in the control region (Equation 4): 
 
log ∑𝐴1 + 𝐴2 + 𝐴3
∑𝐵1 + 𝐵2 + 𝐵3 
 
where A1, A2 and A3 are the normalized interaction frequencies of one primer pair 
in the first cell line, and B1, B2 and B3  are the normalized interaction frequencies 
of one primer pair in the second cell line. Next, the average of these log ratios is 
calculated. The normalization factor is then found by taking the inverse log of this 
average. Finally, the entire dataset that was in the denominator in the calculation, 
in this case, cell line B biological replicate 1, is multiplied by the normalization 
factor. Each normalized interaction frequency is multiplied by the normalization 
factor. This will bring the two datasets to the same scale, and they can now be 
plotted on the same graph. This analysis is then repeated for replicates 2 and 3 
individually. One can subsequently average the normalized biological replicates 
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together to obtain a final data set for each cell line, and these final data sets can 
be plotted on one graph. 
 
Find Peaks of High Interaction Frequency 
3C interaction frequencies are typically plotted versus genomic position 
with respect to the anchor point (Figure 2.4). In general interaction frequencies 
will decrease rapidly with increasing genomic distance. A specific looping 
interaction can be inferred when a peak is observed on top of this overall 3C 
profile. Visual inspection of 3C profiles has been used to identify such looping 
interactions. To obtain further support for a looping interaction additional 
analyses are essential, e.g. 3C analysis of cells or conditions where the looping 
interaction is absent. Figure 2.4 also illustrates the importance of obtaining a 
larger 3C profile so that a local background in non-specific 3C interactions is 
obtained. In the absence of this baseline estimation it is not possible to identify 
peaks in 3C interaction profiles and can lead to misinterpretation of individual 3C 
signals. In some cases it is possible to apply ANOVA statistic test for peak calling 
on the 3C profile, but usually there are not enough data points to perform in-
depth analysis (McCord et al., 2011). 
If a long-range interaction is inferred, it may be necessary to perform 
further experiments to validate the finding. For instance one can analyze the 
genomic region using a different restriction enzyme to confirm the looping 
interaction. Comparison of 3C data to other types of data sets, such as histone 
90 
 
modification patterns or DNase hypersensitive sites, and analysis of the looping 
interaction across cell types that do or do not express the gene of interest can 
help further define the functional elements involved and the role of the interaction 
in gene expression. Final experimental confirmation of the looping interaction and 
the DNA elements involved can be obtained by deleting or mutating the 
interacting regions and/or knocking down transcription factors that may mediate 
the interaction. 
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Analysis of 5C Data 
 
5C experiments involve a number of steps that can locally differ in 
efficiency, thereby introducing biases in efficiency of detection of pairs of 
interactions. These biases could be due to differences in the efficiency of 
crosslinking, the efficiency of restriction digestion (related to crosslinking 
efficiency), the efficiency of ligation (related to fragment size), the efficiency of 5C 
probes (related to annealing and PCR amplification) and finally the efficiency of 
DNA sequencing (related to base composition). All of these potential biases—
several of which are common to other approaches such as chromatin 
immunoprecipitation (for example, crosslinking efficiency, PCR amplification, 
base-composition-dependent sequencing efficiency)—will have an impact on the 
overall efficiency with which long-range interactions for a given locus (restriction 
fragment) can be detected.  
Analysis of 5C data can be accomplished via a published suite of tools 
called my5C (http://my5C.umassmed.edu) (Lajoie et al., 2009). We use an 
updated version of the novoalign mapping algorithm to map our reads 
(V2.07.11 http://novocraft.com). 5C data sets are scanned for misbehaving 
primers (primers that are blowouts or severely underperforming), which are then 
removed from downstream analysis. The data sets are also scanned for 
individual blowout points between a particular forward-reverse probe pair, termed 
singletons. These blowout points are also removed from downstream analysis. 
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The data sets are then coverage corrected in order to allow equal visibility to all 
probes. Once the biases are corrected, the data is run through a peak-calling 
pipeline to identify regions of high interaction frequency that are present in both 
replicates.  
Probe filtering – Cis-Purge 
Not all probes are represented equally in our 5C dataset due to over- and 
under-performance in the assay. As the first step in our data correction pipeline, 
we remove probes that perform significantly differently than the overall set. This 
correction is achieved using a Loess smoothing algorithm. A global average 
Loess is calculated for each data set. This global average Loess is compared to 
individual probe Loess plots. If the individual Loess is more or less than .85 of the 
scaled Z-score distance from the average global Loess, the probe is flagged as 
problematic. If a probe is flagged as problematic in more than 40% of the data, it 
is removed from downstream analysis.  
Singleton removal 
In some 5C datasets there are instances when the interaction between 
two probes was higher than any of its neighboring interactions by an order or 
magnitude or more. These blowout reactions should be removed from the 
dataset to avoid problems downstream during peak calling. We suggest placing a 
high threshold on the entire data set and removing any data points with 
interaction frequencies above that threshold. 
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Coverage correction 
Once the outlier probes and interactions are removed from the 5C data 
set, it is important to normalize each probe in order to compare them to each 
other. Generally, one uses trans space for this type of correction, though it is 
possible to correct a 5C experiment using only cis data (Smith et al in 
preparation, chapter 4 of this thesis). An average Loess value is computed for 
the trans dataset. Separately, a Loess value was calculated for each individual 
probe in the combined dataset. Then a factor is generated by which each probe 
should be lifted or lowered in order to match the average Loess profile from the 
combined dataset.  
𝑉𝐼𝑉𝐹𝑆 − 𝐴𝑆𝑆𝑠𝐼𝐴𝑆
𝑆𝑆𝐼𝐼𝑆𝐼𝑠𝑆 𝑆𝑆𝑆𝐼𝐼𝑆𝐼𝐼𝐼 
The calculated factors were applied to the individual, read-normalized datasets to 
produce the final coverage corrected datasets.  
Peak calling 
To detect significant looping interactions over background we developed an in-
house ‘5C peak calling’ algorithm (Lajoie et al., 2009; Sanyal et al., 2012). We 
call peaks in each 5C biological replicate separately and then take only the peaks 
that intersect across replicates as our final list of significant looping interactions.  
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Troubleshooting 
 
 
Degraded Template 
 
Degradation of a 3C template can be observed when the DNA is run on an 
agarose gel (Figure 2.7A).  In our experience this degradation occurs early in the 
3C protocol, often at the step where cells are lysed. This may be due to 
contaminating nucleases. The quality of a cell pellet can be checked in the first 
steps of the 3C protocol. If the 3C template is degraded we recommend replacing 
all plastics and buffers before redoing the experiment.   
 
Linear Range of PCR Amplification of 3C Template Cannot be Determined 
With Titration PCR 
This problem is most likely the result of high salt concentrations in the 3C 
library preparation. The use of Amicon columns typically removes most salt.  
However, if this problem is observed, the 3C template can be re-purified with 
phenol/chloroform extraction, ethanol precipitated and washed again on Amicon 
columns. 
 
Titration PCR on 3C Template is Very Inefficient for All Pairs of Primers 
While Primers Work Fine on the Control Template 
For large genomes, e.g. from mammals, PCR amplification of ligation 
produces using the control library is much more efficient than for the 
experimental 3C library. To optimize PCR amplification of ligation products with 
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the 3C library it may be important to further optimize the PCR conditions, 
including the time and temperature of annealing and the concentration of 
magnesium ions in the PCR buffer. Several PCR primer pairs for human and 
mouse, which have been used in our lab and reproducibly given good titration 
curves, are listed in Table 2.1 
Poor PCR amplification of ligation products with the 3C library can also be 
the result of inefficient digestion and/or ligation during the 3C procedure. 
Restriction efficiency can be estimated by taking an aliquot of chromatin right 
after digestion in the 3C protocol. DNA is then purified and analyzed by PCR with 
primers designed to amplify a genomic region containing a restriction site. An 
equal amount of DNA purified from an undigested chromatin sample should be 
used as a control. Digestion efficiency in the 3C protocol is then defined as the 
ratio of the amount of PCR product obtained with the 3C DNA divided by the 
amount obtained with genomic DNA. 3C digestion is considered successful when 
a more than 70% reduction of PCR product is observed for the digested 3C 
template compared to the undigested genomic DNA template. 
 
PCR Amplification of Ligation Products Leads to Multiple Bands on the Gel 
There are might be several reasons for multiple bands in a 3C PCR 
(Figure 2.7B-E). We recommend approaching this problem step by step; finding 
and eliminating each possible reason (Figure 2.7B-E). First of all, multiple 
amplified DNA fragments can be the result of the incomplete digestion of the 
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cross-linked chromatin, as is typical in 3C experiments (Figure 2.7C). This 
problem might be especially severe when frequently cutting enzymes are used, 
as the average size of restriction fragments (i.e. potential insert in the ligation 
product) is small and hence non-canonical ligation products can be amplified 
efficiently. If the extra bands are very prominent, one may consider re-doing 3C 
template with increased concentration of restriction enzyme and extended 
incubation time. Multiple bands might also be the result of non-specific annealing 
of PCR primers.  In that case, we recommend first to modify PCR condition 
(increase annealing temperature, Figure 2.7D) and if that does not help to 
redesign the primers (Figure 2.7E). 
 
Contamination in the 5C Template 
 
The issue of contamination occurs frequently in the lab. To prevent this, 
we strongly encourage aliquoting each reagent before beginning the experiment. 
If possible, aliquot into small sizes so that after one use the tube can be thrown 
away. It is also important to use filter tips and clean pipettes while creating the 
5C library. Cleaning working surfaces and pipettes with a DNase solution before 
the creation of each library is helpful. If contamination is discovered after the 
universal PCR (Figure 2.8), the 5C library must be re-made using clean reagents. 
As an alternative, one can attempt to lower the number of cycles during the 
universal PCR step, though is not a recommended solution.  
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Low PE Adapter Ligation Efficiency 
 
If a low amount of ligation product is obtained, it is possible to increase the 
starting concentration of the library. Additionally, ensure that a fresh aliquot of 
dATP is used in the addition of the “A” base step, as multiple freeze-thaw cycles 
negatively impact its effectiveness. 
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CHAPTER III 
IDENTIFYING FUNCTIONAL LONG-RANGE INTERACTIONS OF THE CYSTIC 
FIBROSIS GENE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is adapted from Nele Gheldof, Emily M. Smith, Tomoko M. Tabuchi, 
Christoph M. Koch, Ian Dunham, John A. Stamatoyannopoulos, and Job Dekker. 
“Cell-type-specific Long-range Looping Interactions Identify Distant Regulatory 
Elements of the CFTR Gene.” Nucleic Acids Research 38, no. 13 (July 2010): 
4325–4336. doi:10.1093/nar/gkq175. 
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Contributions 
 
This paper describes the identification of four genomic regions that contact the 
CFTR promoter in three-dimensional space, and identifies two of those regions 
as potential enhancer elements. N.G., E.M.S., and T.M.T. performed the 
experiments. C.M.K., I.D., and J.A.S. provided DHS and methylation data. J.D. 
and E.M.S. prepared the manuscript. 
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Abstract 
 
 
The identification of regulatory elements and subsequent identification of their 
target genes is complicated by the fact that regulatory elements often act over 
large genomic distances. Identification of long-range acting elements is 
particularly important in the case of disease genes as mutations in these 
elements can result in human disease. It is becoming increasingly clear that long-
range control of gene expression is facilitated by chromatin looping interactions. 
These interactions can be captured and analyzed by chromosome conformation 
capture (3C). Here we employed 3C as a discovery tool for ab initio identification 
of long-range regulatory elements that control the cystic fibrosis transmembrane 
conductance regulator gene, CFTR. We identified four elements in a 460 kb 
region around the CFTR locus that loop specifically to the CFTR promoter 
exclusively in CFTR expressing cells. The elements are located 21 and 80 Kb 
upstream and 108 and 202 kb downstream of the CFTR promoter. These 
elements contain DNaseI hypersensitive sites and histone modification patterns 
characteristic of enhancers. We show that two of these elements are enhancers 
using a luciferase assay. Additionally we investigate what proteins may be 
binding these elements using a yeast one-hybrid approach. One promising factor 
discovered is TCF4, binding to the enhancer element 108 kb downstream of the 
promoter.   
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Introduction 
 
Appropriate spatial and temporal control of gene expression depends on 
regulatory input from cis-acting elements such as promoters, enhancers and 
repressors.  Identification of these elements is challenging because they can be 
located far from their target gene, sometimes up to several Mb (Dekker, 2008a; 
Kleinjan and van Heyningen, 2005; West and Fraser, 2005). Detailed knowledge 
of such distant regulatory elements and their mechanism of action will greatly 
contribute to basic understanding of gene expression.   
  Abundant evidence suggests that human disease can be caused by 
mutations that affect distant regulatory elements, while leaving the disease gene 
itself intact. Examples include Aniridia, caused by loss of distant regulatory 
elements of the PAX6 gene, and blepharophimosis syndrome (BPES) that can 
be caused by deletion of regulatory elements located > 600 kb from FOXL2 gene 
(D’haene et al., 2009; Kleinjan et al., 2001). 
Regulatory elements are often characterized by the presence of DNase I 
hypersensitive sites (DHS), which can mark the position where transcription 
factors are bound to DNA. Other chromatin features found at distant regulatory 
elements are increased levels of H3K4me1 and histone acetylation (Heintzman 
et al., 2007, 2009). In addition, these sequences are often conserved across 
species (Maston et al., 2006; Visel et al., 2007). All these features can be used to 
identify putative functional elements and these powerful strategies are currently 
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widely applied (e.g. (Birney et al., 2007; Visel et al., 2007)). However, these 
analyses do not immediately reveal the target genes of these regulatory 
elements.  
 Regulatory elements can directly associate with target promoters through 
chromatin looping (Dekker, 2008; Kleinjan and van Heyningen, 2005; de Laat 
and Grosveld, 2003; West and Fraser, 2005). These looping interactions can be 
detected using chromosome conformation capture, or 3C (Dekker et al., 2002). 
The insight that regulatory elements physically associate with promoters provides 
a methodology to discover novel regulatory elements by performing systematic 
3C analyses to search for genomic elements that are found to interact with a 
specific promoter. Here we tested the feasibility of such an approach by analysis 
of the cystic fibrosis transmembrane conductance regulator (CFTR) locus. 
Identification of extragenic regulatory elements for this locus (and other disease 
related loci) is especially important because 1) they could be screened for 
mutations in patients with no known mutations in the CFTR gene itself, and thus 
aid in proper diagnosis, and 2) they could be included in gene therapy constructs 
(to recapitulate endogenous CFTR regulation). Finally, identification of CFTR 
regulatory elements will provide basic insights into the mechanisms that control 
expression of CFTR, which could also lead to new approaches to boost or 
manipulate CFTR expression in patients. 
The CFTR gene, when both alleles are mutated, causes cystic fibrosis. It 
contains a promoter that has many characteristics of a housekeeping gene 
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including potential binding sites for SP1 (Yoshimura et al., 1991). Also present is 
a critical CCAAT-like element, shown to bind C/EBP (Pittman et al., 1995), 
implicating cAMP as a possible regulator. Supporting a role for cAMP in CFTR 
regulation is data showing that cAMP activation of protein kinase A can regulate 
basal CFTR expression (McDonald et al., 1995) and the discovery that CREB 
and ATF-1 bind the CFTR promoter in a cAMP-responsive manner (Matthews 
and McKnight, 1996). A YY1 element has also been identified that, when 
mutated, significantly increases the expression of CFTR (Romey et al., 2000). 
However, despite the abundance of regulatory elements in the CFTR promoter, it 
is clear that additional elements are required for the complex spatial- temporal 
expression pattern of the CFTR gene (McCarthy and Harris, 2005). Indeed, work 
from the Harris laboratory has identified additional putative regulatory elements 
located within introns of the gene, as well up-and downstream of the locus. For 
instance, HNF1α has been found to interact with a putative regulatory element in 
introns 1, 10, 17a and 20 and over-expression of this protein results in increased 
CFTR mRNA levels (Mouchel et al., 2004; Ott et al., 2009a).  
Here we applied a systematic 3C analysis to a 460 kb chromosomal 
region surrounding the CFTR transcription start site (TSS). We examined 
different cell lines that either express or do not express the gene in order to 
identify regulatory elements that function specifically in CFTR-expressing cells. 
Our approach was validated by identification of previously discovered regulatory 
elements, e.g. an element located 202 kb downstream of the promoter that 
104 
 
coincides with a DNAseI hypersensitive site (referred to as DHS4574+15.3 
(Nuthall et al., 1999a)) and that has been found to be able to act as an insulator 
(Blackledge et al., 2009). Importantly, we discovered an additional regulatory 
element: one located within intron 11 (108 kb downstream of the TSS) that 
interacts with the CFTR TSS exclusively in cells that express the gene. Additional 
3C analyses allowed us to define the locations of long-range acting elements at 
~1 kb resolution. In CFTR expressing cells, these elements contain the 
characteristic features of known regulatory elements, such as the presence of a 
DHS and specific histone modification patterns. Interestingly, we find that 
regulatory elements also interact with each other.  
We suspect that architectural proteins as well as transcription factors 
(TFs) are responsible for creating and maintaining looping interactions. It has 
been shown that the architectural proteins CTCF, cohesion and Mediator 
complexes regulate looping interactions, and that knocking down these proteins 
can change loops (Phillips-Cremins et al., 2013; Sanyal et al., 2012; Splinter et 
al., 2006). In the well-studied β-globin locus, the TFs ELKF, GATA1, FOG1 and 
TAL1 are critical for proper looping formation of the LCR with target genes 
(Drissen et al., 2004; Vakoc et al., 2005; Yun et al., 2014). In order to identify if 
the looping elements are influencing CFTR expression, we used a luciferase 
assay to measure the effect each element has on gene expression. Additionally, 
we placed the active elements in a yeast one-hybrid assay (Deplancke et al., 
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2004; Reece-Hoyes et al., 2011) to discover which human transcription factors 
may bind to these DNA fragments . 
These studies identify novel CFTR regulatory elements and provide 
insights into combinatorial control of the gene. We show that both upstream 
elements (+108 and +202) can act as enhancers in a luciferase assay and 
identified a minimal enhancer region contained within these looping regions. We 
identify high-confidence transcription factors that may play a role in forming or 
maintaining the 3D contacts between the upstream elements and the CFTR 
promoter. These results provide strong evidence that 3C-based approaches 
provide tools for ab initio discovery of regulatory elements and their target genes. 
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Materials and Methods 
 
Cell Culture 
We used six cell lines for the 3C analyses: three CFTR-expressing cell 
lines Caco2, HT29 and HeLa S3, compared to three non-CFTR expressing cell 
lines GM06990, K562 and HepG2. The GM06990 cell line was obtained from 
Coriell Cell Repositories, and the Caco2, HT29, HeLa S3, K562 and HepG2 cell 
lines from the American Type Culture Collection (ATCC). All cell lines were 
grown at 37°C in 5% CO2 in medium containing 1% penicillin-streptomycin. 
Caco2 cells were grown in MEM alpha medium supplemented with 20% fetal 
bovine serum (FBS), HT29 cells in DMEM medium with 10% FBS, HeLa S3 in 
F12K medium with 10% FBS, GM06990 and K562 cells in RPMI medium with 
10% FBS and HepG2 in MEM alpha medium with 10% FBS. Suspension cells 
were harvested at log-phase and monolayer cells were grown to 95% confluency 
before harvesting for RT-PCR and 3C analysis. 
 
RT-PCR 
Total RNA from the six cell lines was isolated using the RNeasy Mini Kit 
(Qiagen).  CFTR RNA transcript levels were analyzed using Power SYBR® 
Green RNA-to-CT 1-Step Kit (Applied Biosystems) on a StepOnePlusTM Real-
Time PCR System (Applied Biosystems). HPRT1 was used to normalize the 
data.  Primer sequences are available in Appendix I. 
107 
 
3C Analysis 
The 3C analysis was performed using EcoRI and BsrGI as described 
previously (Dostie and Dekker, 2007; Gheldof et al., 2006). We generated a 
control library for each enzyme using BAC clones obtained from Invitrogen and 
the Children’s Hospital Oakland Research Institute (CHORI). We used three 
minimally overlapping BAC clones spanning the investigated 450 kb CFTR locus: 
RP11-35E12, RP11-450L14 and CTD-2034E23, as well as the BAC clone RP11-
197K24 from a gene desert region (ENCODE region Enr313) as described in 
Dostie et al. (Dostie and Dekker, 2007). We normalized the data of each 
experiment using the interaction frequencies measured in this gene desert region 
to allow direct comparison of data obtained from the cell line in which CFTR is 
expressed versus the cell line in which CFTR is not expressed. Broad 3C 
analysis of Caco2 versus GM06990 was performed in 4 independent 
experiments, HT29 versus K562 in 2, and HeLa S3 versus HepG2 in 1, and each 
experiment was quantified at least in triplicate. 3C fine mapping of elements III 
and IV was performed with BsrGI in the cell lines Caco2 and GM06990, and 3 
independent experiments were performed. Primer sequences and 3C data are 
available in Appendix I.  
 
 
DNAseI Mapping and Analysis of Histone Modification Patterns in the 
ENCODE Regions 
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DNAseI hypersensitive site data and histone modification data were 
generated as previously described (Dorschner et al., 2004; Koch et al., 2007). 
Data are available at http://genome.ucsc.edu/ENCODE/pilot.html, where detailed 
descriptions of the methods can also be found.  
 
Generation of Reporter Constructs  
The pGL3 basic vector (Promega) was transformed into a Gateway-
compatible destination vector by inserting the R4R2 cassette into the MluI 
restriction site according to the MultiSite Gateway Cloning manual (Invitrogen).  
Insertion of the cassette in the correct orientation to drive transcription of the 
luciferase gene was verified by sequencing.  The R4R2 cassette was a generous 
gift by the Walhout lab.  A 1.7-kb fragment spanning the CFTR basal promoter 
(from – 1,691 to – 35 bp from the ATG translation start site) was amplified with 
primers with B1B2 tails and cloned into the destination vector.   
Potential enhancer elements were amplified with primers containing B4B1R tails 
and each of these elements was cloned upstream of the promoter fragment.  As 
the 4 EcoRI DNA looping elements as identified by 3C were on average 4 kb in 
size, we split each element in smaller overlapping segments of 1.1-1.8 kb to 
allow positioning of the regulatory element more precisely. Elements I and IV 
were split into 3 fragments and Element III was split into 2. Additionally, elements 
III and IV were made without their DHS, and fragments were produced that 
contained only the DHS. Genomic coordinates (hg18, chromosome 7) of each 
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fragment are listed in Table 3.1.  As negative control, the pGL3-basic vector-
promoter alone construct was made by cloning a short 51-bp fragment with 
B4B1R tails located upstream of the CFTR promoter insert (from –1,825 to – 
1,774 bp from the ATG translation start site; coordinates: 116905560-
116905611). Inclusion of this 51 bp fragment in the promoter-only construct, but 
not in the element-promoter constructs did not affect the interpretation of the 
enhancing effects of the elements, as shown by analysis of a pair of promoter 
and promoter-element IV constructs that both lack this sequence yet gave 
identical levels of promoter activation by element IV (data not shown). As a 
positive control, we generated a construct containing a fragment of intron 1 of the 
CFTR gene. This fragment was previously shown to have significant enhancer 
activity (Smith et al., 1996). The intron 1 fragment was amplified using primers 
IA1R and TSR8 as described in Smith et al. (1996) and containing the B4B1R 
tails. We also generated a construct containing the segments with the highest 
enhancer activity from both element III and IV as a fusion. To this end, we 
performed a fusion-PCR (Heckman and Pease, 2007) of element IIIb and IVc, 
and cloned this fused fragment upstream of the CFTR promoter insert. 
Fragments IIIb and IVc were further characterized by analyzing the location of a 
DHS within each of these regions. Fragment IIIb-DHS was created by truncating 
the IIIb fragment so it would not contain the DHS. IIIbDHS is the portion of IIIb 
that contains the DHS. IIIbDHS and IIIb-DHS constructs have a 50bp overlap.  
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Element ID Beginning End 
Promoter 116905694 116907350 
Ia 116822691 116824500 
Ib 116824484 116825593 
Ic 116825438 116827097 
II 116883223 116885151 
Intron1 116916750 116917500 
IIIa 117013018 117014528 
IIIb 117014436 117016269 
III-DHS 117014436 117015582 
IIIDHS 117015552 117016269 
IVa 117105596 117107448 
IVb 117107337 117109457 
IVc 117109425 117110818 
IVd 117109425 117111668 
IV-DHSa 117109425 117110125 
IV-DHSb 117110685 117111668 
IVDHS 117110095 117110715 
 
Table 3.1: Luciferase Fragment Locations. Table with the genomic 
coordinates (Chr7, Hg18) of the elements cloned into the luciferase assay.  IVd is 
an expanded version of element IVc. IVd was used in the second assay in place 
of IVc, but the addition of this extra DNA did not affect the luciferase results. IV-
DHSa and IV-DHSb were combined to create IVd-DHS 
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IVd-DHS was created by combining the regions of IVd that lack the DHS, while 
IVdDHS is the portion of IVd that contains the DHS. 
 
Transfection and Luciferase Assays  
The first round of transient transfections were performed on two 
monolayer cell lines, the CFTR-expressing Caco2 and non-CFTR expressing 
HepG2 cell line grown in 96-well plates to 70-80% confluency.  In all transfection 
experiments the pGL3 constructs were cotransfected with 1/10 the amount of 
DNA of pRL-TK as a transfection control, using Effectene as transfection 
reagent, as indicated in the manufacturer´s manual (Qiagen).  Luciferase assays 
were carried out using the dual luciferase kit (Promega) on a 96-well plate 
reader.  Each transfection experiment was carried out at least five times with 
individual constructs being assayed in duplicate in each experiment.  For the 
second round of testing, Attractene was used as a transfection reagent according 
to the manufacturer’s protocol (Qiagen 2008 cat#301005) modified for 96-well 
plates. 300 ng of each DNA construct was added to Caco2 cells and 250 ng of 
each DNA construct to HepG2 cells in serum-free and antibiotic-free media. 0.75 
µl Attractene was used for Caco2 cells and 0.375 µl Attractene for HepG2 cells. 
Each transfection reaction was performed in quadruplicate with at least three 
biological replicates tested for each construct. 
48 hours after transfection, the cells were assayed using the Dual-Glo 
Luciferase Assay System (Promega 2009 Cat#E2920).  Measurements were 
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made on a Perkin Elmer Victor3 plate reader using Wallac 1420 Manager 
software. Results are expressed as relative luciferase activity, with the pGL3-
promoter construct activity equal to 1. One-tailed t-tests were performed in Excel 
to test significance of the increased luciferase activity. 
 
Yeast One-hybrid  
The Y1H protocol was adapted from Deplancke et al., 2004, 2006; and 
Reece-Hoyes et al., 2011. Gateway cloning was used to create constructs for 
testing. Elements from the luciferase assay were cloned into two destination 
vectors, pMW2 (containing the HIS gene) and pMW3 (containing LacZ) 
(Deplancke et al., 2004). Clones were digested with XhoI and NcoI, respectively, 
to check for the correct insert size. Clones were transformed into the yeast strain 
YM4271 (a gift from the Walhout Lab) and grown at 30˚C for five days. Colonies 
were re-streaked onto a fresh Sc-UH plate and grown at 30˚C overnight, and 
then replica plated onto plates containing 10, 20 and 40 mM 3AT-UH and one 
YEPD plate with a nitrocellulose filter. After growth at 30˚C for two days, the 
YEPD plate with a nitrocellulose filter was used to check LacZ self-activation of 
each bait strain. This was done by a β-galactose overlay assay. The 3AT-UH 
plates were used to check self-activation of the HIS3 gene by the inserted bait 
DNA. These plates were checked for growth over a period of 7 days. Selected 
clones tested as slightly positive in the LacZ self-activation test and grew on 10 
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mM but not on 40 mM 3AT-UH plates. Yeast colony PCR was used to check for 
the correct insertion in yeast using the following primers: 
 
pMW2: M13FW: 5´ - GTAAAAGCACGGCCAGT - 3´ 
  HIS293RV: 5´ - GGGACCACCCTTTAAAGAGA - 3´ 
pMW3: 1HIFW: 5´ - GTTCGGAGATTACCGAATCAA - 3´ 
  LacZ592RV: 5´ - ATGCGCTCAGGTCAAATTCAGA - 3´ 
 
The yeast one-hybrid experiment was performed using a Rotor HAD robot 
(Singer). Yeast carrying the bait elements were mated with the human 
transcription factor array (Reece-Hoyes et al., 2011) on YEPD plates. After one 
night of growth at 30˚C, the colonies were transferred to –UHT plates. After two 
days of growth at 30˚C, the colonies were transferred to plates containing 5 mM 
3AT and 160 mg/L X-Gal. The colonies were assayed for growth and color by 
eye every day or every other day up to 7 days post-transfer. All Y1H results can 
be found in Appendix I. 
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Results 
 
Identification of long-range interactions between the CFTR promoter and 
distant elements 
Long-range looping interactions can be detected using chromosome 
conformation capture (3C) (Dekker et al., 2002). 3C is a widely used method and 
the procedure has previously been described in detail and in chapter 2 of this 
thesis (Dekker et al., 2002; Simonis et al., 2007; Splinter et al., 2003). Briefly, 3C 
employs formaldehyde cross-linking to capture physically interacting chromatin 
segments. Cross-linked chromatin is then solubilized, digested and intra-
molecularly ligated so that pairs of interacting genomic elements are converted 
into unique ligation products. Ligation products are then detected and quantified 
by semi-quantitative PCR (see Materials and Methods and chapter 2 of this 
thesis).   
Here we used 3C as a discovery tool for ab initio identification of distant 
regulatory elements that interact specifically with the active CFTR promoter. We 
performed 3C with Caco2 cells, which express high levels of CFTR, and with 
GM06990 lymphoblastoid cells, which express very low levels of CFTR (Figure 
3.1), to identify genomic elements that physically associate with the CFTR 
promoter. We used a PCR primer located in the EcoRI fragment that contains the 
CFTR transcription start site (TSS) and paired it with primers in restriction 
fragments throughout a 460 kb region surrounding the promoter (primer 
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sequences available in Appendix I). This experimental setup will detect ligation 
(and thus long-range interaction) of the promoter fragment with any of the other 
restriction fragments. The results are shown in Figure 3.2A (3C data available in 
Appendix I).         
In GM06990 cells, we observe that the promoter fragment interacts most 
strongly with nearby restriction fragments and that interaction frequencies 
decrease precipitously for fragments located farther away. This inverse 
relationship between interaction frequency and genomic distance is expected for 
a flexible chromatin fiber in the absence of any specific long-range looping 
interactions (Dekker, 2006, 2008b; Dekker et al., 2002; Gheldof et al., 2006; 
Rippe, 2001). Specific long-range looping interactions would result in peaks of 
interaction frequency super-imposed upon this background of interactions. We 
conclude that in GM06990 cells, the promoter does not engage in specific 
interactions with elements located in the surrounding 460 kb (Figure 3.2A). 
In Caco2 cells, we also observe frequent interactions between the 
promoter fragment and nearby restriction fragments. In addition, we observe 
frequent interactions with several other restriction fragments, as evidenced by 
local peaks in interaction frequency above the background of non-specific 
associations. Two interacting restriction fragments are located 20 kb and 80 kb 
upstream of the TSS; one is located within the CFTR gene 108 kb downstream of 
the promoter in intron 11 and a fourth fragment is located 202 kb downstream of 
the TSS (15 kb downstream of the 3’ end of the gene).  
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Figure 3.1: Expression Level of CFTR as Detected by RT-PCR.  All six cell 
lines were analyzed at the CFTR exon2-exon3 junction and normalized using 
HPRT1 (primer sequences are given Appendix I). HeLa S3, HT29 and Caco2 cell 
lines express CFTR. K562 and HepG2 cells did not produce detectable levels of 
CFTR product. GM06990 cells expressed a low level of CFTR mRNA (here set 
as 1).  HeLa S3 expressed CFTR 2X higher than GM06990, while both HT29 and 
Caco2 show high levels of CFTR mRNA expression (1822 and 22606 fold higher 
than the level in GM06990, respectively). 
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Figure 3.2: Chromosome Conformation Capture (3C) Reveals Four 
Elements that Interact with the CFTR Transcription Start Site. All 
experiments used EcoRI to digest the chromatin. Interaction frequencies 
between the CFTR transcription start site and a 460 kb surrounding region are 
determined by 3C.  Primer sequences and 3C data are found in Appendix I.  A) 
3C profile of Caco2 cells (black circles), which express the CFTR gene, and 
GM06990 cells (open circles), which do not express the gene. B) 3C profile of 
HT29 cells (black circles), which express the CFTR gene, and K562 cells (open 
circles) which do not express the gene. C) 3C profile of HeLa S3 cells (black 
circles) which express the CFTR gene, and HepG2 cells (white circles), which do 
not express the gene.  
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To confirm these results we analyzed two additional pairs of cell lines, 
each composed of one cell line that expresses CFTR and one that does not. 
First, we chose HT29 cells, which express high levels of CFTR (Sood et al., 
1992), and K562 cells, which do not express CFTR (as determined by RT-PCR, 
Figure 3.1). We again performed 3C to analyze long-range interactions with the 
CFTR promoter fragment (Figure 3.2B). We observe that in both cell lines the 
promoter fragment frequently interacts with neighboring fragments, as expected, 
but these interactions are less frequent in HT29 cells than in K562 cells. We have 
previously observed that interaction frequencies around active promoters can be 
reduced, possibly as the result of local chromatin decondensation (Gheldof et al., 
2006). Importantly, we found no evidence for specific long-range looping 
interactions in K562 cells, but we again observe local peaks in interaction 
frequency for multiple restriction fragments in CFTR-expressing HT29 cells. 
These interacting restriction fragments are the same as those observed in Caco2 
cells (Figure 3.2A). In addition, we observe a region encompassing several 
EcoRI restriction fragments around the 3’ end of the CFTR gene that all display 
increased interaction frequencies as compared to K562 cells, suggesting the 
presence of multiple interaction elements in that region.  
 Second, we analyzed HeLa S3 cells that express CFTR at a low level (as 
determined by RT-PCR, Figure 3.1) and HepG2 cells that do not express CFTR. 
In HeLa S3 cells we again detect specific long-range interactions between the 
CFTR promoter fragment and a set of distant fragments, whereas no specific 
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long-range interactions were detected in HepG2 cells (Figure 3.2C). All 
interacting fragments correspond to the same set of fragments detected in Caco2 
and HT29 cells, except one: in HeLa S3 cells the promoter fragment does not 
frequently interact with the fragment located at -21 kb. Instead the promoter 
fragment associates more frequently with the restriction fragment immediately 
adjacent to this fragment, located at -17 kb. In HepG2 this -17 kb fragment also 
interacts with the promoter fragment somewhat more frequently than neighboring 
fragments. The two adjacent fragments located at -17 and -21 kb may contain 
two separate elements, or a single interacting region that displays cell type 
specific differences in the precise point of contact within the promoter. Finally, as 
in HT29 cells, we observe that in HeLa S3 cells the promoter fragment frequently 
interacts with several restriction fragments near and beyond the 3’ end of the 
gene. 
Multiple long-range interactions are observed between the CFTR promoter 
fragment and several restriction fragments upstream and downstream of the 
gene as well as within an intron of the gene. Moreover, these interactions are 
observed only in CFTR expressing cells (Caco2, HT29 and HeLa S3) and not in 
non-expressing cells (K562 and HepG2). Interestingly, GM06990 cells do not 
display these long-range interactions, yet express CFTR at a very low, but 
detectable, level. Thus, the correlation between CFTR expression and looping 
between the promoter and these distal elements is not absolute (see discussion). 
Analysis of digestion efficiency confirmed that these frequent interactions are not 
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due to more efficient digestion of the corresponding restriction sites, consistent 
with many other studies that showed that digestion efficiency is not a major 
contributor to variation in 3C interaction frequencies (not shown, (Dekker, 2007; 
Gheldof et al., 2006; Miele et al., 2009; Tolhuis et al., 2002)).   
For further analyses, we focused on loci that are consistently found to 
interact with the CFTR promoter in all three CFTR expressing cell lines. These 
looping elements are located at -80, -21/-17, +108 and +202 kb from the TSS 
(highlighted by grey bars in Figure 3.2). From here on we refer to these looping 
elements with Roman numerals (I through IV, with element II containing the two 
adjacent restriction fragments located 21 and 17 kb upstream of the TSS). It is 
important to point out that other interacting elements may be present at other 
locations in and around the CFTR locus, as suggested by additional cell-line 
specific peaks, e.g. around the 3’ end of the gene in HT29 cells. Consistently, 
one of these restriction fragments contains an element (located 6.8 kb 
downstream of the gene) that has recently been shown to bind CTCF and to also 
interact with the CFTR promoter in primary epididymis cells (Blackledge et al., 
2009). 
Two of the four identified elements (elements I and II) have been 
previously identified. Element I may play a structural role but does not appear to 
be critical for CFTR regulation as constructs lacking this element faithfully 
reproduce the appropriate expression pattern of CFTR in mouse (Nuthall et al., 
1999a). Element II has previously been shown to play a role in CFTR regulation 
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as deletion of this element reduces CFTR expression (Nuthall et al., 1999a). We 
note that the ENCODE consortium recently identified sites that are bound by the 
CTCF protein in the restriction fragment directly adjacent to element II in Caco2 
cells (John Stamatoyannopoulos, unpublished). The Harris lab also 
demonstrated CTCF binding to this element in Caco2 and Calu3 cells 
(Blackledge et al., 2007). This is interesting because CTCF has been directly 
implicated in mediating long-range looping interactions (Kurukuti et al., 2006; 
Phillips and Corces, 2009; Splinter et al., 2006). Indeed, knocking down CTCF in 
Caco2 cells reduces looping of element II to the CFTR promoter and increases 
CFTR gene expression (Gosalia et al., 2014). In addition, DNaseI hypersensitive 
sites, indicating the presence of putative regulatory elements, have been 
identified in or directly adjacent to both elements I and II (Smith et al., 1995). 
These data validate our 3C-based strategy for regulatory element discovery.  
 
Long-range Interactions Between Looping Elements  
 Long-range regulatory elements not only interact with promoters, but in 
some cases have also been found to interact with other regulatory elements, e.g. 
in the case of the beta-globin locus (Dostie and Dekker, 2007; Splinter et al., 
2006; Tolhuis et al., 2002). To determine whether any long-range interactions 
occur between the looping elements we identified above, we again employed 3C 
analysis in Caco2 and HeLa S3 cells.   
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First we performed 3C analyses anchored on elements I, II (anchored on the 
restriction fragment located 21 kb upstream of the TSS), III and IV in Caco2 and 
GM06990 cells (Figure 3.3). As expected, we find that these elements interact 
frequently with nearby restriction fragments in both cell lines. In addition, these 
elements interact frequently with the CFTR promoter fragment in Caco2 cells, but 
not in GM06990 cells. Elements I and II do appear to interact with elements III 
and IV, as minor peaks at the corresponding locations are visible (Figure 3.3A 
and 3.3C), although these interactions are considerably less frequent than their 
interaction with the promoter fragment. In Caco2 cells elements III and IV are 
found to interact prominently with each other, as strong peaks of interaction 
frequencies are readily detected between the two restriction fragments (Figure 
3.3E and 3.3G). In GM06990 cells we did not detect any obvious peaks in the 3C 
interaction profiles, suggesting that there are no specific looping interactions 
between these elements in that cell line. We note that interactions obtained with 
all 4 anchor elements are generally higher in Caco2 cells as compared to 
GM06990 cells throughout the region, which is as predicted for a locus that is 
more compact as a result of long-range looping interactions (Rippe, 2001). We 
conclude that in Caco2 cells elements III and IV not only interact with the CFTR 
promoter fragment but also associate with each other, whereas elements I and II 
interact mainly with the promoter and less frequently with the other looping 
elements. 
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Figure 3.3: 3C Interaction Profiles for Each of the Four Elements. All 
experiments used EcoRI to digest the chromatin. 3C data can be found in 
Appendix I.  A) The anchor point is set at Element I in Caco2 and GM06990 
cells, showing interactions between Element I and Element II, the transcription 
start site (TSS), and Element III and IV in Caco2 cells, with no notable 
interactions in GM06990 cells. B) The anchor point is set at Element I in HeLa S3 
and HepG2 cells, showing interactions between Element I and Element II, III and 
IV in HeLa S3 cells, with no notable interactions in HepG2 cells. C) The anchor 
point is set at Element II in Caco2 and GM06990 cells, showing interactions 
between Element II and Element I, TSS, Element III and IV in Caco2 cells, with 
no notable interactions in GM cells. D) The anchor point is set at Element II in 
HeLa S3 and HepG2 cells, showing interactions between Element II and Element 
I, III and IV in HeLa S3 cells, with no notable interactions in HepG2 cells. E) The 
anchor point is set at Element III in Caco2 and GM cells, showing interactions 
between Element III and Element I, II, TSS and element IV in Caco2 cells, with 
no notable interactions in GM cells. F) The anchor point is set at Element III in 
HeLa S3 and HepG2 cells, showing interactions between Element III and 
Element I, II, TSS, and Element IV in HeLa S3 cells, with no notable interactions 
in HepG2 cells. G) The anchor point is set at Element IV in Caco2 and GM cells, 
showing interactions between Element IV and Element I, II, TSS, and Element III 
in Caco2 cells, with no notable interactions in GM cells. H) The anchor point is 
set at Element IV in HeLa S3 and HepG2 cells, showing interactions between 
Element IV and Element I, II, TSS, and Element III in HeLa S2 cells, with no 
notable interactions in HepG2 cells.  
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We repeated the 3C analysis in HeLa S3 and K562 cells with the 
exception that for these cells the anchor for element II was on the restriction 
fragment located at -17 kb that we found to interact more frequently with the 
promoter fragment than the -21 kb restriction fragment (Figure 3.2C).  We again 
observe that in HeLa S3 cells, but not in HepG2 cells, elements III and IV interact 
prominently with each other, as compared to background levels at other positions 
in the locus (Figure 3.3F and 3.3H). Elements I and II also display local peaks of 
interaction at the locations of the other looping elements (Figure 3.3B and 3.3D). 
The interaction between element I and IV is particularly prominent in HeLa S3 
cells, whereas this interaction is much less pronounced in Caco2 cells.   
We conclude that in CFTR expressing cells, elements I-IV not only interact 
with the promoter fragment but also with each other. In addition, the interaction 
frequency of these elements is cell line specific. In HeLa S3 cells all elements 
interact prominently with each other. In Caco2 cells only elements III and IV 
interact prominently with each other, and they do so with a frequency that is 
comparable to that of interactions between these elements and the promoter 
fragment.  
 
Fine Mapping of Looping Elements III and IV 
  We did not analyze elements I and II further, as they have been 
characterized before (Blackledge et al., 2007; Gosalia et al., 2014; Nuthall et al., 
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1999a). Rather we focused on elements III and IV in Caco2 cells as they could 
represent novel regulatory elements that control the CFTR gene.   
The above 3C analysis identified individual EcoRI restriction fragments 
that displayed the most prominent interactions with the promoter fragment. The 
size of these restriction fragments averages 4 kb, but the elements that mediate 
these interactions are most likely considerably smaller. In order to determine the 
position of the putative elements at higher resolution, we repeated the 3C 
analysis with another restriction enzyme, BsrGI. We chose this enzyme because 
it cuts the selected EcoRI fragments into smaller pieces. We then analyzed the 
interactions between the BsrGI fragment containing the TSS and several BsrGI 
fragments located around the positions of elements III and IV (Figure 3.4). We 
find a local peak of interaction between the promoter fragment and a 1066 bp 
fragment containing element III, located in the 3’ end of the original 3252 bp 
EcoRI fragment (Figure 3.4A, 3.5A). We also see a peak between the promoter 
fragment and a 1560 bp fragment, located near the 3’ end of the original 6069 bp 
EcoRI fragment containing element IV (Figure 3.4B, 3.5B). These interactions 
were not observed in GM06990 cells. These results confirm the presence of 
looping elements at these locations, and further define the positions of these 
elements. Based on the two independent 3C analyses performed with EcoRI and 
BsrGI we conclude that element III is contained within an 806 bp BsrGI-EcoRI 
fragment and that element IV is contained within the 1560 bp BsrGI restriction 
fragment (Figure 3.5). 
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Above we identified interactions between EcoRI fragments containing elements 
III and IV. We wanted to know if the interactions between elements III and IV are 
mediated by the same elements as the interactions between the promoter 
fragment and element III and IV, respectively, or whether these distinct 
interactions involved other elements contained within the EcoRI restriction 
fragments. Therefore, we tested whether the same BsrGI fragments that interact 
with the promoter fragment also interact with each other. 3C analysis confirmed 
that the BsrGI fragment containing element III interacts most prominently will 
BsrGI fragment that contains element IV (Figure 3.4C).  These results suggest 
that the same elements that interact with the promoter also interact with each 
other. 
 
Additional Evidence for the Presence of Functional Elements in the 
Looping Elements III and IV 
The use of two enzymes in our 3C analysis allowed us to define the 
minimal interacting and functional regions containing elements III and IV. In 
Figure 3.5 we show, in modified UCSC genome browser shots, the EcoRI and 
BsrGI fragments that interacted most prominently with the promoter fragment. 
The minimal region of overlap between these fragments defines the positions of 
elements III and IV (indicated by vertical lines). 
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Figure 3.4: Fine Mapping of the Looping Interactions Between the CFTR 
Promoter and Elements III and IV. 3C primers and data can be found in 
Appendix I.  A-C) 3C profiles using BsrGI to digest the chromatin focused on 
Element III (A), anchored at the TSS. The interaction peak corresponds to a 
1066 bp fragment.  B) 3C focused on Element IV, anchored at the TSS. The 
interaction peak corresponds to a 1560 bp fragment. C) 3C focused on Elements 
IV anchored at Element III. The interaction peak corresponds to a same 1560 bp 
fragment that interacts with the CFTR TSS.  
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Figure 3.5: Data from the ENCODE Consortium in the UCSC Genome 
Browser hg18 [http://genome.ucsc.edu/ENCODE/]. Restriction fragments that show 
3C interaction peaks are outlined with grey boxes.  A boxed outline indicates the 
narrowed-down functional region.  Histone methylation, acetylation and DHS 
data are shown, with “positive hits” shown as darker grey regions.  A) Region 
117013000-117019000 on chromosome 7, which contains element III.  B) 
Region 117100000-117120000 on chromosome 7, which contains element IV. 
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To obtain further evidence that the regions we identified here contain 
functional elements, we determined whether they display chromatin features that 
indicate the presence of regulatory elements. One hallmark of functional 
elements is the presence of DNaseI hypersensitive sites, corresponding to 
nucleosome free regions bound by regulatory protein complexes. In addition, 
regulatory elements, e.g. enhancers, have been found to display characteristic 
histone modifications including increased levels of acetylation and high levels of 
histone H3 monomethylation at the fourth lysine residue (H3K4Me1). The CFTR 
locus was selected for study by the ENCODE pilot project and as part of this 
consortium we generated extensive data related to chromatin structure and 
modification (publicly available http://genome.ucsc.edu/ENCODE/). Figure 3.5 
shows our ENCODE data representing DNaseI hypersensitivity (in Caco2, 
GM06990, and HeLa S3 cells) and a variety of histone modifications (as detected 
in GM06990 and HeLa S3 cells) for the genomic regions containing elements III 
and IV. Strikingly, the minimal regions containing elements III and IV (indicated 
by vertical lines in Figure 3.5) coincide precisely with the presence of DNaseI 
hypersensitive sites. These hypersensitive are found in CFTR expressing cells 
(Caco2 and HeLa S3), but not in GM06990 or HepG2 cells, which do not express 
CFTR. Also in HeLa S3 cells the regions around elements III and IV are enriched 
in H3K4Me1 and acetylated H4. Some H3K4Me1 is also found at element III in 
GM06990 cells. These comparisons strongly suggest that elements III and IV 
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contain functional elements, and indicate that our 3C-based element discovery 
approach identified bona fide CFTR regulatory elements. 
 
Two Looping Elements Act as CFTR Enhancers 
Data from the 3C experiments showed four elements looping to the CFTR 
promoter. Indeed we saw that elements III and IV contained DHS specific to cells 
expressing CFTR. We wondered if any of these four elements acted as an 
enhancer of CFTR expression. To test this, we performed a luciferase assay with 
all four looping elements. We used the CFTR promoter, consisting of 100 bp 
upstream of the transcription start site (TSS) and 1556 bp downstream of the 
TSS (hg18 chr7 116905696-116907350, total size 1656 bp), Gateway cloned into 
the pGL3 vector immediately upstream of the luciferase gene. Different genomic 
fragments (Table 3.1) were Gateway cloned directly upstream of the promoter, 
creating the following construct: Element – CFTR Promoter – Luciferase. The 
constructs were transfected into both Caco2 and HepG2 cells.  
The results of the first assay can be seen in Figure 3.6. Figure 3.6A-E 
shows the genomic locations of all four elements.  We split each element 
fragment (defined as the EcoRI fragment that was found to interact with 
the CFTR promoter fragment) into smaller fragments of 1.1–1.8 kb to allow 
location of the position of a potential regulatory element more precisely (Figure 
3.6): element I into three (Ia, Ib and Ic), element III into two (IIIa and IIIb) and 
element IV into three fragments (IVa, IVb and IVc). As a positive control we used 
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a known enhancer located in intron 1 (Smith et al., 1996). Luciferase activity was 
measured in CFTR-expressing Caco2 cells and non-CFTR-expressing HepG2 
cells and normalized to the level detected with the CFTR promoter alone. As 
shown in Figure 3.6F, we find that the known enhancer (intron 1) activates 
the CFTR promoter in both Caco2 cells and HepG2 cells, although to a 
significantly higher level in HepG2 cells. The strong activity of the intron 1 
enhancer in HepG2 cells was unexpected, given that this enhancer has been 
reported to be specific to intestinal cells (Rowntree et al., 2001; Smith et al., 
1996). Interestingly, we found that the DHS present at this enhancer in intestinal 
cells is also prominently present in HepG2 cells (J.A.S., unpublished results), 
suggesting that this enhancer may be active in these cells. Additionally, we note 
that this element loops to the CFTR promoter in both Caco2 and GM06990 cells 
(Figure 3.7), indicating that it may not be cell type-specific. Elements I and II 
have been previously described as having little effect on increasing CFTR 
expression (Smith et al., 1995). Accordingly, we did not see any enhancer activity 
from either of these elements in the assay. Furthermore, only one fragment (IVc), 
encompassing the distal portion of the EcoRI fragment containing element IV, 
modestly activates the CFTR promoter to a similar extent in both cell types. 
Importantly, fragment IVc overlaps the BsrGI restriction fragment that most 
prominently interacted with the promoter fragment, allowing us to further narrow 
down the element’s position to a 1002 bp locus (Figure 3.6E). We noted that 
when element IIIb and IVc were both cloned into the luciferase vector they  
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Figure 3.6: Luciferase Assay Shows Elements IIIb and IVc Act as Additive 
CFTR Enhancers A-E) Data showing the luciferase fragments in the USCS 
Genome Browser. DNase1 Hypersensitivity (DHS) data is given for HepG2 and 
Caco2 cells. A) The locations of all fragments used in the luciferase assay. B) 
Zoom in to element I. The yellow rectangles show the regions cloned into the 
luciferase vector directly upstream of the luciferase gene. C) Zoom in to element 
II. D) Zoom in to element III. E) Zoom in to element IV. F) Results from the 
luciferase assay. Results were normalized so the level of expression in the 
construct containing the promoter alone is set to 1. A one-tailed T test was used 
to determine p-values. Error bars represent the standard error of the mean.  
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Figure 3.7: An Enhancer Element in Intron 1 Loops to the CFTR Promoter.  
BsrGI was used to digest the chromatin. The grey bar outlined in black 
represents the promoter anchor point.  The grey bar with no outline shows the 
interaction peak of the fragment containing the enhancer in intron 1. In both 
GM06990 (open circles) and Caco2 (closed circles) the enhancer elements 
interacts with the promoter, though only Caco2 cells express CFTR, while 
GM06990 cells do not.   
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enhanced activity more than when they were cloned in separately. Additionally, 
both fragments contain a DHS specific to Caco2 cells (Nuthall et al., 1999b; Sabo 
et al., 2004, 2006). Using 3C, we have shown that these two regions contained 
enough information to maintain the looping contact when cut with BsrGI. Thus, 
we investigated these two elements further. 
In the second round of luciferase assays, we fragmented elements IIIb 
and IVc, creating constructs containing the entire element, constructs containing 
just the DHS, and constructs with everything except the DHS (Figure 3.8). We 
then assayed these constructs in the luciferase assay as described (see 
Materials and Methods). As seen in Figure 3.8F, when element IIIb or IVc lose 
their DHS, the enhancer activity is abolished. The DHS region alone is enough to 
create enhanced luciferase expression (though not as strongly as the entire 
element). When both these minimal DHS elements are combined, an increase in 
enhancer activity is observed in both Caco2 and HepG2 cell lines. This result 
agrees with our 3C data which show elements III and IV in close three-
dimensional proximity to each other and to the promoter, suggesting they may 
act in concert to regulate CFTR. Using both the DHS and luciferase data, 
combined with our earlier studies done with 3C, we conclude that the minimal 
area needed to enhance CFTR expression coincides with the DHS sites within 
each fragment. Thus, we define the minimal enhancer of element III to be 717 bp 
(chr7 hg18:117015552-117016269) and the minimal enhancer of element IV to  
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Figure 3.8: DHS Within Elements III and IV are Necessary and Sufficient for 
Enhancer Function. A-E Data showing the luciferase fragments in the USCS 
Genome Browser. DNase1 Hypersensitivity (DHS) data is given for HepG2 and 
Caco2 cells. A) The CFTR gene is shown with the locations of fragments used in 
the luciferase assay. B) Zoom in to the CFTR promoter region. The red rectangle 
shows the region cloned into the luciferase vector directly upstream of the 
luciferase gene. C) Zoom in to the positive control region Intron1. D) Zoom in to 
element III. “IIIwhole” is the minimal looping region identified by 3C. “III-DHS” is 
the minimal looping region without the DHS. “IIIDHS” is just the DHS site as 
defined in Caco2 cells. E) Zoom in to element IV. “IVwhole” is the minimal 
looping region identified by 3C. “IV-DHS” is the minimal looping region without 
the DHS – these two fragments were combined. “IVDHS” is just the DHS site as 
defined in Caco2 cells. F) Results from the luciferase assay. Results were 
normalized so the level of expression in the construct containing the promoter 
alone is set to 1. A one-tailed T test was used to determine p-values. Error bars 
represent the standard error of the mean.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
140 
 
be 620 bp (chr7 hg18:117110095-117110715). We used these minimal 
enhancers to identify which transcription factors may bind to the DNA. 
 
 Identifying Transcription Factors that Bind to the Minimal Enhancer 
Elements 
After identifying the minimal regions that enhanced CFTR expression, we 
wanted to know what transcription factors might be mediating both the enhancer 
effect and/or the three-dimensional contacts. Experimental technologies for 
identifying protein-DNA interactions include ChIP, DamID, Protein-binding 
microarrays (PBMs), and SELEX. However, these technologies require prior 
knowledge of the proteins of interest. We wanted to discover unknown proteins 
that bind to a known DNA sequence. For this type of experiment, the best 
approach is to use the Yeast One-hybrid technique (Y1H) (Deplancke et al., 
2004, 2006; Reece-Hoyes et al., 2011) (Figure 3.9). This technique uses 
elements of interest as “bait” and a library of human transcription factors as 
“prey.” Yeast contain inserts of the bait in two different genomic locations (HIS3 
and URA3) to decrease the amount of false positives (Figure 3.9A). The yeast is 
then mated to a library of yeast expressing one human transcription factor each. 
The yeast are plated on selective media and assayed for both growth and color 
(Figure 3.9B, C). We did not screen elements I and II because they do not show 
DHS or enhancer activity in our cell lines of interest. The baits that covered the  
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Figure 3.9: The Experimental Procedure and Sample Readout for the Yeast 
one-hybrid (Y1H) Assay. A) Depiction of the molecular biology used in the 
assay. The yeast strain YM4271 contains two insertions of the same DNA bait 
sequence – one located at the HIS3 locus and another, containing the LacZ 
gene, located at the URA3 locus. A plasmid containing the human transcription 
factor (hTF) of interest cloned downstream of the GAL4 activation domain (AD) 
and containing the TRP1 gene for selection is transformed into the yeast strain. 
Readout comes from growth on Sc-UHT media + 3 amino-trizole (3AT) + X-gal. 
B) The timeline of the experiment. On Day 0, the yeast containing the bait DNA 
sequence is plated on YEPD media. The next day the yeast is transferred to 
square plates with YEPD media for use with the robot. On Day 4, the bait strain 
is mated with the human array, which contained 1,536 clones. On Day 5 the 
mated yeast are transferred to selective media, and readout begins on Day 6. C) 
Samples of Y1H readout. Each bait-prey mating is plated in quadruplicate, 
allowing for high confidence when scoring the assay. Yeast must grow and turn 
blue in 2 out of the 4 locations to be called positive. The growth and color 
intensity were rated by eye for 7 days following plating on selective media. Three 
positive examples and one negative example are shown for comparison.  
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DHSs of elements III and IV were identical to the fragments IIIDHS and IVDHS 
from the luciferase assay.  
 
Yeast one-hybrid Identified High-confidence Transcription Factors 
Screening element III resulted in two high-confidence hits: TCF4 (also 
called TCF7L2) and LEF1. This result was surprising and interesting. TCF4 and 
LEF1 act together to bind specific DNA elements and are known downstream 
activators of the WNT signaling pathway (Beildeck et al., 2009; Hatzis et al., 
2008; Korinek et al., 1998). Gratifyingly, additional evidence exists confirming 
these TFs as valid interactions. ChIP-seq has identified TCF4 binding to both 
element III and element IV in intestinal cells (Mokry et al., 2010). Additionally, a 
2007 paper by Paul et al. showed that RNAi against TCF4 in Caco2 cells 
reduced expression of CFTR by half (Paul et al., 2007). With this evidence, we 
are quite confident that TCF4 and LEF1 do indeed play a role in regulating CFTR 
gene expression.  
Screening element IV resulted in five high-confidence hits: ESRRB, 
ESRRG, THRB, NR5A1 and NR5A2. The ESRRB protein has similarity to the 
estrogen receptor though its function is unknown, and ESRRG is known to act as 
a transcription factor in the absence of a bound ligand. THRB is a nuclear 
hormone receptor for triiodothyronine. NR5A1 is involved in sex determination, 
and NR5A2 acts as a tissue-specific transcription factor in pancreas and liver. As 
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of yet there is no additional evidence relating these proteins to CFTR gene 
expression. 
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Discussion 
 
3C Identified Four Elements That Loop to the CFTR Gene Promoter 
 We have employed 3C to identify long-range regulatory elements that may 
be involved in controlling the CFTR gene. We identified 4 elements that interact 
with the CFTR promoter specifically in CFTR-expressing cells. These looping 
elements appear to be gene regulatory elements based on the following 
observations. First, two of the elements had been previously identified as 
putative regulatory elements and one of these elements (element II) has been 
found to directly affect CFTR expression (Gosalia et al., 2014; Nuthall et al., 
1999a; Smith et al., 1996).  Second, these elements contain DNaseI 
hypersensitive sites and, in the case of elements III and IV patterns of histone 
modifications in CFTR expressing cells that have previously been found to be 
predictive of distal regulatory elements (Heintzman et al., 2007, 2009). Third, we 
show that elements III and IV contain DHS that act as enhancers in a luciferase 
assay. 
 Our studies did not identify all previously discovered regulatory elements 
around the CFTR locus. There are several reasons for this. First, we did not 
analyze all restriction fragments throughout the 460 Kb surrounding the CFTR 
promoter. For instance, we did not analyze interactions between the CFTR 
promoter and a known enhancer of the CFTR gene that is located 10 kb 
downstream of the promoter in intron 1 when we used EcoRI. The Harris lab has 
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recently shown that this element interacts with and regulates the CFTR promoter 
(Ott et al., 2009a). We have been able to confirm this looping interaction in our 
3C experiments using BsrGI (Figure 3.7). Second, we have focused on only 
those elements that consistently interact with the CFTR promoter in CFTR 
expressing cell lines (Caco2, HT29, HeLa S3). We did find that in some cell lines 
(e.g. HT29) there are additional elements that appear to frequently interact with 
the CFTR promoter, for instance a region just downstream of the gene. 
Consistently, the Harris lab has shown that that region contains additional 
elements that loop to the CFTR promoter in primary epididymis cells (Blackledge 
et al., 2009). Thus, we have been able to confirm previously detected regulatory 
elements (elements I and II, as well as the known enhancer in intron 1), thereby 
validating our approach, and we have discovered novel CFTR regulatory 
elements.   
 
Elements III and IV can act as CFTR Enhancers 
In this study we focused on elements III and IV. Further 3C experiments 
allowed us to narrow the regions of interaction of these elements down to ~ 1kb. 
In addition, these elements coincide precisely with the presence of DNaseI 
hypersensitive sites present in CFTR expressing cells and with regions enriched 
in histone modifications associated with enhancers (Heintzman et al., 2007). 
Combined, these independent lines of research provide strong evidence that true 
CFTR regulatory elements were identified. 
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We find that element IV consistently enhances luciferase expression. 
Element III has weak enhancer activity. However these elements combined 
display an additive enhancer effect. Additionally, we were able to identify the 
minimal region necessary for enhancement by deleting the DHS region from the 
constructs and noting that the enhancer effect disappears (Figure 3.8). When the 
DHS regions were placed in the construct alone or together, these minimal 
elements maintained enhancer activity. DHS’s are known to be marks of open, 
active chromatin (Birney et al., 2007). Thus it is not surprising that the minimal 
enhancer elements contain DHS. Locating the minimal enhancer elements also 
allowed us to define the smallest element to introduce into the yeast one-hybrid 
system to reduce off-target effects and false positive results. 
 
The Presence of Looping Elements Does Not Correlate with Gene 
Expression 
The long-range looping interactions described here are clearly correlated 
with expression of the CFTR gene. However, we note that the frequency of 
looping is not quantitatively related to the level of CFTR expression. The 
frequency of interaction between the CFTR promoter region and elements III and 
IV is quite comparable in Caco2 cells and HeLa S3 cells, despite the fact that 
Caco2 cells express the gene at a much higher level (Figure 3.1). This indicates 
that these long-range interactions are not sufficient for high levels of expression. 
One possible explanation is that in Caco2 cells additional transcription factors 
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and/or co-regulators bind these elements to further activate the gene. We also 
point out that the long-range looping interactions between the CFTR promoter 
and elements I – IV are not required for a low level of expression, as GM06990 
cells express very low, but detectable, levels of CFTR while none of these long-
range interactions is detected. It is possible that this low level is simply due to 
basal promoter activity or is the result of long-range interactions with other distal 
regulatory element. For instance, we find that in GM06990 cells the promoter is 
interacting with the enhancer element in intron 1 (Figure 3.7), and we note that 
intron 1 activates CFTR promoter expression in HepG2 cells (Figures 3.6 and 
3.8). Thus, the 3D contact with intron 1 in GM06990 cells may be enough to 
promoter CFTR gene expression at a very low level. 
The four elements we uncovered in our 3C analysis interact with the 
CFTR promoter in all three CFTR expressing cells. These elements also all 
interact with each other, suggesting they form a single cluster of interacting 
chromatin segments. We do note that the frequency of interaction between pairs 
of elements varies (Figure 3.3), and is also somewhat different between cell 
lines. Thus, although the overall conformation of the locus is comparable in 
Caco2 and HeLa S3 cells, there may be slight differences in the frequencies with 
which long-range interaction occur. Alternately, HeLa S3 cells may be in a poised 
conformation, ready to express CFTR at a higher level upon some stimulus. 
  
High-confidence Human Transcriptions Factors Bind to CFTR Enhancers 
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We tested the elements found to be enhancers in a yeast one-hybrid 
assay (Deplancke et al., 2004, 2006; Reece-Hoyes et al., 2011). This assay 
contained clones for 988 human transcription factors. We used the minimal 
enhancer regions identified in the luciferase assay to act as the bait for the hTFs. 
Any hTF that had a positive hit in all three biological references was placed into 
our high-confidence category. For element III we identified two high-confidence 
hTFs: LEF1 and TCF4. For element III we identified five high-confidence hTFs: 
ESRRB, ESRRG, THRB, NR5A1 and NR5A2.  
We identified some transcription factors as false positives, including ZIC1 
and ZIC3. These TFs gave extremely high readouts with many of the tested 
baits. It is hard to identify false negatives in the Y1H, though they will indeed 
occur. FOXA1 has been shown by ChIP to be bind element III specifically in 
Caco2 cells (Yigit et al., 2013). FOXA1 is included in the Y1H array at position 
01_A01 but the clone’s sequence was incorrect. Therefore we did not actually 
test FOXA1 in the Y1H, though the hTF name is included on the list of hTFs 
available in the assay.  
Once we obtained our high-confidence hits, we did a literature search to 
see if there was any previous evidence linking the hTFs with CFTR gene 
expression. We were able to find literature supporting TCF4 and LEF1 binding to 
element III (Mokry et al., 2010). Interestingly, Mokry et al found TCF4 binding to 
both element III and IV, but our yeast one-hybrid screen only found TCF4 binding 
to element III. We know from our 3C experiments that the enhancer in element III 
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and the enhancer in element IV are all connected in three-dimensional space. 
Therefore, it could be that the TCF4 found at element IV by ChIP resulted from 
its close proximity to element III. Alternatively, theY1H might not have picked up 
TCF4 binding at element IV.  
Identification of extragenic elements that affect expression of CFTR will 
not only provide basic insights into spatio-temporal regulation of this important 
gene, it may also be important for genetic diagnosis of Cystic Fibrosis. A 
significant number of patients with Cystic Fibrosis symptoms do not appear to 
carry mutations in the CFTR exons or promoter, suggesting that extra-genic or 
intronic mutations may be present, e.g. in long-range acting gene regulatory 
elements. In the absence of information of the positions of distant regulatory 
elements it is not feasible to screen for mutations in a very large genomic region. 
Thus, identification of CFTR regulatory elements, as we have described here, 
provides new targets for mutation screening. Further, gene therapy approaches 
for Cystic Fibrosis could benefit from knowledge of gene regulatory elements by 
including such elements in CFTR gene targeting constructs. 
 We have shown that 3C technology can be used to discover novel 
regulatory elements throughout gene loci. A variety of 3C adaptations have 
recently been developed that allow large-scale detection of chromatin looping 
interactions (Dostie et al., 2006; Lieberman-Aiden et al., 2009; Simonis et al., 
2006; Zhao et al., 2006). Using these technologies, it may become possible to 
map the regulatory elements that control genes throughout the genome.  
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CHAPTER IV 
 
THREE-DIMENSIONAL STUDY OF THE CYSTIC FIBROSIS LOCUS 
REVEALS CELL-TYPE SPECIFIC CHROMATIN LOOPING AND WELL-
DEFINED TAD STRUCTURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is adapted from the paper "Regulation of gene expression around 
the CFTR locus through cell type-specific chromatin looping in the context of 
invariant topologically associating domains" by E.M. Smith, B. Lajoie, G. Jain and 
J. Dekker, in preparation.  
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Contributions 
 
 
This paper examines a 2.8 Mb region surrounding the CFTR gene and shows 
well-defined TAD structure in the region. It analyzes gene expression and looping 
interactions within the region. E.M.S. and B.L. designed the 5C experiment. 
E.M.S. performed the experiments. E.M.S., B.L. and G.J. performed data 
analysis. E.M.S. and J.D. wrote the manuscript. J.D. provided guidance and 
feedback throughout the project. 
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Abstract 
 
 
Three-dimensional genome structure plays an important role in gene expression 
and regulation. Chromosomes are organized into active and inactive 
compartments, while genes are regulated by specific looping interactions 
between promoters and regulatory elements. In between these two levels of 
structure, topologically associating domains (TADs) have recently been 
described. TADs occur throughout the genome range in size from a few hundred 
kilobases to around a megabase. Major questions include TADs relationship to 
long-range looping interactions between genes and regulatory elements.  Here 
we examine chromosome conformation of a 2.8 Mb region on human 
chromosome 7 surrounding the cystic fibrosis gene (CFTR) in a panel of different 
cell types. We find the same set of 6 TAD boundaries present in all cell types 
studied, irrespective of gene expression status or internal looping. In contrast the 
internal organization of TADs is cell line-specific. This is particularly exemplified 
by the CFTR promoter that interacts with distinct sets of cell type-specific 
regulatory elements located within the same TAD. Interestingly, interactions 
between TAD are also highly cell type-specific and often occur in clusters at and 
around TAD boundaries. These data shed new light on the roles of TAD 
boundaries in constraining as well as mediating long-range looping interactions 
and gene regulation. 
 
153 
 
Introduction 
 
 
The three-dimensional (3D) structure of chromosomes is thought to play a 
critical role in gene regulation. At the nuclear level, individual chromosomes 
occupy their own territories within the cell nucleus (Bolzer et al., 2005; Cremer 
and Cremer, 2001), with some intermingling where they touch (Branco and 
Pombo, 2006). Larger chromosomes tend to be positioned more peripherally, 
while the smaller chromosomes are preferentially located near other small 
chromosomes in the center of the nucleus (Boyle et al., 2001, 2011; Croft et al., 
1999). Chromosomes themselves are compartmentalized so that active (open) 
and inactive (closed) chromatin domains are spatially separated.  In Hi-C data 
this is apparent by the detection of A and B compartments (Lieberman-Aiden et 
al., 2009): large (several Megabases (Mb)) chromatin domains that alternate 
along the length of the chromosomes. A compartments represent active regions 
of chromosomes as assessed by gene expression and the presence of chromatin 
features such as DNase1 sensitivity and the presence of active histone 
modifications (H3K4Me3, H3K27Ac). B compartments typically display less or no 
transcription and are composed of closed chromatin (Lieberman-Aiden et al., 
2009; Zhang et al., 2012). These compartments tend to cluster with themselves, 
i.e. A compartments interact more frequently with other A compartments and less 
frequently with B compartments, and vice versa. A compartments may represent 
transcription factories where active genes cluster together, while inactive 
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chromatin is constrained to repressed sites in the nucleus such as the nuclear 
periphery (Cook, 1999; Guelen et al., 2008; Iborra et al., 1996; Wansink et al., 
1993).  
At a considerably smaller scale, chromatin organization plays a direct role 
in regulation of gene expression through looping interactions between gene 
promoters and their distal regulatory elements, including enhancers and CTCF-
bound insulator-like elements. Such locus-specific looping interactions mostly 
occur on a scale of a few kilobases (kb) to 1 Mb (Amano et al., 2009; Baù et al., 
2011; Gheldof et al., 2010; Lettice et al., 2003; Murrell et al., 2004; Ott et al., 
2009b; Palstra et al., 2003; Phillips-Cremins et al., 2013; Sagai et al., 2005; 
Sanyal et al., 2012; Tolhuis et al., 2002; Vernimmen et al., 2007; Wright et al., 
2010). This is consistent with genetic analyses and functional studies that show 
that most regulatory elements act on a length scale of several hundred kb 
(Kleinjan and van Heyningen, 2005). 
Recently, a new feature of chromatin organization was described at 
intermediate length scales: topologically associating domains (TADs) (Dixon et 
al., 2012; Nora et al., 2012; Sexton et al., 2012). TADs are defined as contiguous 
chromatin domains that display relatively high levels of self-association, 
separated by boundaries. Loci located in adjacent TADs interact much less 
frequently, suggesting that TAD boundaries act as physical insulators. TADs 
range in size from a few hundred kb to a few Mb, and are found across cell types 
and across species (Dixon et al., 2012; Nora et al., 2012). TAD boundaries seem 
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to correlate with CTCF sites, consistent with an insulation-type role (Dixon et al., 
2012; Phillips-Cremins et al., 2013). However, not all TAD boundaries occur at a 
CTCF site, indicating that the presence of a CTCF site is not sufficient for 
formation of a TAD boundary. Deletion of a TAD boundary region causes the two 
neighboring TADs to partially intermingle (Nora et al., 2012). TADs seem to be 
invariant between the small set of cell types studied to date (Dixon et al., 2012; 
Nora et al., 2012) although differences in the internal organization of TADs has 
been observed between different cell lines (Phillips-Cremins et al., 2013). TADs 
are also structurally modulated during the cell cycle, when they disappear in 
mitosis and reform in early G1 (Naumova et al., 2013).  
Several lines of evidence indicate that TADs are important for appropriate 
regulation of gene expression. First, genes located within a TAD show, in some 
cases, increased correlation in their expression during cell differentiation, as 
compared to genes located in different TADs (Nora et al., 2012). Second, 
domains of histone modifications and lamin association, both features related to 
the expression status of genes, can correlate with TADs (Dily et al., 2014; Nora 
et al., 2012). Third, using an enhancer sensor approach functional domains were 
identified that represent target regions of enhancers. These domains correlated 
well with TADs, suggesting that regulatory elements can act on entire TADs as a 
structural unit (Symmons et al., 2014). Further, looping interactions between 
promoters and enhancers occur frequently within TADs and less frequently 
between TADs (Jin et al., 2013).   
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A major question is whether TADs are defined by their boundaries only or 
whether their formation is determined or facilitated by looping interactions 
between loci, e.g. between promoters and enhancers, located within them 
(Giorgetti et al., 2014). Thus, a key question is whether TADs act upstream of 
chromatin looping or whether TADs are, at least in part, driven by looping 
interactions within them. Another question is whether and how TADs interact with 
each other, and whether specific elements are involved. 
 In order to examine the relationship between TAD structure and looping 
interactions in more depth, we analyzed a 2.8 Mb region on chromosome 7 
containing the cystic fibrosis transmembrane conductance regulator gene 
(CFTR). We and others have previously used 3C to identify several regulatory 
elements located up to 200 kb from the CFTR promoter that directly loop and 
interact with the promoter and with each other (Gheldof et al., 2010; Ott et al., 
2009). We expand our original study to include 11 more genes and a 700 kb 
gene-poor region. We use a variety of cell types to understand how the 3D 
structure of the locus may contribute to CFTR gene regulation. We find that 7 
TADs exist in this region, and that all the known regulatory elements of CFTR are 
contained within one TAD. We find that all cell lines maintain the same TAD 
structure, regardless of gene expression within the TAD. We provide detailed 
information about the types of loops that occur within and between TADs.  
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Materials and Methods 
 
Cell Culture 
Five cell lines were used in the experiments in this chapter. All cell lines 
were grown with antibiotic (1% penicillin–streptomycin). GM12878 
lymphoblastoid cells (Coriell Cell Repositories) were grown in RPMI 1640 
medium supplemented with 2mM L-glutamine and 15% fetal bovine serum 
(FBS). HepG2 hepatocellular carcinoma cells (ATCC) were grown in MEMα with 
10% FBS. Caco2 colorectal adenocarcinoma cells (ATCC) were grown in MEMα 
with 20% FBS. Calu3 lung adenocarcinoma cells (ATCC) were grown in ATCC-
formulated E-MEM with 10% FBS. Capan1 pancreas adenocarcinoma cells 
(ATCC) were grown in IMDM with 20% FBS. Cell densities were maintained as 
recommended using Accutase (Life) to detach adherent cells from plates.  
 
Chromosome Conformation Capture Carbon Copy (5C) 
5C experiment 
5C was carried out as previously described (Sanyal et al., 2012). We 
investigated a 2.8 Mb region on Chromosome 7 (hg18 chr7:115797757-
118405450) containing the ENCODE region ENm001. The 5C experiment was 
designed to interrogate looping interactions between HindIII fragments containing 
transcription start sites (TSSs) and any other HindIII restriction fragment (distal 
fragments) in the target region. Libraries were generated for five cell lines: 
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Caco2, Calu3, Capan1, GM12878 and HepG2, with two biological replicates for 
each line.  
5C probe design 
5C probes were designed at HindIII restriction sites (AAGCTT) using 5C 
primer design tools previously developed and made available online at My5C 
website (http://my5C.umassmed.edu) (Lajoie et al., 2009). Probes were designed 
based on the ENCODE manual region 1 design (Sanyal et al., 2012) with 
additional probes placed throughout the region when appropriate. We also added 
probes in a gene desert region approximately 700 kb in length. All probe 
locations can be found in Table 4.1. Probe settings were: U-BLAST, 3; S-BLAST, 
100; 15-MER, 3,000; MIN_FSIZE, 250; MAX_FSIZE, 20,000; OPT_TM, 65; 
OPT_PSIZE, 40.  
Generation of 5C libraries 
3C was performed with HindIII restriction enzyme as previously described 
(Naumova et al., 2012) for Caco2, Calu3, Capan1, GM12878 and HepG2 cells 
separately with two biological replicates for each cell line. The 3C libraries were 
then interrogated by 5C. The region was analyzed by pooling all probes for a final 
concentration of 0.5 fmol μl−1. In total, 75 reverse probes and 605 forward probes 
were pooled for a possible 44,770 interactions in the CFTR region (Probes can 
be found in Appendix I). 5C was performed as described (Sanyal et al., 2012) 
with the following changes: 10 ligation reactions were performed for each 5C 
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library, each containing an amount of 3C template that represents 400,000 
genome equivalents and 2 fmol of each primer.  
5C read mapping 
Sequencing data was obtained from an Illumina GAIIx machine and was 
processed by a custom pipeline to map and assemble 5C interactions, as 
previously described (Lajoie et al., 2009; Sanyal et al., 2012). We used an 
updated version of the novoalign mapping algorithm 
(V2.07.11 http://novocraft.com). Statistics regarding the 5C library quality, 
mapping efficiency, etc. can be found in Table 4.1. A table summarizing the read 
depth of each 5C library can be found in Table 4.2. Pearson correlation 
coefficients between the biological replicates can be found in Table 4.3. 
5C bias correction  
5C experiments involve a number of steps that can differ in efficiency, 
thereby introducing biases in efficiency of detection of pairs of interactions. 
These biases could be due to differences in the efficiency of crosslinking, the 
efficiency of restriction digestion (related to crosslinking efficiency), the efficiency 
of ligation (related to fragment size), the efficiency of 5C probes (related to 
annealing and PCR amplification) and finally the efficiency of DNA sequencing 
(related to base composition). All of these potential biases—several of which are 
common to other approaches such as chromatin immunoprecipitation (for 
example, crosslinking efficiency, PCR amplification, base-composition-dependent 
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Mapping Caco2 R1 
 
Caco2 R2 
 # numRawReads 13,734,053 
 
13,763,949 
 # numQCFailedReads 0 0.00% 0 0.00% 
#numQCPassedReads 13,734,053 100.00% 13,763,949 100.00% 
# side1Mapped 13,215,901 96.20% 13,121,771 95.30% 
# side2Mapped 13,184,787 96.00% 13,040,901 94.70% 
# noSideMapped 263,970 1.90% 326,612 2.40% 
# oneSideMapped 539,478 3.90% 712,002 5.20% 
# bothSideMapped 12,930,605 94.10% 12,725,335 92.50% 
# errorPairs 
 
0.00% 0 0.00% 
# invalidPairs 447 0.00% 843 0.00% 
# validPairs 12,930,158 94.10% 12,724,492 92.40% 
     Mapping Calu3 R1 
 
Calu3 R2 
 # numRawReads 19,323,745 
 
26,078,596 0.00% 
# numQCFailedReads 0 0.00% 0 100.00% 
#numQCPassedReads 19,323,745 100.00% 26,078,596 98.80% 
# side1Mapped 18,669,930 96.60% 25,754,552 98.30% 
# side2Mapped 18,640,276 96.50% 25,625,059 0.30% 
# noSideMapped 333,334 1.70% 80,343 2.40% 
# oneSideMapped 670,616 3.50% 616,895 97.30% 
# bothSideMapped 18,319,795 94.80% 25,381,358 0.00% 
# errorPairs 8 0.00% 0 0.00% 
# invalidPairs 11,169 0.10% 877 97.30% 
# validPairs 18,308,618 94.70% 25,380,481 
 
     Mapping Capan1 R1 
 
Capan1 R2 
 # numRawReads 18,671,787 
 
28,715,154 
 # numQCFailedReads 0 0.00% 0 0.00% 
#numQCPassedReads 18,671,787 100.00% 28,715,154 100.00% 
# side1Mapped 18,433,875 98.70% 28,281,242 98.50% 
# side2Mapped 18,283,457 97.90% 27,887,919 97.10% 
# noSideMapped 56,948 0.30% 99,813 0.30% 
# oneSideMapped 512,346 2.70% 1,061,521 3.70% 
# bothSideMapped 18,102,493 97.00% 27,553,820 96.00% 
# errorPairs 1 0.00% 0 0.00% 
# invalidPairs 1,254 0.00% 5,937 0.00% 
# validPairs 18,101,238 96.90% 27,547,883 95.90% 
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Mapping GM12878 R1 GM12878 R2 
# numRawReads 33,025,556 
 
29,352,987 
 # numQCFailedReads 0 0 0 0.00% 
#numQCPassedReads 33,025,556 100 29,352,987 100.00% 
# side1Mapped 12,811,429 38.8 28,698,758 97.80% 
# side2Mapped 12,876,439 39 28,526,444 97.20% 
# noSideMapped 19,462,222 58.9 205,409 0.70% 
# oneSideMapped 1,438,800 4.4 1,069,954 3.60% 
# bothSideMapped 12,124,534 36.7 28,077,624 95.70% 
# errorPairs 3 0 37 0.00% 
# invalidPairs 20,454 0.1 65,809 0.20% 
# validPairs 12,104,077 36.7 28,011,778 95.40% 
     Mapping HepG2 R1 
 
HepG2 R2 
 # numRawReads 33,762,419 
 
27,522,416 
 # numQCFailedReads 0 0.00% 0 0.00% 
#numQCPassedReads 33,762,419 100.00% 27,522,416 100.00% 
# side1Mapped 32,908,047 97.50% 26,989,444 98.10% 
# side2Mapped 32,301,383 95.70% 26,840,431 97.50% 
# noSideMapped 254,633 0.80% 155,116 0.60% 
# oneSideMapped 1,806,142 5.30% 904,725 3.30% 
# bothSideMapped 31,701,644 93.90% 26,462,575 96.10% 
# errorPairs 3 0.00% 24 0.00% 
# invalidPairs 20,263 0.10% 36,035 0.10% 
# validPairs 31,681,378 93.80% 26,426,516 96.00% 
 
Table 4.1 Mapping Statistics of All Libraries Used in this Study.  
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Raw Data 
 
cis-purged Data 
 
#interactions #reads #interactions #reads 
Caco2-R1 50,986 12,930,158 24,492 9,240,611 
Caco2-R2 50,970 12,724,492 27,090 9,783,411 
Calu3-R1 66,029 18,308,618 36,812 12,073,332 
Calu3-R2 148,785 25,380,481 39,883 15,507,757 
Capan1-R1 126,462 18,101,240 38,046 6,041,896 
Capan1-R2 161,499 27,547,883 39,308 8,722,529 
GM12878-R1 88,198 24,408,480 37,880 9,907,568 
GM12878-R2 190,199 28,011,778 40,190 15,253,503 
HepG2-R1 161,365 31,681,378 39,568 24,630,673 
HepG2-R2 147,911 26,426,516 39,909 16,945,637 
 Singleton-removed Data Coverage-corrected Data 
 
#interactions #reads #interactions #reads 
Caco2-R1 24,449 7,265,532 20,351 7,354,017 
Caco2-R2 27,046 9,453,039 22,278 8,248,685 
Calu3-R1 36,768 11,970,277 32,886 8,222,536 
Calu3-R2 39,908 15,378,124 36,733 8,522,545 
Capan1-R1 38,002 5,760,920 35,337 8,853,211 
Capan1-R2 39,264 8,380,681 36,799 8,897,244 
GM12878-R1 37,836 9,687,772 34,869 10,734,618 
GM12878-R2 40,146 14,800,666 39,392 9,711,216 
HepG2-R1 39,524 24,508,802 35,515 11,181,660 
HepG2-R2 39,865 16,718,446 35,701 9,771,604 
 
Table 4.2 Read Counts for Each Correction Step. 
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Table 4.3: Pearson Correlation of All Replicates. 
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sequencing efficiency)—will have an impact on the overall efficiency with which 
long-range interactions for a given locus (restriction fragment) can be detected. 
We implemented the following steps to estimate and correct for such technical 
biases. 
Probe filtering – Cis-Purge 
Not all probes are represented equally in our 5C dataset due to over- and 
under-performance in the assay. As the first step in our data correction pipeline, 
we remove probes that perform significantly differently than the overall set. The 
relative performance of each probe is determined as follows. First, a global 
average relationship between interaction frequency and genomic distance is 
calculated using Loess smoothing for each data set. Interaction profiles anchored 
on each probe across the 2.8 Mb region is then compared to this global average. 
If the individual Loess is more or less than .85 of the scaled Z-score distance (a 
measurement of the number of standard deviations a data point is from the 
mean) from the average global Loess, the probe is flagged as problematic. If a 
probe is flagged as problematic in more than 40% of the datasets, it is removed 
from downstream analysis. Using this threshold we removed 34 probes from 
downstream analysis (Table 4.4). 
Singleton removal 
As we examined the 5C datasets, we noticed several instances when the 
interaction between two probes was higher than its neighboring interactions by  
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Trim Amount: 0.85 
 
Flagged Probe 
#datasets in 
which this 
probe is flagged 
5C_2410_EMS03_FOR_102 10 
5C_2410_EMS03_FOR_140 10 
5C_2410_EMS03_FOR_349 10 
5C_2410_EMS03_FOR_429 10 
5C_2410_EMS03_FOR_773 10 
5C_2410_EMS03_FOR_165 10 
5C_2410_EMS03_FOR_2 10 
5C_2410_EMS03_REV_10 9 
5C_2410_EMS03_FOR_75 9 
5C_2410_EMS03_FOR_74 9 
5C_2410_EMS03_REV_13 8 
5C_2410_EMS03_FOR_8 8 
5C_2410_EMS03_FOR_51 8 
5C_2410_EMS03_FOR_54 7 
5C_2410_EMS03_FOR_197 7 
5C_2410_EMS03_FOR_762 7 
5C_2410_EMS03_REV_111 7 
5C_2410_EMS03_FOR_228 7 
5C_2410_EMS03_FOR_389 7 
5C_2410_EMS03_FOR_350 7 
5C_2410_EMS03_REV_523 6 
5C_2410_EMS03_FOR_407 6 
5C_2410_EMS03_FOR_1 6 
5C_2410_EMS03_FOR_57 5 
5C_2410_EMS03_FOR_129 5 
5C_2410_EMS03_FOR_677 5 
5C_2410_EMS03_FOR_117 5 
5C_2410_EMS03_FOR_248 4 
5C_2410_EMS03_FOR_246 4 
5C_2410_EMS03_FOR_864 4 
5C_2410_EMS03_FOR_283 4 
5C_2410_EMS03_FOR_607 4 
5C_2410_EMS03_FOR_658 4 
5C_2410_EMS03_FOR_298 4 
 
Table 4.4: Probes Removed in the Probe Filtering Step of the Correction 
Method 
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an order or magnitude or more. Although there were not many of these blowouts, 
we removed them from the dataset to avoid problems downstream during peak 
calling. Thus, we removed any interaction that had a Z-score of 12 or more, 
resulting in the removal of 44 individual interactions from downstream analysis 
(Table 4.5). To calculate the Z-score of a given data point, we used the following 
equation:  
𝑍 = (𝑥 − 𝜇)/𝜎 
where the Z-score (Z) is the raw score (x) minus the population mean (µ) divided 
by the standard deviation (σ). This measurement was calculated for the given 
distance of the raw score, meaning the average and standard deviation were 
calculated only for points separated by the same genomic distance as the data 
point (x). 
 
Coverage correction 
Once the outlier probes and interactions are removed from the 5C data 
set, the profiles of each probe were normalized so that they could be 
quantitatively compared to each other. Here, we applied a slightly different 
method compared to the one we used before (Sanyal et al., 2012) based only on 
local (cis) chromatin interaction data (within the CFTR region) because that data 
is the most reliably detected. First, all 5C datasets were read normalized (each 
interaction value was divided by the number of reads obtained for that dataset). 
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z-score 12 
Probe-Probe interaction 
#datasets in which 
this interaction is 
flagged 
5C_2410_EMS03_FOR_124_5C_2410_EMS03_REV_17 10 
5C_2410_EMS03_FOR_128_5C_2410_EMS03_REV_17 10 
5C_2410_EMS03_FOR_464_5C_2410_EMS03_REV_405 10 
5C_2410_EMS03_FOR_126_5C_2410_EMS03_REV_17 9 
5C_2410_EMS03_FOR_128_5C_2410_EMS03_REV_203 9 
5C_2410_EMS03_FOR_21_5C_2410_EMS03_REV_203 9 
5C_2410_EMS03_FOR_339_5C_2410_EMS03_REV_898 9 
5C_2410_EMS03_FOR_605_5C_2410_EMS03_REV_777 9 
5C_2410_EMS03_FOR_7_5C_2410_EMS03_REV_405 9 
5C_2410_EMS03_FOR_817_5C_2410_EMS03_REV_405 9 
5C_2410_EMS03_FOR_90_5C_2410_EMS03_REV_613 9 
5C_2410_EMS03_FOR_93_5C_2410_EMS03_REV_405 9 
5C_2410_EMS03_FOR_467_5C_2410_EMS03_REV_719 8 
5C_2410_EMS03_FOR_548_5C_2410_EMS03_REV_405 8 
5C_2410_EMS03_FOR_579_5C_2410_EMS03_REV_72 8 
5C_2410_EMS03_FOR_125_5C_2410_EMS03_REV_17 7 
5C_2410_EMS03_FOR_19_5C_2410_EMS03_REV_203 7 
5C_2410_EMS03_FOR_214_5C_2410_EMS03_REV_761 7 
5C_2410_EMS03_FOR_71_5C_2410_EMS03_REV_761 7 
5C_2410_EMS03_FOR_87_5C_2410_EMS03_REV_782 7 
5C_2410_EMS03_FOR_105_5C_2410_EMS03_REV_405 6 
5C_2410_EMS03_FOR_208_5C_2410_EMS03_REV_711 6 
5C_2410_EMS03_FOR_503_5C_2410_EMS03_REV_420 6 
5C_2410_EMS03_FOR_125_5C_2410_EMS03_REV_665 5 
5C_2410_EMS03_FOR_132_5C_2410_EMS03_REV_17 5 
5C_2410_EMS03_FOR_139_5C_2410_EMS03_REV_405 5 
5C_2410_EMS03_FOR_154_5C_2410_EMS03_REV_405 5 
5C_2410_EMS03_FOR_641_5C_2410_EMS03_REV_420 5 
5C_2410_EMS03_FOR_68_5C_2410_EMS03_REV_594 5 
5C_2410_EMS03_FOR_98_5C_2410_EMS03_REV_405 5 
5C_2410_EMS03_FOR_12_5C_2410_EMS03_REV_203 4 
5C_2410_EMS03_FOR_136_5C_2410_EMS03_REV_405 4 
5C_2410_EMS03_FOR_237_5C_2410_EMS03_REV_665 4 
5C_2410_EMS03_FOR_394_5C_2410_EMS03_REV_405 4 
5C_2410_EMS03_FOR_5_5C_2410_EMS03_REV_808 4 
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5C_2410_EMS03_FOR_502_5C_2410_EMS03_REV_420 4 
5C_2410_EMS03_FOR_503_5C_2410_EMS03_REV_421 4 
5C_2410_EMS03_FOR_597_5C_2410_EMS03_REV_666 4 
5C_2410_EMS03_FOR_626_5C_2410_EMS03_REV_420 4 
5C_2410_EMS03_FOR_63_5C_2410_EMS03_REV_405 4 
5C_2410_EMS03_FOR_641_5C_2410_EMS03_REV_421 4 
5C_2410_EMS03_FOR_672_5C_2410_EMS03_REV_203 4 
5C_2410_EMS03_FOR_751_5C_2410_EMS03_REV_665 4 
5C_2410_EMS03_FOR_883_5C_2410_EMS03_REV_405 4 
 
 
Table 4.5: Individual Interactions Removed in the Singleton Removal Step 
of the Correction Method. We used a z-score threshold of 12 as our cutoff. This 
cutoff maintained interactions we saw from 3C experiments (Gheldof et al. 2010, 
Ott et al., 2009) but still eliminated points displaying interactions orders of 
magnitude larger than their neighbors. 
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Second, to determine differential performance of probes due to non-
biological technical biases (see above) we combined all 10 5C datasets. Next, a 
global average relationship between interaction frequency and genomic distance 
was calculated using Loess smoothing, and the interaction profile detected with 
each probe was compared to this average. In the absence of any technical 
detection bias we assume that the overall domain-wide profile of each probe is 
similar to the dataset-wide average profile. For each probe we then calculated a 
correction factor by which the profile of that probe should be lifted or lowered in 
order to match the average Loess profile from the combined dataset. The 
calculated factors for each probe were then applied to correct each of the 10 
individual, read-normalized datasets to produce the final bias corrected datasets. 
By combining the datasets before correction, we reduce the risk of overcorrecting 
certain probes that were truly giving high biological signals in one cell line. When 
the datasets were combined, this high signal was averaged with the other lower 
signals, giving that interaction a less stringent correction. If correction factors 
were calculated for each dataset separately, the interaction would be penalized 
for giving such a high interaction and corrected too harshly. Data corrections did 
not change the overall structure of the data. In fact, analysis of specific probes 
from raw and corrected data show only few differences in their profiles, indicating 
that probes display only minor differences in detection efficiency.   
 
Insulation Index (TAD calling) 
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To define regions of our dataset that contain TAD boundaries we 
calculated an insulation score along the locus. This method is based on the 
concept that TAD boundaries act as physical insulators that prevent or inhibit 
interaction across them.  First, 5C data was binned at 100 kb with a 10x step 
size. Next, we calculated for each bin the combined number of observed 
interactions across it by summing all interactions between loci located up to 250 
Kb upstream with loci located up to 250 Kb downstream of the bin. This sum was 
then calculated for each bin along the 2.8 Mb locus, and then divided by the 
average sum of all bins to obtain insulation scores. Insulation scores are then 
plotted along the locus to obtain an insulation profile. Local minima in the 
insulation profiles were detected by identifying the bins with the lowest insulation 
scores in a local 500 kb window. We set the midpoint of this low-value bin as the 
boundary.  
Peak calling 
To detect statistically significant looping interactions at the restriction 
fragment level we applied a ‘5C peak calling’ algorithm as described before 
(Lajoie et al., 2009; Sanyal et al., 2012) with the following modifications. We 
called peaks on three different sub-sets of the data – all the data, intraTAD data 
and interTAD data. Peaks were defined as signals that are significantly higher 
than expected. Expected values were calculated as follows: For peak calling of 
the complete dataset we calculated the average interaction frequency for each 
genomic distance using Loess smoothing (alpha value 0.01). This provides a 
171 
 
weighted average and a weighted standard deviation at each genomic distance.  
For peak calling within or between TADs separately, we calculated the average 
interaction frequency for each genomic distance using Loess smoothing using 
only intraTAD or interTAD data respectively (alpha value 0.01). We assume the 
large majority of interactions are not significant looping interactions and therefore 
we interpret this weighted average as the expected 5C signal for a given 
genomic distance. Observed 5C signals are then transformed into a Z-score by 
calculating the (observed-expected/standard deviation) as described earlier, 
where the observed value is the detected 5C signal for a specific interaction, 
expected is the calculated weighted average of 5C signals for a specific genomic 
distance and standard deviation is the calculated weighted standard deviation of 
5C signals for a specific genomic distance. Once the Z-scores have been 
calculated, their distribution is fit to a Weibull distribution. P-values are then 
mapped to each Z-score and then also transformed into q-values for FDR 
analysis. The ‘qvalue’ package from R was used to compute the q-values for the 
given set of p-values determined from the fit to the Weibull distribution. We used 
a stringent FDR threshold of 0.001%. We detected all known looping interactions 
in the CFTR locus in the appropriate cell lines, consistent with previous 3C 
studies (Gheldof et al., 2010; Ott et al., 2009). We called peaks in each 5C 
biological replicate separately and then took only the peaks that intersect across 
replicates as our final list of significant looping interactions. Using this cutoff, we 
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saw a comparable number of peaks as in previous 5C studies (Sanyal et al., 
2012).  
qRT-PCR 
Gene expression levels were determined with qRT-PCR. Three technical 
replicates and three biological replicates were performed for each cell line. Gene 
expression levels were analyzed using a StepOnePlus instrument (Applied 
Biosystems) with the Power SYBR Green RNA-to-Ct 1-step kit (Life 
Technologies). Results were normalized to HPRT as an internal control. Any 
results with a Ct value higher than 34 were considered “not expressed.” RT-PCR 
primers were designed in neighboring exons using the Primer3 tool 
(http://fokker.wi.mit.edu/primer3/input.htm). Primers were tested for effectiveness by 
checking their titration ability and whether they gave a single melt curve. Primers 
used for this experiment can be found in Appendix I.  
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Results 
 
 
Generation of 5C Chromatin Interaction Profiles in 5 Cell Lines 
To determine the relationship between the location of TADs and the 
presence of chromatin looping interactions between genes and regulatory 
elements we applied chromosome conformation capture carbon copy, or 5C 
(Dostie et al., 2006). 5C is particularly suited for such analysis as it allows 
simultaneous high-resolution (single restriction fragment) detection of looping 
interactions (Sanyal et al., 2012) and analysis of large chromosomal domains to 
identify TADs (Nora et al., 2012). We applied 5C to analyze the conformation of a 
2.8 Mb domain on human chromosome 7 (Figure 4.1A). This region was chosen 
because it is centered on the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene where we and others previously identified several cell-
type specific looping interactions between the CFTR promoter and distal 
enhancers and CTCF-bound elements (Gheldof 2010, Ott 2009). This domain 
contains the ENCODE manual region ENm001 (Sanyal et al., 2012), is overall 
quite rich in gene content but also contains a large 700 kb gene-poor domain. 
Additionally, it contains several TADs as defined by a lower-resolution Hi-C 
analysis (Dixon 2012).   
We used a 5C probe set (Figure 4.1A) based on a previously published 
design (Sanyal et al., 2012) which placed reverse probes on gene promoters and 
forward probes on the remaining restriction fragments in the region. This design 
allows analysis of long-range interactions between gene promoters and  
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Figure 4.1: Walk-through of the Modifications Made to the 5C Data when it 
is Run Through our Pipeline. A) 5C region showing probe design. Red 
fragments = reverse probes. Blue fragments = forward probes. B) Raw 5C data 
plotted as all reverse primers vs. all forward primers. Color scale: white to orange 
to red to black, where white represents no interaction frequency and black 
represents the highest interaction frequency. It is apparent that some probes are 
misbehaving in the raw data (stripes on the heatmap). C) Steps in our data 
correction pipeline. Misbehaving probes are removed first (cis-purge), followed 
by removal of PCR blowouts (singleton removal). The final step normalizes all 
probes to each other (coverage correction). For full details see Methods. D) 5C 
data after coverage correction. White stripes running through the heatmap 
indicate misbehaving primers that were removed in the correction steps. E) 
Binned heatmap of raw data, before running it through the pipeline. F) Binned 
final 5C data after it has been run through the pipeline. Data is binned in 100 kb 
windows with a 10x step, meaning each square represents 10 kb. 
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surrounding chromatin, e.g. distal enhancers. We expanded the published probe 
set for ENm001 (Sanyal et al., 2012) to include additional forward and reverse 
probes on previously unused fragments and to incorporate the additional 700 kb 
gene-poor region. The final design contains 74 reverse probes and 605 forward 
probes for a possible 44,770 interrogated interactions.  
We selected a panel of cell types to study, including three cell lines known 
to express the CFTR gene (Caco2, Calu3 and Capan1). These cell lines are 
derived from different locations in the body: Caco2 are colon-derived colorectal 
adenocarcinoma cells; Calu3 are lung-derived adenocarcinoma cells; Capan1 
are pancreas-derived adenocarcinoma cells. It is likely that distinct cell type-
specific enhancers may be involved in the expression of CFTR in these diverse 
tissues. We also included two cell lines that do not express the gene: the 
lymphoblastoid cell line GM12878 and the liver-derived hepatocellular carcinoma 
cell line HepG2 .   
5C data is displayed as a heatmap, where an increase in color intensity 
corresponds with an increase in interaction frequency between two regions of the 
genome. Figure 4.1B shows raw data obtained from GM12878 cells. Reverse 
probes are plotted as rows and forward probes as columns. Each intersection 
between a reverse and forward probe represents a measured interaction 
frequency between two genomic loci. As expected, neighboring genomic regions 
interact with each other quite frequently, creating a black “diagonal” through the 
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middle of the heatmap. As the distance between fragments increases, the 
interaction frequency predictably decreases (Dekker, 2006; Dekker et al., 2002).  
When examining the raw data (Figure 4.1B), it is clear that some probes 
over- or under-perform in the assay, creating horizontal and vertical stripes 
across the heatmap (dark stripes for over-performing probes and white stripes for 
under-performing probes). We removed data obtained with probes that 
performed aberrantly (either too high or too low, see Figure 4.1C, Methods). In 
addition, some probe pairs detect specific interactions that produce extremely 
strong signals (orders of magnitude greater than their neighbors), which in our 
experience are probably due to PCR amplification steps in the 5C protocol. We 
removed individual interactions when deemed an outlier (Figure 4.1C, Methods). 
Finally, we corrected the data for any remaining minor variations in probe 
efficiency, as we did previously (Sanyal et al., 2012), but with some modifications 
(see Methods). The corrected data is displayed in Figure 4.1D. Figure 4.1E and F 
show the same data as Figure 4.1B and D, but here the heatmaps are binned, 
displaying the 5C region versus itself (all heatmaps in this paper are binned in 
100 kb bins, 10x step, unless otherwise noted). Pearson correlation analysis 
showed that replicates of the same cell line are highly correlated and also tend to 
be more correlated with each other than with replicates from different cell lines 
(Table 4.3). 
 
Identification of Topologically Associating Domains (TADs) 
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Topologically Associating Domains (TADs) are consecutive regions 
hundreds of kb in size where loci located within the TAD associate and mix more 
frequently with each other than with loci located in adjacent TADs (Dixon et al., 
2012; Nora et al., 2012). Visual inspection of the binned 5C interaction maps 
indicates that TAD structures are readily detected as triangles of strong self-
association along the region (Figures 4.1E, 4.1F and 4.2). We employed a 
straightforward approach to quantify the pattern of TAD signals along the locus.  
The approach is based on the observation that TAD boundaries represent loci 
across which only very few long-range chromatin associations occur, i.e. 
between loci located upstream and downstream of the boundary.  We quantified 
the relative frequency of interactions occurring across each bin throughout the 
2.8 Mb region.  We refer to this number as the insulation score of a genomic 
location.  We then plotted these scores along the region to obtain an “insulation 
profile” for each cell line (Figure 4.2A-E, Figure 4.3, see Methods).  Minima in the 
insulation profile represent TAD boundaries since these locations are sites where 
interactions across them occur at a low frequency.  Insulation profiles and the 
locations of TAD boundaries were not dependent on the size of the window used 
for calculation of the insulation score (Figure 4.3).  Figure 4.2 shows binned 5C 
interaction maps for all cell lines with their insulation profiles plotted below.  
Strikingly, although the amplitude of the signal varies, the insulation profiles of all 
5 cell lines are overall very similar, with TAD boundaries present at 
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Figure 4.2: Calling TADs on the 5C data using an Insulation Index. A-E) 
Heatmaps and corresponding insulation indexes for each cell line: Caco2, Calu3, 
Capan1, GM12878 and HepG2. Dips on the graph represent boundaries 
between two TADs. F) The insulation indexes for all 5 cell lines plotted in one 
graph. G) The heatmap is a combined map of all our data. Below is the average 
insulation index of all the data. H) Our insulation index method run on human 
embryonic stem cell Hi-C data from Dixon et al., 2012. This heatmap is binned as 
in the Dixon et al. paper with 40 kb bins. Its color scale is from 0 to 35.  I) The 
TAD calls in the 5C region based on our insulation index compared with the TAD 
calls made with the method in Dixon et al., 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
180 
 
the same locations (Figure 4.2F, Figure 4.3). Further, we compared our 5C data 
to previously published Hi-C data in human embryonic stem cell lines (ESC) 
(Dixon et al., 2012) (Figure 4.2H). The overall TAD organization in ESCs as 
detected by Hi-C and quantified using our insulation score approach is again very 
similar to the organization we detected by 5C (Figure 4.2H).  We note that there 
are some differences (e.g. the region around position 116,250,000). These could 
represent real differences in TAD boundary positions, or experiment dependent 
variations in interaction patterns, e.g. due to the lower resolution of the Hi-C data.   
These analyses show that the overall TAD organization is conserved 
across 5 differentiated human cell lines.  Some differences in TAD positions may 
be present between ESCs and differentiated cells.  These results confirm and 
extend earlier observations that TADs are similar, but not always identical, in 
different cell types (Dixon et al. 2012, Nora et al. 2012). Since the insulation 
profiles are extremely similar between cell lines (Figure 4.2F, Figure 4.3), we 
created a consensus insulation profile by calculating the average profile across 
all 5 differentiated cell lines to use for downstream analysis (Figure 4.2G). 6 TAD 
boundaries are present in the regions, defining 7 TADs. 
Previous studies have shown that, in general, TAD boundaries are 
enriched in gene promoters and CTCF sites (Dixon et al., 2012). We examined 
our TAD boundary regions to identify what chromatin features are present.  We  
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Figure 4.3: Insulation Index of All Cell Lines and Different Window Search 
Spaces. A) The insulation index method is shown in the diamonds slid along the 
the heatmap. The sum of each diamond is plotted as a point in the insulation 
index. Below the heatmap is plotted the insulation index for all cell lines and the 
average, as in Figure 4.2. B) Pearson correlations between the insulation 
indexes plotted above. C) Insulation indexes run on the combined heatmap using 
different window sizes. As the window size increases the index smooths out but 
maintains the same peaks and dips. D) Pearson correlation of the different 
window sizes. 
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noticed that only a few of our TAD boundaries were close to a gene promoter.  
Indeed, the boundary between TADs 1 and 2 is 9291 bp from the 3´ end of the 
CAV1 gene. The closest promoter is 45 kb away. Additionally, the boundary 
between TADs 2 and 3 occurs 8812 bp from the end of the CAPZA2 gene, and 
the boundary between TADs 3 and 4 occurs 3440 bp from the end of the ST7 
gene. Also the boundary between TADs 4 and 5 occurs within the ASZ1 gene, 
7245 bp from its termination site but 57 kb from its promoter. The boundary 
between TADs 5 and 6 is very close to the end of the CTTNBP2 gene (185 bp).  
The boundary between TADs 6 and 7 is the only one that is closer to a gene 
promoter than a gene end, located 13.5 kb from the LSM8 promoter. Although 
there is a global enrichment of TAD boundaries occurring near gene promoters, 
we conclude that this is not the case for every TAD boundary, suggesting that 
gene promoters do not determine TAD boundaries. We do find that most 
boundaries are located very close to CTCF sites, and that many of these sites 
are at the 3´ end of genes. However, CTCF sites are found within TADs as well, 
indicating that CTCF is not sufficient for boundary formation, consistent with 
previous reports (Bortle et al., 2014; Dixon et al., 2012; Nora et al., 2012; Zuin et 
al., 2014).     
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Figure 4.4: Gene Expression Within the 5C Region is Not Related to TAD 
Structure. Relative gene expression is plotted for the 5 cell types studied. The 
TAD structure of the locus is shown below the graph for reference. Genes 
promoters with different expression patterns can be located within the same 
TAD. Primers can be found in Appendix I. 
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TAD positions are not affected by cell-type specific gene expression 
To investigate the relationship between TAD boundaries and gene 
expression we measured the expression level of all genes in the 2.8 Mb regions 
in the 5 cell lines (Figure 4.4).  Interestingly, we find that several TADs are 
entirely transcriptionally silent in some cell lines, while displaying transcription of 
at least one gene in others. Yet, TAD boundaries are the same whether or not 
the TAD contains an expressed gene. This is particularly well illustrated in 
GM12878 and HepG2 cells where TADs 4, 5 and 6 are transcriptionally inactive, 
but the same set of TAD boundaries that separate them are present in cells that 
do express genes located in these TADs. On the other hand, TADs 1 and 2 have 
at least one gene active in each cell line but the precise set of genes that is 
active differs between different cell lines, and TAD boundaries are invariant as 
well. Together, these observations indicate that TAD boundaries occur 
irrespective of gene transcription and are not determined by the expression 
status of genes located within TADs.  
 
Identification of long-range looping interactions 
 Next we set out to identify specific and statistically significant long-range 
interactions such as promoter-enhancer contacts throughout the 2.8 Mb domain. 
Previously, we developed and applied a statistical methodology to identify pair-
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wise interactions in a 5C dataset that occur significantly more frequently than 
expected (Phillips-Cremins et al., 2013; Sanyal et al., 2012). The approach first 
calculates the expected baseline contact frequency of pairs of loci dependent on 
their genomic site separation. Then, individual interactions between pairs of loci 
are identified that are significantly above this baseline (referred to as looping 
interactions). Here we further refined this approach by taking into consideration 
the presence of TADs. Specifically, we calculated the expected baseline 
interactions separately for interactions occurring within and between TADs. For 
comparison we also performed our peak-calling on the entire dataset ignoring 
TADs, as we did previously (Figure 4.5F, Methods). Using a FDR of 0.001% the 
two different approaches give similar but not identical sets of statistically 
significant looping interactions, indicating that the presence of TADs has some 
impact on our ability to detect significant signals (Figure 4.5). We use the set of 
significant interactions detected when explicitly taking TADs in consideration, and 
observed in two independent biological replicates, for our analyses. 
 Loci located within a TAD interact more frequently than pairs of loci 
located in different TADs (Dixon et al., 2012; Hou et al., 2012; Jin et al., 2013; 
Nora et al., 2012). This can be visualized for our 5C data set by plotting all intra-
TAD and inter-TAD interactions as a function of their genomic site separation 
(Figure 4.6). This plot shows that at a given genomic distance, intra-TADs 
interactions occur more frequently than inter-TAD interactions. As a result the 
interaction frequency of statistically significant looping interactions within TADs 
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Figure 4.5: Peak Calling Overlap of the Entire Data versus IntraTAD and 
InterTAD spaces. A) Peak calling on Caco2 cells. B) Peak calling on Calu3 
cells. C) Peak calling on Capan1 cells. D) Peak calling on GM12878 cells. E) 
Peak calling on HepG2 cells. F) Heatmap displaying the divisions between the 
peak calling space. The green section of this map indicates peaks called on the 
entire data without taking into account TAD structure. Alternately, we called 
peaks on only intraTAD structure (blue triangles) and interTAD structure (red 
space).  
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Figure 4.6: Scaling Plots for All Cell Lines - Interactions and Peaks. A-E) 
Smoothed (10%) read count for all interactions. F-J) Non-smoothed read count 
for all significant interactions called as peaks. Green: Interactions/Peaks from the 
entire dataset. Red: Interactions/Peaks from the interTAD space. Blue: 
Interactions/Peaks from the intraTAD space.  
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is also much higher than the interaction frequency of inter-TAD looping 
interactions, even when they involve loci separated by the same genome 
distance (Figure 4.6F-J). Generally, the frequency of statistically significant 
looping interactions between TADs is much lower than those that occur within 
TADs because they involve loci that are separated by much larger genomic 
distances. This implies that intra-TAD interactions occur in a larger fraction of 
cells, whereas inter-TAD interactions are considerably less frequent in the cell 
population. Finally, the relative number of statistically significant intra-TAD 
looping interactions (305 out of 34372 interrogated interactions (0.88%)) detected 
is much higher than the relative number of significant inter-TAD looping 
interactions (617 out of 112723 interrogated interactions (0.54%)). This is 
consistent with previous reports which showed that looping interactions between 
gene regulatory elements occurs more frequently within TADs (Dixon et al., 
2012; Jin et al., 2013). We conclude that intra-TAD looping interactions display 
higher contact frequencies, even when corrected for genomic distance, implying 
these interactions occur in a larger fraction of cells and occur more often than 
inter-TAD looping interactions.  
When we compared looping interactions among the 5 cell lines we find 
that the majority of interactions are cell type-specific with a minority of 
interactions observed in 2 or more cell lines, and with only a handful interactions 
observed in all 5 cell lines. This holds for interactions within TADs and for 
interactions that occur between TADs (Figure 4.7A, B). This is consistent with  
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Figure 4.7: Interactions Within or Between TADs are Mostly Cell-Type 
Specific. A) Flower plot showing all intraTAD interactions. B) The number of cell 
lines that share significant intraTAD interactions. C) Flower plot showing all 
interTAD interactions. D) The number of cell lines that share significant interTAD 
interactions. E) Webplot displaying all interTAD interactions, with TADs and gene 
locations across the top. F) The blue plot shows interTAD interactions, while the 
grey plot shows the insulation index as in Figure 4.2. 
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other 5C analysis (Phillips-Cremins et al., 2013; Sanyal et al., 2012). Thus, 
looping interactions are highly tissue-specific, while TAD organization is largely 
cell type invariant. 
 
A Single TAD Constrains All Known CFTR Promoter-Enhancer Loops 
We focused our analysis on long-range interactions of the CFTR gene.  
Previous studies have identified a number of putative regulatory elements within 
and flanking the CFTR gene. These were identified as DNase 1 hypersensitive 
sites (DHS), often representing nucleosome free DNA sequences that can 
interact with transcription factors. Functional characterization using reporter 
assays showed that several of these DHSs are putative cell-type specific 
enhancers (reviewed in McCarthy and Harris, 2005; Ott and Harris, 2011) 
(Gheldof et al., 2010; Ott et al., 2009; Zhang et al., 2013, chapter 5 of this thesis). 
These elements are spread out over several hundred kb making it difficult to 
predict what gene(s) they regulate. 3C studies revealed that several of these 
elements directly loop to the CFTR promoter and to each other specifically in 
cells that express CFTR, but not (or much less frequently) in cells that do not 
express CFTR  (Gheldof et al., 2010; Ott et al., 2009). The CFTR promoter was 
found to interact with four elements, which we call elements I, II, III and IV. 
Elements I and II are CTCF-bound sites located ~21 and ~80 kb upstream of the 
gene in Caco2 cells (Gheldof et al., 2010, chapter 3 of this thesis). Elements III 
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and IV, located in intron 11 and +202 kb downstream from the TSS, act as 
enhancer elements when tested in a luciferase assay and contain chromatin 
marks typically associated with enhancer activity (Gheldof et al., 2010; Ott et al., 
2009, chapter 3 of this thesis). These studies strongly suggest that these 
elements regulate the CFTR gene.  
The 5C analysis presented here reproduced most of the previously 
identified looping interactions between the CFTR promoter and distal regulatory 
elements. First, in all three CFTR expressing cells (Caco2, Capan1, Calu3) we 
detected significant interaction frequencies between the CFTR promoter and the 
known CFTR enhancer located within intron 11, element III (108 Kb downstream) 
(Figure 4.8G-K). In cells that do not express CFTR this interaction is either 
strongly reduced (GM12878), or not significant (HepG2). Furthermore, we find 
that the CFTR promoter engages in additional cell type-specific looping 
interactions. First, in Caco2 cells the CFTR promoter interacts with a region just 
downstream of the gene (202 kb downstream of the promoter) that contains a 
known enhancer, consistent with previous 3C studies performed with this cell line 
(Gheldof et al,. 2010; Ott et al., 2009, chapter 3 of this thesis). This interaction is 
not observed in Calu3 and Capan1 cells, or in the non-expressing HepG2 cells, 
but it is significant in non-expressing GM12878 cells (Figure 4.8G-K) (see 
discussion). Second, in Calu3 and Caco2 cells, but not in Capan1 cells, the 
CFTR promoter also engages in looping interactions with sites upstream of the 
promoter (Figure 4.8G-I). In both Caco2 and Calu3 cell lines the promoter loops  
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Figure 4.8: 3C-style Plots of intraTAD Looping Interactions of the CFTR 
Promoter. A-E) Heatmaps showing TAD 5, the TAD that houses the CFTR 
gene. Insulation plots of the region are below, with dips in the plots indicating 
TAD boundaries. F) Image from the UCSC Genome Browser depicting the genes 
inside TAD 5. G-K) 3C-style plots for probe REV_421 located at the CFTR 
promoter. Grey lines indicate elements I-IV identified by our 3C experiments 
(Gheldof et al. 2010, chapter 3 of this thesis). Colored balls depict interactions 
that are significantly higher than background (peaks).    
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to a site located ~21 kb upstream that binds the CTCF protein, consistent with 3C 
experiments (Figure 4.8G and H) (Gheldof et al., 2010; Ott et al., 2009, chapter 3 
of this thesis). In addition, in Calu3 cells the promoter loops to several additional 
sites located further upstream. We note that the entire region up to around 100 
kb upstream is interacting frequently, and statistically significantly, with the CFTR 
promoter.  However, three peaks in the interaction profile stand out as the 
highest peaks in the region. The other weaker, but significant, interactions 
probably represent indirect interactions that are brought in relative close 
proximity of the CFTR promoter as a result of the other prominent looping 
interactions present in the region (see discussion). One prominent peak occurs at 
and around a site located ~80 kb upstream that corresponds to a CTCF-bound 
element. We previously found this site to weakly interact with the CFTR promoter 
in Caco2 cells (Gheldof et al., 2010, chapter 3 of this thesis) but our current 5C 
analysis detects this interaction in Calu3 cells, not Caco2. Interestingly, another 
prominent looping interaction that is specific for lung-derived Calu3 cells involves 
a site located ~35 kb upstream of the promoter. This region contains a previously 
identified lung-specific enhancer (Zhang et al., 2013). From these analyses we 
conclude that the CFTR promoter engages in several long-range looping 
interactions with enhancers that are active in the corresponding cell line. The 
promoter also interacts with several distal CTCF-bound elements. The role of 
cell-type specific interactions with otherwise tissue invariant CTCF sites is 
currently not known (see discussion). Interestingly, we note that in all cell lines 
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studied the CFTR promoter is interacting with the right boundary of its TAD. As 
described below, TAD boundaries often engage in long-range interactions, 
including with elements located in other TADs. The relevance of these 
interactions is currently not known. Finally, we note that the ASZ1 gene, located 
in the same TAD as CFTR, is inactive in all cell lines and does not engage in any 
significant long-range looping interactions (Figure 4.9). This further shows that 
the distal elements that interact with the CFTR promoter do not interact with 
other (inactive) promoters in the domain. 
Of additional interest is the impact of these diverse intraTAD interactions 
on the boundaries of TAD5. Figure 4.9A-E show a zoomed in view of TAD5, with 
the insulation score of this zoomed-in region plotted below. TAD5 is indicated as 
the black box, while the neighboring TADs 4 and 6 are indicated by the grey 
boxes. The numerous significant interactions present inside the CFTR gene in 
Caco2 cells (Figure 4.9M) are indicated in the 5C heatmap as a dark triangle 
located to the right in TAD5 (Figure 4.9A). The numerous significant interactions 
present between the CFTR promoter and the upstream region in Calu3 cells are 
indicated by the black triangle located in the left of TAD5 (Figure 4.9B). The 
relatively flat 3C profiles in Capan1, GM12878 and HepG2 cells are represented 
by lack of intraTAD structure in their corresponding heatmaps (Figure 4.9C-E). 
Although the looping patterns within TAD5 differ between cell lines, the boundary 
regions of this TAD are clearly defined in all cell lines. This indicates that 
intraTAD looping does not affect TAD boundaries. 
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Figure 4.9: 3C-style Plots of intraTAD Looping Interactions of the ASZ1 
Promoter. A-E) Heatmaps showing TAD 5, the TAD that houses the CFTR gene 
and some of the ASZ1 gene. Insulation plots of the region are below, with dips in 
the plots indicating TAD boundaries. F) Image from the UCSC Genome Browser 
depicting the genes inside TAD 5. G-K) 3C-style plots for probe REV_404 
located at the ASZ1 promoter.  
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Long-range Looping Interactions Within Other TADs in the Region 
 We also detected statistically significant long-range looping interactions 
within the other TADs. We find that active gene promoters are more likely to be 
involved in long-range interactions than promoters that are not expressed, 
consistent with our earlier findings (Figure 4.10) (Sanyal et al., 2012). For 
instance the CTTNBP2 gene is only expressed in Capan1 cells, and it is 
engaged in long-range looping interactions only in that cell type. There are 
exceptions to this trend. For example, the CAV2 gene interacts with several 
elements throughout its TAD in Calu3 and Capan1 cells, which both express the 
gene. No looping interactions are detected other cell lines which express the 
gene, Caco2 and HepG2. This may be due to technical reasons (e.g. no 5C 
probe was included for a restriction fragment that contains Caco2 or HepG2-
specific elements, or the interaction is simply missed due to false-negatives). 
Alternatively, in some cell types no distal looping interactions are required for 
gene activation. Based on previous analyses from our lab and those of others 
(Jin et al., 2013; Phillips-Cremins et al., 2013; Sanyal et al., 2012), it is most 
likely that the looping interactions in these TADs involve gene regulatory 
elements, e.g. enhancers, and architectural elements such as CTCF-bound 
elements.  
 Our analysis also identified significant long-range looping interactions 
between loci located in different TADs.  As mentioned above, these interactions 
tend to be much longer range (more then several hundred kb), and much lower in 
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contact frequency (Figure 4.6).  Interestingly, these interactions were highly cell 
type-specific, as were the interactions within TADs (Figure 4.7C, D). Strikingly, 
when we examined which loci engage in such inter-TAD interactions, we found a 
strong correlation with TAD boundaries (Figure 4.7E, F). Thus, while the 
positions of TAD boundaries are invariant, loci located near them engage in 
highly cell type-specific, but rather weak, long-range interactions with other 
TADs.   
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Figure 4.10: Genes that are Not Expressed are Unlikely to Have Looping 
Interactions. In the 2.8 Mb region we examined, genes that are not expressed 
are much less likely to have significant looping interactions between elements 
and their gene promoters. *This analysis does not include the ST7 gene because 
we do not have a probe at that gene promoter. 
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Discussion 
 
 
We present a study of a 2.8 Mb region on chromosome 7 of the human 
genome surrounding the cystic fibrosis locus.  This study expanded our previous 
3C study centered on the cystic fibrosis transmembrane conductance regulator 
gene (CFTR), which identified four DNA elements interacting with the CFTR 
promoter in cells that express the gene (Gheldof et al., 2010; chapter 3 of this 
thesis). We wanted to learn more about potential CFTR regulatory elements. Our 
5C experiment included 5 human cell lines: a colorectal adenocarcinoma 
(Caco2), a lung adenocarcinoma (Calu3), a pancreatic adenocarcinoma 
(Capan1), a lymphoblastoid (GM12878) and liver hepatocyte (HepG2). Among 
these cells, Caco2, Calu3 and Capan1 express high levels of CFTR, while 
GM12878 and HepG2 do not express CFTR.  
 
TADs Exist Regardless of Gene Expression Status or intraTAD Looping 
Elements 
An obvious feature of our data set is the clearly defined topologically associating 
domains (TADs) present in all cell lines we studied. TADs have been proposed to 
be unchanging between cell types, and we provide more evidence that this is 
indeed the case (Figure 4.2). Importantly, we note that TADs are present 
independently of gene expression. Throughout the region there are 12 genes, 
some of which are differentially expressed between the cell lines in our 
investigation. For example, in HepG2 and GM12878 cells, a string of four genes 
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(WNT2, ASZ1, CFTR and CTTNBP2) spanning three TADs are not expressed. 
The division between TADs 4, 5 and 6 are still clearly demarcated in both these 
cell lines. Thus TADs are not maintained or determined by gene expression.  
We see that a majority (5/6) of our TAD boundaries are located very close to the 
3´ end of genes, in contrast to earlier claims that TAD boundaries are marked by 
gene promoters (Dily et al., 2014; Dixon et al., 2012). However, we note that in a 
recent study Dily et al. find a genome-wide enrichment of gene promoters at 
TADs, yet they observed that in median gene promoters were located >200 kb 
from the boundaries (Dily et al., 2014). Therefore we caution against accepting 
that a genome-wide rule applies to every, or perhaps even a significant number 
of, TAD boundaries. We note that the specific loops found within TADs do not 
seem to affect their structure or location. We see that the majority of significant 
loops that occur in our data are unique to one cell line (Figure 4.7A, B), though 
TADs are invariant between cell lines. We see an example of this feature when 
we look within TAD5 (Figure 4.8), which shows that although looping interactions 
inside that TAD differ between the 5 cell lines, the TAD boundaries remain 
constant. Thus it appears that TADs are not defined by the interactions within 
them. 
 
Actively Transcribed Genes Do Not Always Have Looping Interactions  
 We have shown that expressed genes have significantly more looping 
interactions than non-expressed genes (Figure 4.10). It is clearly not the case 
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that all expressed genes have looping interactions. An interesting observation is 
that some expressed genes have looping interactions in some cell lines but not in 
others. For example, CAV2 shows looping to its promoter in Calu3 and Capan1 
lines, but not in Caco2, GM12878 or HepG2 lines, even though it is expressed in 
all five lines. This is similar to the MET gene, which is expressed in all cell lines 
studied except GM12878, and shows looping interactions in all except Caco2 
cells. Perhaps in the case of MET the probe was less efficient in Caco2 cells, and 
there may be looping interactions occurring that we did not observe. In the case 
of CAV2 however, it is unclear why some cell lines display looping while others 
do not. One example of a gene not being expressed but containing a significant 
looping interaction is the CFTR promoter contacting the TAD boundary region in 
HepG2 cells (Figure 4.8K). This interaction seems likely to be a structural 
interaction, as it is also present in the other cell lines (Figure 4.8).  
 
Interactions Between TADs  
We detected statistically significant interactions between loci located in 
different TADs. These interactions are as cell type-specific as the looping 
interactions within TADs. However, these interactions also differ in at least two 
ways from looping interactions within TADs. First, looping interactions between 
TADs are much weaker (fewer reads) than looping interactions within TADs 
(Figure 4.6). This can mean that they occur in fewer cells in the population 
(Gibcus and Dekker, 2013). Second, they often involve loci located at or near 
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TAD boundaries (Figure 4.7E, F), whereas looping interactions within TADs can 
occur throughout these domains. The functional relevance of these interactions is 
currently not known. 
Loci located near TAD boundaries often engage in looping interactions 
with loci located in different TADs (Figure 4.7E, F). These interactions tend to be 
much longer-range than interaction within TADs, and consequently are at least 
an order of magnitude weaker and probably more stochastic in the cell 
population (Figure 4.6) (Gibcus and Dekker, 2013). Interestingly, these 
interactions are highly cell type-specific. The roles, if any, of these interactions in 
gene regulation are currently not known. Possibly they play an architectural role. 
For instance, we previously proposed that cell type invariant TADs assemble into 
higher order structures such as A- and B- compartments that are cell type-
specific and related to chromatin status (Gibcus and Dekker, 2013). 
   
A Number of Different Looping Strategies Are Present at the CFTR Locus 
The CFTR gene is contained within one TAD (number 5). TAD 5 also 
contains all the known CFTR regulatory elements (reviewed in McCarthy and 
Harris, 2005; Ott and Harris, 2011; Gheldof et al., 2010; Ott et al., 2009; Zhang et 
al., 2013, chapter 5 of this thesis). We see that, in Caco2 cells, the CFTR 
promoter interacts with elements II, III and IV as identified previously in our 3C 
experiment (Gheldof et al., 2010; chapter 3 of this thesis). We do not see the 
CFTR promoter looping to element I in Caco2 cells in 5C, which we saw by 3C 
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(Gheldof et al., 2010; chapter 3 of this thesis). This is because we used a 
stringent FDR cutoff when calling significant peaks – at a lower FDR threshold 
we do see the interaction between the CFTR promoter and element I in Caco2 
cells, but we also dramatically increase the number of interactions called 
significant. We chose to use a more stringent FDR to decrease false positives 
rather than capture this interaction in Caco2 cells.  
 Interestingly, we see that Cau3 cells interact with the region upstream of 
the CFTR gene almost exclusively, only contacting element III within the gene 
body. A known lung-specific enhancer is located 35 kb upstream of the CFTR 
promoter (Zhang et al., 2013). Unfortunately our probe design does not cover the 
exact location of this enhancer, but we see a very strong signal from its 
neighboring fragment (the second very high peak in the upstream region, Figure 
4.7H). We infer that this strong peak occurs because the CFTR promoter is 
contacting its neighboring fragment just as (or more) frequently. Additionally we 
see that the CFTR promoter in Cau3 cells interacts very frequently with elements 
I and II identified in our 3C study (though we did not use a lung cell line in the 3C 
work) (Gheldof et al., 2010, chapter 3 of this thesis). These elements are known 
to contain CTCF binding cites (Sabo et al., 2004). These elements may be active 
enhancers in Calu3 cells, or they may play another role, perhaps structurally. 
Further tests need to be done to confirm the function of these elements in lung 
cells. 
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 All cell lines show at least one interaction with the 3´ end of the TAD. This 
is also corroborated by our 3C study, which showed this whole region interacted 
with the CFTR promoter in HeLa S3 and HT-29 cells (Gheldof et al., 2010, 
chapter 3 of this thesis). This may be a functional interaction (as is the element 
IV-CFTR promoter interaction in Caco2 cells) or it may be a structural interaction 
– or both.  
 In this chapter, we show that all the known CFTR regulatory 
elements are contained within the same TAD, and that different cell lines display 
diverse patterns of promoter-element looping within that TAD. We show that 
TADs are present regardless of gene expression status. We also describe 
differences between loops that occur inside TADs versus loops that occur 
between TADs. We propose that TAD boundaries play two important roles: first 
they constrain frequent looping interactions between gene promoters and gene 
regulatory elements within TADs. Second, they are involved in weaker longer-
range interactions with other TADs, possibly leading to formation of higher order 
chromatin architectures. Overall, this study expands our knowledge of the CFTR 
gene and TAD organization. 
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CHAPTER V 
CONCLUSION AND FUTURE DIRECTIONS 
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 This thesis studies the relationship between three-dimensional structure of 
chromatin and gene regulation, focusing on the cystic fibrosis transmembrane 
conductance regulator (CFTR) locus as a model. Using the chromosome 
conformation capture technologies presented herein, this work identifies 3D 
looping between the CFTR gene promoter and a set of genomic elements, two of 
which act as enhancers. This work detects a common topologically associating 
domain structure of the CFTR locus in a variety of cell types, regardless of the 
expression status of the genes within the domains or the looping contacts they 
create. Possible transcription factors that may mediate CFTR expression 
enhancement were identified.  This work has contributed to our understanding of 
3D genome structure, how this structure is related to cell type-specific gene 
regulation and contributed new information for the field of Cystic Fibrosis 
research. 
 
Implications for Genome-Wide Association Studies (GWAS) 
 GWAS are used to identify mutations associated with disease. In many 
GWAS, mutations, or single nucleotide polymorphisms (SNPs) are often found in 
non-genic regions and thus are hard to assign to a gene. 3C technology has 
already begun helping properly assigning SNPs to target genes (Ahmadiyeh et 
al., 2010; French et al., 2013; Harismendy et al., 2011; Visser et al., 2012; Zhou 
et al., 2012). Knowledge of TAD structure may also help GWAS identify target 
genes by limiting search space to within the SNP-containing TAD. Additionally, 
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GWAS authors can also use existing Hi-C and 5C studies to see if a looping 
interaction is present between their SNP location and a gene of interest. 
However, as gene-element looping can be very cell type-specific, researchers 
should include their own follow-up 3C studies in relevant cell lines. Techniques 
such as C technology will continue to help in the search for disease-causing 
mutations and should be more widely adapted in the field. 
 
Implications for CFTR Mutation Screens 
 All children born in the United States are screened for a number of 
diseases at the time of birth, including Cystic Fibrosis. Babies are screened for a 
digestive chemical produced in the pancreas, and if the newborn has a high 
amount of this chemical, the child may have CF. At this point mutation screens 
are carried out. The child will also be screened if a parent is a known carrier of a 
CF allele, or if there is a family history of CF. The current screen checks for the 
most common 23 mutations and was put into use in 2004 (American College of 
Obstetricians and Gynecologists, 2011). Generally it is cost-prohibitive and 
unnecessary to screen for more mutations, but in some cases a CF mutation is 
not found in the patient. In addition to screening for further mutations, our 
research suggests that including known CFTR enhancers may reveal novel CF-
causing mutations, as it is known that deleting or mutating an enhancer can 
result in complete loss of gene function (Sagai et al., 2005).  
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Elements III and IV are CFTR –specific Enhancers 
 Elements III and IV were shown to contact the CFTR promoter in three 
independent 3C experiments (Gheldof et al., 2010; Ott et al., 2009b, Chapter 3 of 
this thesis). These elements overlapped DNase1 hypersensitive sties identified 
by the Harris lab (Nuthall et al., 1999b; Smith et al., 2000). Additionally, these 
sites contained H3K4 acetylation and H3K4me3 in cells that express the CFTR 
gene, which imply enhancer-type elements in the human genome (ENCODE 
consortium). Since these sites loop to the CFTR promoter, they were tested as 
potential regulatory elements of CFTR. We investigated the regulatory potential 
of these elements and found that in a luciferase assay elements III and IV do 
indeed drive expression of a luciferase gene under the control of the CFTR  
promoter. We placed the element of interest directly upstream of the CFTR 
promoter. The classical definition of an enhancer is an element that will enhance 
gene expression regardless of its genomic position or its orientation. Elements III 
and IV were found to enhance CFTR-driven luciferase expression in a different 
assay, where the elements were placed behind the luciferase gene (Ott et al., 
2009b), meeting the first requirement of the classical enhancer definition. 
However, the function of these elements when they are in the reverse orientation 
has yet to be tested. Given the corroborating genomic evidence discussed in 
chapter 3 and the success of these elements to enhance CFTR expression in 
two independently performed assays I am confident in classifying them as 
enhancer elements.  
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Elements I and II May Be CFTR Repressors 
 Although we discovered four elements looping to the CFTR promoter 
(Gheldof et al., 2010; Ott et al., 2009b, chapter 3 of this thesis), only two of them 
displayed enhancer activity in the luciferase assay, as discussed above and in 
chapter 3 of this thesis. Elements I and II did not show any increase in CFTR 
expression, even though they form 3D contacts with the promoter. ChIP-seq 
tracks from the ENCODE consortium and data from the Harris lab show that 
elements I and II bind to CTCF in Caco2, GM12878 and HepG2 cells (Blackledge 
et al., 2007, 2009; Sabo et al., 2004). Interestingly, elements I and II were also 
identified by the Harris lab as containing DHS sites, and element II was shown to 
be important for CFTR expression of a yeast artificial chromosome (Nuthall et al., 
1999a; Smith et al., 1995). Element II has been shown to act as an enhancer-
blocker (Blackledge et al., 2007). A recent study has shown that knocking down 
CTCF and RAD21 (cohesin) using siRNA decreases 3D interactions between 
element II and the CFTR promoter, resulting in a 2.5-fold increase in CFTR gene 
expression (Gosalia et al., 2014). Thus it appears that element II is acting as a 
moderator of CFTR by constraining gene expression. Additionally, element Ic 
may be interpreted as a repressive element from our luciferase assays (chapter 3 
of this thesis). Thus elements I and II may play an important regulatory role in 
CFTR gene expression. 
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What is a TAD?   
 TADs are regions of the genome where interactions occur preferentially 
within the same TAD (Dixon et al., 2012; Nora et al., 2012). TADs are defined by 
clear boundary regions that show depletion for interactions occurring between 
the regions on either side of the boundary. TADs have been shown to be similar 
across cell lines and species (Dixon et al., 2012; Nora et al., 2012; Sexton et al., 
2012). In our study we found that the TAD structure in our 2.8 Mb region was 
extremely similar between the 5 cell lines studied, in agreement with the 
published studies. 
TADs are not defined by the looping that occurs within them. We clearly 
show that different intraTAD loops exist in the 5 cell lines we studied, yet TAD 
boundaries are similar across these 5 cell lines. TADs are also not defined by 
gene expression, as we show that cell lines with diverse gene expression status 
maintain the same TAD boundaries. I believe that TADs are best defined by their 
boundaries, however, what constitutes a TAD boundary is not yet clear. 
It has been reported that TAD boundaries are enriched for CTCF sites and 
for gene promoters (Dixon et al., 2012). This analysis used TAD boundary calls 
from a genome-wide Hi-C experiment, and their TAD calling method placed a 
boundary with +/- 20 kb accuracy. Therefore, the enrichment of CTCF and gene 
promoters occurs in a 40 kb window, within which a TAD boundary is located. In 
our 5C experiment, we placed each boundary at the midpoint of a 10 kb bin. We 
noted that CTCF was not enriched in our boundary regions compared to the rest 
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of the 2.8 Mb dataset, and that our boundary regions tended to be enriched for 
the ends of genes instead of gene promoters. CTCF sites also occur in locations 
without a boundary, indicating that CTCF alone is not sufficient for boundary 
formation.  Additional evidence comes from Zuin et al. who show that TAD 
boundaries are unchanged following knockdown of CTCF or RAD21 (Zuin et al., 
2014). Though genome-wide studies allow a general claim to be made about 
these boundary areas, individual boundaries may not meet those assertions. It is 
clear that more research is needed to identify what creates and maintains TAD 
boundaries. 
 
Possible TAD Function in the Human Genome 
It has been suggested that TADs may correlate with gene expression, i.e. 
that genes within a TAD have similar expression status (Dily et al., 2014; Nora et 
al., 2012). This seems to be a reasonable conclusion if TADs constrain 
regulatory elements – the same regulatory elements would be present in one 
TAD and thus could regulate all the genes within. Indeed, Dily et al. showed that 
genes responsive to hormones resided in TADs that contained other genes 
similarly responsive to the hormone (i.e. in a TAD with one gene strongly induced 
by the presence of a hormone, other genes in that TAD were also upregulated, 
and in TADs where one gene was strongly repressed by a hormone other genes 
in that TAD were also repressed). They saw this effect in about 20% of TADs. 
Though this effect may be present for hormonal response, our dataset shows 
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that one gene in a TAD can be highly expressed while another gene located in 
the same TAD is not expressed at all. As mentioned earlier, the CFTR enhancers 
do not interact with the ASZ1 gene promoter located in the same TAD. We 
conclude that TADs do not impose a similar regulation pattern over the genes 
contained within them.  
TADs could play an important role in the process of gene promoters 
contacting their appropriate regulatory elements by creating a smaller genomic 
search space. We note that all known CFTR regulatory elements are contained 
within one TAD. A promising hypothesis for TAD function may be that promoters 
are limited to the area within their TAD when they search for their target 
regulatory elements. Interestingly, in our dataset we observe that gene promoters 
are not limited to interactions within their own TAD. For example, the MET gene 
promoter, which is expressed in Caco2, Calu3, Capan1 and HepG2 cells, shows 
a combined 25 out of 55 interactions occurring in the interTAD space. Similarly, 
the two fragments at the promoter of CFTR have 41/80 and 31/71 interTAD 
interactions, while the promoter fragment of CTTNBP2 has 11/14 interactions in 
the interTAD space. Thus, TAD boundaries are not absolute barriers, and gene 
promoters do show interactions beyond their local TAD. However, interactions in 
the interTAD space are overall much weaker than the interactions in the intraTAD 
space. The interTAD interactions could be important for structural interactions 
rather than gene regulation. TADs may provide an important environment for 
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proper gene regulation. Experiments proposed below will help address the role of 
TADs in the human genome. 
 
CFTR As A Model Locus for Further Investigations into TAD Structure and 
Gene Regulation 
 The contents of this thesis have set up a model locus for further study of 
the impact of 3D genome structure on gene expression. Our 5C analysis has 
identified specific TAD boundaries in a 2.8 Mb region of the genome surrounding 
the CFTR gene. We have shown that the entire CFTR gene and all its known 
regulatory elements are contained within one TAD (Smith et al. in preparation, 
chapter 4 of this thesis), and that known enhancers make physical contact with 
the CFTR promoter (Gheldof et al., 2010; Ott et al., 2009b, Smith et al. in 
preparation, chapter 3 and 4 of this thesis). Many questions remain in the field 
about how TADs function and about how looping elements form and are 
maintained, and how they contribute to gene regulation. One technology that will 
help answer these questions is the recently described CRISPR/Cas9 
endonuclease mechanism (reviewed in Hsu et al., 2014). CRISPR/Cas9 is a 
molecular machine discovered in bacterial genomes, used as a defense against 
viruses. It has been co-opted by molecular biologists in order to edit the human 
genome. Cas9 is an endonuclease that makes a double strand break at its target 
site (determined by the CRISPR sequence). Human cells can be transfected with 
Cas9 and given CRISPR sequences in the form of guide RNAs (gRNA) that 
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guide the Cas9 enzyme to a targeted location, creating a double strand break at 
a precise genomic location. This system provides a pwerful tool for modifying the 
human genome. In our case, the CRISPR/Cas9 system can be used for many 
follow-up experiments.  
In our model locus, there are three known enhancers that interact with the 
CFTR promoter: and element in intron1 and elements III and IV (Gheldof et al., 
2010; Ott et al., 2009b). Using CRISPR/Cas9, it is possible to delete one or both 
of these elements from the genome and assay both gene expression and 
looping. I hypothesize that both CFTR gene expression and looping would be 
disrupted, with gene expression decreasing and looping to these elements 
abolished. It is also possible to swap these two elements. In this case I 
hypothesize that CFTR gene expression and looping would be maintained, since 
both elements are present within the TAD boundaries. It would be very 
interesting to swap one or both of the CFTR enhancers with other known 
enhancer elements. I hypothesize that CFTR expression would change 
(correlating with the strength of the new enhancer) and that looping would occur 
between the new enhancer and the CFTR promoter. Additionally one could 
delete the two known enhancers (elements III and IV) and put one or both of 
them back into the locus at a different position. In this case I hypothesize that 
CFTR gene expression would be maintained at a similar level to pre-swap, but 
that new looping interactions would appear between the promoter and the new 
locations of the elements.  
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   Another set of interesting experiments that can be facilitated by the 
CRISPR/Cas9 system include moving the known CFTR enhancers into a 
neighboring TAD, without disrupting the TAD boundary. I predict that in this 
instance, CFTR gene expression would decrease and the promoter would no 
longer loop to these enhancers, since they are now located in a different TAD. 
This assumes that our idea that TADs create a small search space for gene 
promoters to find their target enhancers is true. It is possible that the CFTR gene 
promoter would loop into the neighboring TAD to contact its enhancers. This 
would force us to adjust our current TAD model, since the TAD boundary would 
not be preventing the gene promoter from searching neighboring TADs to find its 
enhancers.  
 This brings us to the TADs themselves. CRISPR/Cas9 can also be used 
to aid in our understanding of what TAD function is in the genome. TADs seem to 
be defined by their boundary elements. CTCF is enriched at these boundaries, 
though this is not true for every boundary case (Dixon et al., 2012). At this time 
how a TAD boundary is created and maintained is still unknown. It would be 
interesting to entirely delete one or more boundaries in our locus and, using 5C, 
look to see what happens to the TADs. I predict that the two TADs next to the 
deleted boundary would mix into one larger TAD, as this has occurred before 
(Nora et al., 2012). Next, I would try to place a known boundary region inside a 
stable TAD. I hypothesize that placing a boundary region into a TAD would 
create a new boundary, cutting the current TAD into two smaller TADs. It would 
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be very interesting to place a boundary like this between a gene promoter and its 
known regulatory element and test to see if the looping interaction between these 
two gene loci is maintained or disrupted when a boundary is placed in between 
them. 
 These types of experiments are natural extensions of the results in this 
thesis. They would allow us to investigate the details of enhancer function and 
TAD structure. The locus presented in this thesis is a great model system to test 
these ideas. It contains 12 genes, one that is clinically relevant (CFTR), some 
that are variably expressed, and some that are off in most cell types and some 
that are on in most cell types. The more knowledge we gain about the CFTR 
gene and its surrounding DNA will only benefit the current therapies available to 
Cystic Fibrosis patients. Indeed, I submit the idea that proper gene therapy, if 
ever realized, will require more than just the CFTR gene, but will need to include 
its proper regulatory elements. This work provides a baseline for future 
experiments that will allow researchers to learn more about the proper three-
dimensional genomic structure of the genome and of the CFTR gene.  
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Table A.1: Primer Sequences and Chromosome Positions Used in the 3C 
Experiments. 
 
3C primers 
  
Name Sequence (5´-3´) 
     EcoRI fragment position 
(HG18) 
EcoRI CFTR primers 
start 
(Chromosom
e 7) 
end 
(Chromosom
e 7) 
CFTR324 GATCTCTCCTTTCACTGAGCACCATAGG 116773744 116777008 
CFTR325 GGCAACAGAAACTAACTGTGAGAGGGGCTA 116777009 116778018 
CFTR32
7 TGTGTAGCACAGGTGCCTGACATATAGC 116778535 116793159 
CFTR330 GAACCTAGGAGTTTGAGACCAACTGTGG 116797877 116804745 
CFTR331 CCAACTTTGTCTCTTCAGATAGCTCTCC 116804746 116807423 
CFTR337 TCCCATCTGTTTCTTTCTTTGGCGAGCG 116820538 116822605 
CFTR338 GCTACATGTAAAGTGTCCAGAACAGGCG 116822606 116827113 
CFTR339 GGATTAGCTACAGAAGAGAATTAATGGCCTGG 116827114 116828613 
CFTR343 CAGTAGACCATTACACCCAACCATTGCC 116833484 116835882 
CFTR348 GAACTGGACTGGCAAGAGACACAATGGA 116837533 116844091 
CFTR350 TCCTGGACCAATGAAACATCTCCGATGG 116849034 116854362 
CFTR35
2 TCTAGGACATCTACACTTCATAGCGGGG 116849034 116854362 
CFTR355 ACGTCTGGTGGGTTATGGTGTGCTCCTA 116863884 116868023 
CFTR357 GGGCATCCACATAGGAAAGGAAGAAGTC 116877428 116880943 
CFTR359 GCCCTAGGTGGGTCTAAAAGTTCCAGTT 116883208 116885279 
CFTR360 AACCCCATTGTCTCAGCCACAAAACTCC 116885280 116890156 
CFTR362 GGTTTTTCCCCCACCCCATTTTAGAGCA 116891302 116898038 
CFTR363 GAACTGGGAATTGGCTGTCCTTTTGACC 116898039 116901211 
CFTR368 CACATACAGGTGCCATGCCTGCATATAG 116903489 116907872 
CFTR369 CCCAGGATCATGTTCGGATCAATCTAGTGTGC 116907873 116917169 
CFTR371 AGAAACCATGTGTGAGACAACCATGTTGAG 116920524 116925167 
CFTR374 CCACCTTGTTCTAAGCACAGCAATGAGC 116927536 116936141 
CFTR375 CTTTGCAGGTCCACTTCTATCTGCTGGG 116936142 116940935 
CFTR378 GGCCCATGCCACCCAAATATTATGTAAGC 116943215 116947747 
CFTR379 TTCCCACCAGGAATGCAATCACTTGAGC 116947748 116949548 
CFTR38
4  CAGCACGTGCATTGAACCCATAAGAACC 116954209 116959011 
CFTR386 GGTTCTAGGAGACTCAGTGAAAGTTGATACAC 116959563 116964868 
CFTR388 GAAGACCACTATGCTAAAGCTTCCCACG 116965514 116975353 
CFTR390 CTCTTTCAAAGCTGTAGACTGTGACTCAGC 116975463 116986175 
CFTR391 GGTAATATTGTTCCCATGAGCCTTTCTTGGAG 116986176 116990697 
CFTR393 ACCACTTCTCCTGCACTTGACAATACCG 116991712 116992706 
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CFTR395 GGAGGATAAGACTCAAACAGGTAGTGGG 116994136 116997094 
CFTR39
6 GCCCTCTGTTTGTAGAATGATGCTTGCC 116997095 116998150 
CFTR397 AGGCATGAAGAGATTCTTTCCCAAGGGG 116998151 117002217 
CFTR400 ATTGACCCTTGGACAATGTGGGGGTTAG 117003291 117005125 
CFTR40
2 TGGATCAGAGGAACCAAACAGAAAAGCC 117005136 117007103 
CFTR405 ATCAACCCCACAGTAACTGTCTCG 117008018 117013017 
CFTR406 GACAGGAAACTAACCCTAACTGAGCACC 117013018 117016269 
CFTR407 CTCAGTTCTATGTTGGATGTCTAGAAGCC 117016270 117018702 
CFTR410 TAGTCCCCACAACTACCCTGGAAGGTAT 117019552 117021424 
CFTR412 CAGCTGTGATCTTGGCTTTCTTGTGAGG 117023248 117029897 
CFTR413 AGGTAGGTGGGTTGAGGCCAAATTATGC 117029898 117033264 
CFTR415 GACAGTGAATACTGGCAGAGCAAATGCC 117035191 117039940 
CFTR417 GATTCCCATCATAGTGCTGTCACCCATG 117042373 117044539 
CFTR420 TATCTGGGAAGGATTGAGCCACAGGATC 117051477 117053896 
CFTR421 GCGATCTGTGAGCCGAGTCTTTAAGTTC 117053897 117054925 
CFTR422 GTTTCACAGACCTTCATTTGCCTGAGCC 117054926 117057582 
CFTR425 TCCATCCATTCTTCCATCTGGCTATCCC 117062277 117068221 
CFTR426 TACCACAGGTGAGCAAAAGGACTTAGCC 117068222 117070058 
CFTR427 CTCAACCTGGCGATTGCTAACTTGGAGG 117070059 117073275 
CFTR428 GCAGAGACACAGATCCAAACCATACCAC 117073276 117075081 
CFTR432 GCCTCCTGTTACTCATCTTTGAATCTGGGG 117078729 117088313 
CFTR433 TAGGAAGATCCCTGGGGTGTTTGTATGG 117088314 117090094 
CFTR434 TGGCCTTCATACACTCAGGAGTACTTGC 117090095 117091392 
CFTR435 TCAGGTAGTACCTTTCTCAACCACCTTCTC 117091393 117093441 
CFTR437 ATCAAGGGTACACTGCCTTCTCAACTCC 117093828 117096070 
CFTR438 ACTGAAGCCTGTCAACAGGGACAAGAAC 117096071 117105570 
CFTR439 GGGTTTCATAGTGCTGCACTCAGTTC 117105571 117111634 
CFTR440  GTTTAGGCTTGCTAGGAGGACAGCTAGG 117111635 117114566 
CFTR441 TTGGCATAGATAAGTCACTCACCTGAGG 117114567 117127743 
CFTR442 TGCAGGATTCTGATTCCATTCCCTCAGC 117127744 117131345 
CFTR444 TGCCTTATGAGTGGCTGTAACGTTCAGC 117145780 117148471 
CFTR446 TGTGTACACCTGATTCACCTGGAAAGGC 117149228 117151618 
CFTR448 GTAATAGTGGCAAAGCCAGGGCTAGAGT 117152182 117156149 
CFTR44
9 GGGGACAGGACATGTTGAGTTTGTTACG 117156149 117159202 
CFTR45
2 TCAGGGCTTATGGAGAGGTGAAAGAAGG 117161794 117166672 
  
     EcoRI fragment position 
(HG18) 
EcoRI Gene desert primers 
start 
(Chromosom
end 
(Chromosom
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e 16) e 16) 
GD2 AGCTTCACCTCTCAAACTACAGGACTGG 60845578 60849115 
GD3 GTATACTCAGTTGAGCAGCCCATGACAC 60849116 60851238 
GD5 
GTTCTCTGTCTTATAATTATGCTACAAGAATGAG
G 60851792 60855935 
GD6 GTTTAAGACCCTCAGTATACTAGTCATAGAAGG 60855936 60858531 
GD7 GATGCCATTTCTTATCTTGTCTTGGCAGGTC 60858532 60866968 
GD8 GCAGCAAAGCAAACCAAAAGAACAACAGG 60866969 60873873 
GD9 GTGTCATGGAATCAAAGGTGAGTGAGGG  60873874 60876657 
GD11 CTTAGGACCCTGTGACTCCTGTTTTCTCC 60877690 60880026 
GD17 GGCTGGCTGAGGTCATTCATGCAATCTT 60894707 60905483 
GD18 CCATTCCATCATACACCCTCATCTCACTGCC 60905484 60908417 
  
BsrGI fragment position 
(HG18) 
BsrGI CFTR primers 
start 
(Chromosom
e 7) 
end 
(chromosome 
7) 
EMS1 CTGAATATCATGTCGCAATTAGTGCATC  116903317 116904928 
EMS2 TGTTAACAGCCAAGTGCTACCTAATTT  116904940 116910993 
EMS3 TTTACTCATAGCTCGTGACAATGCAGGC  117109806 117111366 
EMS19 GTGAATATGCTAATGCTGGCCTTAATTC  117096897 117101305 
EMS18 ATCCATCACTGGCTACTTGGTTTGCTTC  117092945 117096897 
EMS20 CAACAAAAACACCCACCGTGAGGTGATG  117111366 117118556 
EMS21 CACCTTTGTTGTCTACTGAGCAGAGGTAGC  117118556 117118931 
EMS27 GAAACTTTCCGTAAAATTATCGATTCCAG 117101305 117109806 
EMS33 TTTCCACTATACTCTGTCATGTTCAGAG 116903167 116903316 
EMS34 CACCTTAAAGCAAGTACGCATGATAAAG 116910993 116916818 
EMS35 TTGGGGAAAGTCGATTCAAGGCAGTAAC 116916819 116921623 
EMS21a GATACACCTTTGTTGTCTACTGAGCAGAG 117118556 117118930 
EMS36 GCAGGATACCAAGTCTATCTTAGCACCATA 117003597 117005294 
EMS37 CAATAGTACATCTGGCAAGGTCATGCAAAC 117005422 117008602 
EMS38 ACCTATCTAACTCTTCGCATTCTTGAAGTC 117014031 117014185 
EMS39 TCTAGGATTCTGCATAATACTGGACAGAGA 117014186 117015473 
EMS40 GTGTAATGTGTTGTCCAGTTTTGGATGATG 117016422 117016451 
EMS41 GCTTAGACTACTCATCTACCTCAATACTTC 117018151 117018180 
EMS42 CTAAACTCAAGTCCCATGCTACCTTCAGAG 117025603 117025632 
EMS43 ATTAACACTCCTCTAGTTAGAACAAAGAGG 117028400 117028429 
EMS44 CCCAGTTAATAGATATTTCGATTGTTCC 116921624 116923928 
  
BsrGI fragment position 
(HG18) 
BsrGI Gene desert primers 
start 
(Chromosom
end 
(chromosome 
16) 
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e 16) 
EMS13 CTTTAGATAATGCCGATCTACTTTCTGGG 60835929 60839882 
EMS14 TTTCCCCGTGTGACTATGAAGGATACAG 60839882 60844701 
EMS15 TGCACTCCGGCCAAGGTAGCAGAACAAGA 60844701 60852673 
EMS16 GGTGGTAAGTCCTGCAACCATTTAGTGC 60867202 60871330 
EMS17 TCATACTGATGACCCTAACCCTGTGCAG 60898436 60900384 
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Table A.2: All 3C Interaction Values. Start and end coordinates, chr7 hg18. 
Fragments named based on EcoR1 restriction site number in the region, except 
for the BsrGI fine mapping experiment. Values listed are the averages if at least 
three independent values, with SE = standard error of those values.  
 
3C experimental data 
Anchor at Promoter: Fragment 368 
   
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
116773744 116777008 EcoRI-324 
   116777009 116778018 EcoRI-325 0.059028 0.2255 0.029706 0.1762 
116804746 116807423 EcoRI-331 0.072963 0.3203 0.035137 0.1519 
116822606 116827113 EcoRI-338 0.109829 0.7058 0.05593 0.1032 
116837533 116844091 EcoRI-348 0.184689 0.4268 0.031965 0.1075 
116849034 116854362 EcoRI-350 0.196216 0.3278 0.024463 0.0653 
116863884 116868023 EcoRI-355 0.163491 0.4788 0.048081 0.055 
116883208 116885279 EcoRI-359 0.365195 1.5935 0.035409 0.1925 
116885280 116890156 EcoRI-360 0.390279 0.8674 0.099406 0.0938 
116891302 116898038 EcoRI-362 0.509712 0.9929 0.03367 0.1138 
116898039 116901211 EcoRI-363 0.823164 1.3186 0.067132 0.155 
116907873 116917169 EcoRI-369 0.984552 1.0857 0.066975 0.0738 
116920524 116925167 EcoRI-371 0.669593 0.8284 0.04563 0.0941 
116927536 116936141 EcoRI-374 
   116936142 116940935 EcoRI-375 0.24437 0.3449 0.040186 0.0259 
116943215 116947747 EcoRI-378 
   116947748 116949548 EcoRI-379 0.1404 0.4799 0.01642 0.1339 
116959563 116964868 EcoRI-386 0.106288 0.3279 0.017809 0.0648 
116975463 116986175 EcoRI-390 0.05664 0.1933 0.019519 0.047 
116994136 116997094 EcoRI-395 
   116998151 117002217 EcoRI-397 0.101649 0.312 0.041325 0.0055 
117003291 117005125 EcoRI-400 
   117008018 117013017 EcoRI-405 0.121977 0.3161 0.027904 0.0762 
117013018 117016269 EcoRI-406 0.09631 0.9639 0.027054 0.046 
117016270 117018702 EcoRI-407 0.054558 1.0794 0.009394 0.1323 
117019552 117021424 EcoRI-410 
   117023248 117029897 EcoRI-412 
   117035191 117039940 EcoRI-415 0.048333 0.3034 0.016351 0.0198 
117051477 117053896 EcoRI-420 
   117053897 117054925 EcoRI-421 0.086966 0.3144 0.024326 0.0479 
117070059 117073275 EcoRI-427 0.081519 0.1614 0.026643 0.0295 
117073276 117075081 EcoRI-428 
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117078729 117088313 EcoRI-432 
   117088314 117090094 EcoRI-433 
   117090095 117091392 EcoRI-434 0.0824 0.2484 0.034428 0.044 
117096071 117105570 EcoRI-438 0.098919 0.3143 0.009577 0.0377 
117105571 117111634 EcoRI-439 0.127753 0.626 0.037908 0.0472 
117111635 117114566 EcoRI-440 0.062175 0.448 0.030215 0.0541 
117114567 117127743 EcoRI-441 0.085828 0.2377 0.018547 0.0388 
117127744 117131345 EcoRI-442 
   117145780 117148471 EcoRI-444 
   117149228 117151618 EcoRI-446 
   
       
Start End name HepG2 HeLa 
SE 
HepG2 
SE 
HeLa 
116773744 116777008 EcoRI-324 
   116777009 116778018 EcoRI-325 0.095055 0.0849 0.030743 0.0461 
116804746 116807423 EcoRI-331 0.208439 0.2737 0.04823 0.0709 
116822606 116827113 EcoRI-338 0.189723 0.422 0.037485 0.0683 
116837533 116844091 EcoRI-348 0.197211 0.2846 0.024337 0.1353 
116849034 116854362 EcoRI-350 0.138971 0.2379 0.009357 0.1245 
116863884 116868023 EcoRI-355 0.251463 0.2756 0.126408 0.0287 
116883208 116885279 EcoRI-359 0.665637 0.5145 0.095394 0.0946 
116885280 116890156 EcoRI-360 0.661475 0.8481 0.070451 0.1166 
116891302 116898038 EcoRI-362 0.549455 0.3763 0.174991 0.0434 
116898039 116901211 EcoRI-363 1.073387 0.771 0.045413 0.1322 
116907873 116917169 EcoRI-369 1.122547 0.7069 0.08207 0.0397 
116920524 116925167 EcoRI-371 0.564628 0.7585 0.081609 0.2329 
116927536 116936141 EcoRI-374 0.147572 0.1892 0.027432 0.0078 
116936142 116940935 EcoRI-375 
   116943215 116947747 EcoRI-378 
   116947748 116949548 EcoRI-379 0.120832 0.1446 0.015455 0.0186 
116959563 116964868 EcoRI-386 0.052881 0.2178 0.01475 0.0535 
116975463 116986175 EcoRI-390 0.06216 0.1312 0.007956 0.0179 
116994136 116997094 EcoRI-395 
   116998151 117002217 EcoRI-397 0.051556 0.1624 0.026291 0.0277 
117003291 117005125 EcoRI-400 
   117008018 117013017 EcoRI-405 0.084211 0.1991 0.02476 0.0421 
117013018 117016269 EcoRI-406 0.087058 0.4297 0.020314 0.0657 
117016270 117018702 EcoRI-407 0.057757 0.1754 0.018444 0.0319 
117019552 117021424 EcoRI-410 
   117023248 117029897 EcoRI-412 
   117035191 117039940 EcoRI-415 0.073816 0.0422 0.038378 0.0121 
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117051477 117053896 EcoRI-420 
   117053897 117054925 EcoRI-421 0.088373 0.0243 0.051973 0.0246 
117070059 117073275 EcoRI-427 0.050296 0.0727 0.026232 0.0247 
117073276 117075081 EcoRI-428 
   117078729 117088313 EcoRI-432 
   117088314 117090094 EcoRI-433 
   117090095 117091392 EcoRI-434 0.082921 0.31 0.047573 0.0971 
117096071 117105570 EcoRI-438 0.023515 0.2455 0.012048 0.0086 
117105571 117111634 EcoRI-439 0.046716 0.4706 0.016642 0.0444 
117111635 117114566 EcoRI-440 0.054599 0.1758 0.011503 0.046 
117114567 117127743 EcoRI-441 0.067805 0.1572 0.011872 0.014 
117127744 117131345 EcoRI-442 0.045559 0.3247 0.045105 0.1318 
117145780 117148471 EcoRI-444 0.085247 0.1151 0.037509 0.0586 
117149228 117151618 EcoRI-446 
   
       
Start End name K562 HT29 SE K562 
SE 
HT29 
116773744 116777008 EcoRI-324 0.015124 0.1162 0.004882 0.0128 
116777009 116778018 EcoRI-325 
   116804746 116807423 EcoRI-331 0.065392 0.1781 0.008163 0.0621 
116822606 116827113 EcoRI-338 0.067476 0.2755 0.013022 0.043 
116837533 116844091 EcoRI-348 0.082678 0.2135 0.006645 0.028 
116849034 116854362 EcoRI-350 0.088788 0.2075 0.016058 0.021 
116863884 116868023 EcoRI-355 0.137671 0.2569 0.018188 0.0374 
116883208 116885279 EcoRI-359 0.242225 0.3901 0.047365 0.0559 
116885280 116890156 EcoRI-360 0.219342 0.3265 0.028884 0.0473 
116891302 116898038 EcoRI-362 0.329156 0.2653 0.027368 0.0407 
116898039 116901211 EcoRI-363 0.583964 0.3852 0.040811 0.0478 
116907873 116917169 EcoRI-369 0.607507 0.2643 0.020956 0.0271 
116920524 116925167 EcoRI-371 0.492266 0.2242 0.072069 0.0513 
116927536 116936141 EcoRI-374 0.150291 0.1484 0.022919 0.0398 
116936142 116940935 EcoRI-375 
   116943215 116947747 EcoRI-378 0.08382 0.1123 0.013717 0.0242 
116947748 116949548 EcoRI-379 
   116959563 116964868 EcoRI-386 
   116975463 116986175 EcoRI-390 0.057818 0.0821 0.007832 0.0388 
116994136 116997094 EcoRI-395 0.034532 0.0718 0.004406 0.0181 
116998151 117002217 EcoRI-397 
   117003291 117005125 EcoRI-400 0.024274 0.1183 0.013262 0.0365 
117008018 117013017 EcoRI-405 
   117013018 117016269 EcoRI-406 0.043408 0.2176 0.011537 0.0299 
227 
 
117016270 117018702 EcoRI-407 
   117019552 117021424 EcoRI-410 0.044562 0.1012 0.012435 0.0289 
117023248 117029897 EcoRI-412 0.026932 0.0397 0.002326 0.0198 
117035191 117039940 EcoRI-415 0.028748 0.026 0.006036 0.0067 
117051477 117053896 EcoRI-420 0.023855 0.0759 0.019714 0.0041 
       Anchor at Element I - Fragment 338 
   
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
116797877 116804745 EcoRI-330 0.254685 0.5284 0.049502 0.0725 
116820538 116822605 EcoRI-337 1.722173 1.1985 0.204827 0.0996 
116827114 116828613 EcoRI-339 1.308083 1.3419 0.110867 0.2041 
116849034 116854362 EcoRI-350 0.206251 0.2153 0.065428 0.0521 
116863884 116868023 EcoRI-355 0.252983 0.4468 0.073971 0.1321 
116883208 116885279 EcoRI-359 0.217338 0.5313 0.112178 0.1689 
116885280 116890156 EcoRI-360 
   116891302 116898038 EcoRI-362 0.142764 0.7456 0.057846 0.2309 
116903489 116907872 EcoRI-368 0.109829 0.7058 0.05593 0.1032 
116907873 116917169 EcoRI-369 0.240473 0.5779 0.089852 0.083 
116920524 116925167 EcoRI-371 
   116943215 116947747 EcoRI-378 0.111934 0.1292 0.028472 0.0185 
116965514 116975353 EcoRI-388 0.053488 0.0798 0.004437 0.0443 
116998151 117002217 EcoRI-397 0.097606 0.277 0.020365 0.0638 
117013018 117016269 EcoRI-406 0.098859 0.2723 0.012458 0.0386 
117016270 117018702 EcoRI-407 0.045716 0.2055 0.018914 0.0283 
117035191 117039940 EcoRI-415 0.103985 0.1072 0.011148 0.0409 
117061386 117062276 EcoRI-424 0.251107 0.132 0.043936 0.0407 
117088314 117090094 EcoRI-433 0.150655 0.3941 0.010713 0.0664 
117096071 117105570 EcoRI-438 0.177773 0.2453 0.066427 0.0058 
117105571 117111634 EcoRI-439 0.123496 0.2536 0.017319 0.0683 
117111635 117114566 EcoRI-440 0.114591 0.1514 0.030705 0.0357 
117127744 117131345 EcoRI-442 0.062213 0.3032 0.017502 0.0416 
117145780 117148471 EcoRI-444 
   
       
Start End name HepG2 HeLa 
SE 
HepG2 
SE 
HeLa 
116797877 116804745 EcoRI-330 0.319813 0.7106 0.016533 0.0894 
116820538 116822605 EcoRI-337 1.305474 1.2247 0.033585 0.0979 
116827114 116828613 EcoRI-339 1.367229 1.1811 0.132693 0.099 
116849034 116854362 EcoRI-350 0.294874 0.4376 0.04853 0.1478 
116863884 116868023 EcoRI-355 0.107873 0.2804 0.021437 0.1965 
228 
 
116883208 116885279 EcoRI-359 0.274132 0.4182 0.119795 0.0695 
116885280 116890156 EcoRI-360 0.417959 0.7101 0.099026 0.1489 
116891302 116898038 EcoRI-362 0.143237 0.5268 0.059961 0.1703 
116903489 116907872 EcoRI-368 0.189723 0.422 0.037485 0.0683 
116907873 116917169 EcoRI-369 
   116920524 116925167 EcoRI-371 0.096782 0.2346 0.014691 0.0955 
116943215 116947747 EcoRI-378 0.100889 0.0893 0.058148 0.018 
116965514 116975353 EcoRI-388 0.020868 0.0748 0.020197 0.0471 
116998151 117002217 EcoRI-397 0.111503 0.2199 0.037132 0.1023 
117013018 117016269 EcoRI-406 0.100502 0.3567 0.035413 0.0402 
117016270 117018702 EcoRI-407 
   117035191 117039940 EcoRI-415 0.062414 0.1494 0.046212 0.054 
117061386 117062276 EcoRI-424 0.032764 0.435 0.016115 0.1258 
117088314 117090094 EcoRI-433 0.079868 0.431 0.038075 0.0818 
117096071 117105570 EcoRI-438 0.169819 0.4213 0.053504 0.0083 
117105571 117111634 EcoRI-439 0.053686 0.5933 0.039055 0.0969 
117111635 117114566 EcoRI-440 0.066429 0.1837 0.039418 0.0966 
117127744 117131345 EcoRI-442 0.057082 0.3243 0.048285 0.0399 
117145780 117148471 EcoRI-444 0.109981 0.1697 0.054748 0.112 
       Anchor at Element II - Fragment 359 
   
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
116804746 116807423 EcoRI-331 0.2277 0.5477 0.071372 0.1042 
116822606 116827113 EcoRI-338 0.217338 0.5313 0.112178 0.1689 
116833484 116835882 EcoRI-343 0.361827 0.8007 0.231007 0.2829 
116863884 116868023 EcoRI-355 0.584795 0.7231 0.194489 0.07 
116877428 116880943 EcoRI-357 1.350006 1.4773 0.134305 0.0715 
116883208 116885279 EcoRI-359 
   116885280 116890156 EcoRI-360 1.327891 1.2762 0.051307 0.0978 
116891302 116898038 EcoRI-362 
   116898039 116901211 EcoRI-363 
   116903489 116907872 EcoRI-368 0.365195 1.5935 0.035409 0.1925 
116907873 116917169 EcoRI-369 
   116920524 116925167 EcoRI-371 0.518776 0.8335 0 0.2548 
116943215 116947747 EcoRI-378 0.16953 0.1997 0.025429 0.03 
116965514 116975353 EcoRI-388 
   116994136 116997094 EcoRI-395 0.125006 0.2409 0.060316 0.0416 
116998151 117002217 EcoRI-397 
   117013018 117016269 EcoRI-406 0.092062 0.4933 0.027538 0.0705 
117016270 117018702 EcoRI-407 0.132119 0.6796 0.035192 0.2415 
229 
 
117029898 117033264 EcoRI-413 0.093554 0.2941 0.028888 0.0276 
117051477 117053896 EcoRI-420 0.142561 0.2979 0.071592 0.0463 
117073276 117075081 EcoRI-428 0.120912 0.2003 0.060801 0.0661 
117091393 117093441 EcoRI-435 
   117096071 117105570 EcoRI-438 
   117105571 117111634 EcoRI-439 0.101915 0.3518 0.017523 0.0424 
117127744 117131345 EcoRI-442 
   117152182 117156149 EcoRI-448 0.148889 0.3261 0.055404 0.039 
       
Start End name HepG2 HeLa 
SE 
HepG2 
SE 
HeLa 
116804746 116807423 EcoRI-331 0.194641 0.3358 0.122792 0.2063 
116822606 116827113 EcoRI-338 0.417959 0.7101 0.099026 0.1489 
116833484 116835882 EcoRI-343 0.392633 0.5442 0.073409 0.104 
116863884 116868023 EcoRI-355 0.570234 0.6693 0.085609 0.1318 
116877428 116880943 EcoRI-357 2.346159 1.0749 0.262381 0.1245 
116883208 116885279 EcoRI-359 1.908843 1.4083 0.166004 0.1967 
116885280 116890156 EcoRI-360 
   116891302 116898038 EcoRI-362 1.250003 0.631 0.185834 0.0635 
116898039 116901211 EcoRI-363 1.405198 0.8714 0.036471 0.1931 
116903489 116907872 EcoRI-368 0.661475 0.8481 0.070451 0.1166 
116907873 116917169 EcoRI-369 
   116920524 116925167 EcoRI-371 
   116943215 116947747 EcoRI-378 0.170959 0.4377 0 0.1118 
116965514 116975353 EcoRI-388 0.223925 0.3565 0.004055 0.1007 
116994136 116997094 EcoRI-395 
   116998151 117002217 EcoRI-397 0.178905 0.2337 0.020779 0.0407 
117013018 117016269 EcoRI-406 0.170655 0.59 0.054152 0.0969 
117016270 117018702 EcoRI-407 
   117029898 117033264 EcoRI-413 0.191264 0.3003 0.037448 0.0813 
117051477 117053896 EcoRI-420 0.233349 0.1456 0.126907 0.0761 
117073276 117075081 EcoRI-428 
   117091393 117093441 EcoRI-435 0.318457 0.5282 0.052486 0.1651 
117096071 117105570 EcoRI-438 
   117105571 117111634 EcoRI-439 0.176969 0.528 0.038786 0.0716 
117127744 117131345 EcoRI-442 0.262463 0.6111 0.114092 0.1122 
117152182 117156149 EcoRI-448 
   
       
Start End name K562 HT29 SE K562 
SE 
HT29 
116804746 116807423 EcoRI-331 0.332786 0.5915 0.175332 0.3216 
230 
 
116822606 116827113 EcoRI-338 0.274132 0.4182 0.119795 0.0695 
116833484 116835882 EcoRI-343 0.313688 0.4168 0.296745 0.1149 
116863884 116868023 EcoRI-355 0.76115 0.542 0.221117 0.1692 
116877428 116880943 EcoRI-357 1.737913 1.4452 0.434226 0.341 
116883208 116885279 EcoRI-359 
   116885280 116890156 EcoRI-360 1.908843 1.4083 0.166004 0.1967 
116891302 116898038 EcoRI-362 
   116898039 116901211 EcoRI-363 
   116903489 116907872 EcoRI-368 0.665637 0.5145 0.095394 0.0946 
116907873 116917169 EcoRI-369 0.260161 0.2956 0.104427 0.1092 
116920524 116925167 EcoRI-371 
   116943215 116947747 EcoRI-378 0.360015 0.3916 0.097008 0.0047 
116965514 116975353 EcoRI-388 0.15566 0.0445 0.048838 0.0436 
116994136 116997094 EcoRI-395 0.073374 0.1175 0.037159 0.0293 
116998151 117002217 EcoRI-397 
   117013018 117016269 EcoRI-406 0.105428 0.2689 0.033887 0.0454 
117016270 117018702 EcoRI-407 
   117029898 117033264 EcoRI-413 0.037639 0.3288 0.022237 0.0389 
117051477 117053896 EcoRI-420 0.03192 0.078 0.031526 0.0128 
117073276 117075081 EcoRI-428 0.135132 0.3435 0.046305 0.0673 
117091393 117093441 EcoRI-435 0.128634 0.2702 0.048733 0.1034 
117096071 117105570 EcoRI-438 0.351526 0.1406 0.029004 
 117105571 117111634 EcoRI-439 0.567412 0.0255 0.046177 
 117127744 117131345 EcoRI-442 0.1352 0.6263 0.035918 0.0872 
117152182 117156149 EcoRI-448 0.155954 0.2316 0.042735 0.1566 
       Anchor at Element III - Fragment 406 
   
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
116804746 116807423 EcoRI-331 0.017301 0.1466 0.012728 0.0166 
116822606 116827113 EcoRI-338 0.098859 0.2723 0.012458 0.0386 
116849034 116854362 EcoRI-350 0.034164 0.2178 0.015033 0.0707 
116863884 116868023 EcoRI-355 0.07663 0.3239 0.025211 0.0588 
116883208 116885279 EcoRI-359 0.092062 0.4933 0.027538 0.0705 
116885280 116890156 EcoRI-360 
   116891302 116898038 EcoRI-362 0.06332 0.4369 0.01918 0.0754 
116903489 116907872 EcoRI-368 0.09631 0.9639 0.027054 0.046 
116907873 116917169 EcoRI-369 0.129613 0.7198 0.026181 0.043 
116920524 116925167 EcoRI-371 0.082935 0.4924 0.048947 0.0323 
116947748 116949548 EcoRI-379 0.105267 0.2142 0.041681 0.0262 
116959563 116964868 EcoRI-386 0.14584 0.3186 0.062296 0.0385 
231 
 
116986176 116990697 EcoRI-391 0.164215 0.2877 0.024379 0.0532 
117003291 117005125 EcoRI-400 0.299104 0.8186 0.006406 0.0514 
117016270 117018702 EcoRI-407 0.558641 1.4461 0.04279 0.042 
117019552 117021424 EcoRI-410 
   117042373 117044539 EcoRI-417 0.160777 0.3252 0.027017 0.0544 
117068222 117070058 EcoRI-426 0.108055 0.4172 0.036531 0.023 
117090095 117091392 EcoRI-434 0.067027 0.5391 0.019846 0.0384 
117105571 117111634 EcoRI-439 0.088219 0.6045 0.02756 0.0831 
117127744 117131345 EcoRI-442 
   117149228 117151618 EcoRI-446 0.107094 0.281 0.045659 0.0422 
       
Start End name HepG2 HeLa 
SE 
HepG2 
SE 
HeLa 
116804746 116807423 EcoRI-331 0.099695 0.1798 0.021341 0.0356 
116822606 116827113 EcoRI-338 0.100502 0.3567 0.035413 0.0402 
116849034 116854362 EcoRI-350 0.093923 0.2227 0.026431 0.0993 
116863884 116868023 EcoRI-355 0.064584 0.2234 0.029959 0.0491 
116883208 116885279 EcoRI-359 0.105428 0.2689 0.033887 0.0454 
116885280 116890156 EcoRI-360 0.170655 0.59 0.054152 0.0969 
116891302 116898038 EcoRI-362 0.083668 0.2735 0.064624 0.0519 
116903489 116907872 EcoRI-368 0.087058 0.4297 0.020314 0.0657 
116907873 116917169 EcoRI-369 
   116920524 116925167 EcoRI-371 0.101026 0.3301 0.019326 0.0734 
116947748 116949548 EcoRI-379 0.073574 0.0972 0.015759 0.0037 
116959563 116964868 EcoRI-386 0.073332 0.0958 0.014309 0.0483 
116986176 116990697 EcoRI-391 0.102106 0.132 0.041825 0.0385 
117003291 117005125 EcoRI-400 0.409836 0.3966 0.040836 0.0375 
117016270 117018702 EcoRI-407 
   117019552 117021424 EcoRI-410 0.423273 0.4545 0.016615 0.0432 
117042373 117044539 EcoRI-417 0.16042 0.268 0.063396 0.0743 
117068222 117070058 EcoRI-426 0.055721 0.246 0.010634 0.1085 
117090095 117091392 EcoRI-434 0.125978 0.3476 0.03103 0.113 
117105571 117111634 EcoRI-439 0.064345 0.4983 0.02095 0.0801 
117127744 117131345 EcoRI-442 0.039965 0.297 0.026499 0.0178 
117149228 117151618 EcoRI-446 
   
       Anchor at Element IV - Fragment 439 
   
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
116804746 116807423 EcoRI-331 0.049524 0.0578 0.024889 0.0009 
116822606 116827113 EcoRI-338 0.123496 0.2536 0.017319 0.0683 
232 
 
116833484 116835882 EcoRI-343 0.077888 0.1371 0.02814 0.0361 
116849034 116854362 EcoRI-350 0.057388 0.121 0.027801 0.0341 
116883208 116885279 EcoRI-359 0.101915 0.3518 0.017523 0.0424 
116885280 116890156 EcoRI-360 
   116898039 116901211 EcoRI-363 0.05697 0.1997 0.041046 0.0111 
116903489 116907872 EcoRI-368 0.127753 0.626 0.037908 0.0472 
116920524 116925167 EcoRI-371 0.114751 0.292 0.039124 0.034 
116947748 116949548 EcoRI-379 
   116959563 116964868 EcoRI-386 0.058143 0.2227 0.010776 0.0273 
116965514 116975353 EcoRI-388 0.137084 0.2715 0.018633 0.0126 
116991712 116992706 EcoRI-393 0.054297 0.3156 0.022269 0.0704 
117003291 117005125 EcoRI-400 0.101937 0.3829 0.02802 0.0251 
117013018 117016269 EcoRI-406 0.088219 0.6045 0.02756 0.0831 
117035191 117039940 EcoRI-415 0.102279 0.1227 0.046829 0.0307 
117054926 117057582 EcoRI-422 
   117078729 117088313 EcoRI-432 0.191792 0.4739 0.01247 0.0166 
117093828 117096070 EcoRI-437 0.500427 0.2866 0.056936 0.0667 
117111635 117114566 EcoRI-440 0.908109 0.883 0.016413 0.0255 
117127744 117131345 EcoRI-442 0.323102 0.4276 0.101611 0.0245 
       
Start End name HepG2 HeLa 
SE 
HepG2 
SE 
HeLa 
116804746 116807423 EcoRI-331 0.013254 0.3049 0.009316 0.0539 
116822606 116827113 EcoRI-338 0.053686 0.5933 0.039055 0.0969 
116833484 116835882 EcoRI-343 0.062249 0.3652 0.027459 0.0814 
116849034 116854362 EcoRI-350 0.053271 0.2769 0.02409 0.1268 
116883208 116885279 EcoRI-359 0.073231 0.5674 0.025453 0.0462 
116885280 116890156 EcoRI-360 0.176969 0.528 0.038786 0.0716 
116898039 116901211 EcoRI-363 0.072794 0.5461 0.013026 0.1069 
116903489 116907872 EcoRI-368 0.046716 0.4706 0.016642 0.0444 
116920524 116925167 EcoRI-371 0.125269 0.4505 0.048806 0.0904 
116947748 116949548 EcoRI-379 0.043544 0.2709 0.021189 0.0765 
116959563 116964868 EcoRI-386 0.03143 0.1385 0.02705 0.0375 
116965514 116975353 EcoRI-388 0.057233 0.2927 0.006505 0.0703 
116991712 116992706 EcoRI-393 0.084916 0.2593 0.019332 0.0882 
117003291 117005125 EcoRI-400 0.040701 0.3956 0.010032 0.0743 
117013018 117016269 EcoRI-406 0.064345 0.4983 0.02095 0.0801 
117035191 117039940 EcoRI-415 0.017003 0.3872 0.008242 0.0782 
117054926 117057582 EcoRI-422 0.11625 0.193 0.013081 0.0327 
117078729 117088313 EcoRI-432 0.129096 0.6628 0.02938 0.0222 
117093828 117096070 EcoRI-437 0.345992 0.6406 0.025566 0.1492 
233 
 
117111635 117114566 EcoRI-440 0.688112 0.9445 0.028563 0.0789 
117127744 117131345 EcoRI-442 0.225562 0.7307 0.041095 0.12 
       BsrGI Fine Mapping 
     
Start End name GM06990 Caco2 
SE 
GM06990 
SE 
Caco2 
Anchor at Promoter, looking at Element III 
   117014031 117014185 EMS38 0.24 0.3513 0.037574 0.0574 
117014186 117015473 EMS39 0.28093 0.4803 0.041359 0.054 
117016422 117016451 EMS40 0.288757 0.606 0.04583 0.0556 
117018151 117018180 EMS41 0.261154 0.4173 0.035647 0.0512 
Anchor at Promoter, looking at Element IV 
   117101305 117109806 EMS27 0.146282 0.2666 0.021951 0.031 
117109806 117111366 EMS3 0.205144 0.4522 0.053743 0.0734 
117111366 117118556 EMS20 0.201013 0.3901 0.029906 0.0484 
Anchor at Element III, looking at Element IV 
   117101305 117109806 EMS27 0.114342 0.3771 0.017601 0.0294 
117109806 117111366 EMS3 0.117414 0.874 0.023627 0.0895 
117111366 117118556 EMS20 0.076762 0.2799 0.020966 0.0275 
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Table A.3: Primers Used in qRT-PCR. Gene names are listed in italics with 
their abbreviation in bold lettering. F and R refer to forward and reverse primers. 
Sequences for each primer are listed followed by the exon number and genome 
location (hg18). 
 
 
 
Primer Name Primer Sequence 
Exon 
# 
Genome Coordinates 
(hg18) 
TES: testin isoform 1  
   
 
TES_F_A GCCCCTTGTTTAAAATGCAA 2 115661854-115661873 
 
TES_R_A TGCTCAAGAGGACATCATGC 3 115676346-115676365 
CAV2:  caveolin 2 isoform a and b   
  
 
CAV2_F_A GGCTCAACTCGCATCTCAAG 1 115927202-115927221 
 
CAV2_R_A CAGGAACACCGTCAGGAACT 2 115927656-115927675 
CAV1:  caveolin 1  
   
 
CAV1_F_A GAGCTGAGCGAGAAGCAAGT 2 115953887-115953906 
 
CAV1_R_A CAAATGCCGTCAAAACTGTG 3 115986275-115986294 
MET:  met proto-oncogene isoform a precursor  
  
 
MET_F_B CCAATGACCTGCTGAAATTG 11 116197041-116197060 
 
MET_R_B CTTTTCCAAGGACGGTTGAA 12 116198805-116198824  
CAPZA2: capping protein (actin filament) muscle Z-line 
  
 
CAPZA2_F_A GAAGGAGGCAACTGATCCAA 5 116331553-116331572 
 
CAPZA2_R_A GCTTGGAACTGATGGCTTTC 6 116333601-116333620 
ST7: suppression of tumorigenicity 7 isoform b  
  
 
ST7_F_A TTCCAGTAACGGGGACTCAG 3 116546967-116546986 
 
ST7_R_A TGGATTTCGCCATACTTTGC 4 116557086-116557105 
WNT2: wingless-type MMTV integration site family  
  
 
WNT2_F_B GTGGATGCAAAGGAAAGGAA 3 116742416-116742435 
 
WNT2_R_B AGCCAGCATGTCCTGAGAGT 4 116725090-116725109 
ASZ1: ankyrin repeat, SAM and basic leucine zipper  
  
 
ASZ1_F_B CACGTCAGGGTCATAAA 6 116812115-116812137 
 
ASZ1_R_B GCTGTTGAAGTTTTCCTTCCA 7 116810346-116810366 
CFTR: cystic fibrosis transmembrane conductance regulator  
 
 
CFTR2-3F CCCTTCTGTTGATTCTGCTG 2 116931609-116931628 
 
CFTR2-3R AAGGGCATTAATGAGTTTAGGA 3 116936357-116936378 
CTTNBP2: cortactin binding protein 2   
  
 
CTTNBP2_F_C AAAATGGCTTCACACCCTTG 6 117210181-117210200 
 
CTTNBP2_R_C TGTCTGTCCTCCATCAGCAG 7 117207818-117207837 
LSM8: U6 snRNA-associated Sm-like protein LSm8  
 
 
 
LSM8_F_A CAGCTCTTCACAGGGGGTAG 3 117615633-117615652 
 
LSM8_R_A CTGCTCGAATATTCCCCAAA 4 117619247-117619000 
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ANKRD7: ankyrin repeat domain 7 isoform b 
  
 
ANKRD7_F_A ACCTTTGCACCTAGCCTGTG 2 117661724-117661743 
 
ANKRD7_R_A ATCTGGGTCTGCACCAAAGT 3 117662034-117662053 
HPRT1: Chromosome X: hypoxanthine phosphoribosyltransferase 1 
 
HPRT2-3F TGAGGATTTGGAAAGGGTGT 2 133435114-133435133 
 
HPRT2-3R TAATCCAGCAGGTCAGCAAA 3 133436965-133436984 
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IV DHS 1 1 19_B11 GCM1 - - 4VW 4VS 
IV DHS 1 1 19_D07 DMTF1 - - 4W 4W 
IV DHS 1 1 19_E01 ZIC3 4W 4VS 4VS 4VS 
IV DHS 2 2 1_A02 ESRRB 
    IV DHS 2 2 2_B06 THRB 
    IV DHS 2 2 5_A09 ESRRG 
    IV DHS 2 2 7_D01 NR5A1 
    IV DHS 2 2 8_F12 NR5A2 
    IV DHS 2 2 14_F02 ZIC3 - - 4VW 4W 
IV DHS 2 2 19_A08 NR5A2 - 4VW 4W 4W 
IV DHS 2 2 19_B10 ZIC1 - 3VW 3W 3W 
IV DHS 2 2 19_E01 ZIC3 - 4W 4M 4W 
IV DHS 3 3 01_A02 ESRRB - 4W 4S 4VS 
IV DHS 3 3 01_A03 FOXC1 - 3S 3VS 3VS 
IV DHS 3 3 02_B06 THRB - 4VW - 4VW 
IV DHS 3 3 05_A09 ESRRG - 4W 4M 4S 
IV DHS 3 3 05_F06 ZNF471 - - 2VW 3VW 
IV DHS 3 3 08_F12 NR5A2 - 4VW - 4W 
IV DHS 3 3 10_E03 
MIXED 
(ERROR) - 4M 4VS 4VS 
IV DHS 3 3 10_C07 TEAD2 - - 4W 4W 
IV DHS 3 3 11_C03 TEAD2 - - 4W 4W 
IV DHS 3 3 14_F02 ZIC3 - 4W 4W 4M 
IV DHS 3 3 15_D07 REL - 3S 3VS 3VS 
IV DHS 3 3 19_A08 NR5A2 - 3W 3W 3W 
IV DHS 3 3 19_E01 ZIC3 - 4VS 4VS 4VS 
IV DHS 3 3 19_H08 
 
- - - 2VW 
         PFA 1 3 
  
- - - - 
PFA 2 3 15_H04 GRHL2 - - 3M 3M 
PFA 2 3 19_E01 ZIC3 - - 4M 4M 
PFA 3 3 14_F02 ZIC3 - - 4VW 4W 
PFA 3 3 15_H04 GRHL2 - - 3W 3W 
PFA 3 3 19_E01 ZIC3 - - 4W 4W 
         
PFB 1 2 10_E03 
MIXED 
(ERROR) - 2W 2S 2S 
PFB 1 2 19_E01 ZIC3 - 4W 4M 4S 
PFB 2 3 01_A02 ESRRB - - - 3VW 
PFB 2 3 03_F01 ZBTB7B - - - 4VW 
PFB 2 3 04_A01 SPIB - - - 3VW 
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PFB 2 3 05_A09 ESRRG - - 4VW 4VW 
PFB 2 3 05_C01 DMBX1 - - 2VW 3W 
PFB 2 3 05_F01 RXRG - 4VW 4W 4W 
PFB 2 3 06_A12 NKX2-2 - - - 4VW 
PFB 2 3 10_E03 MIXED(ERR0R) - 2W 2W 2M 
PFB 2 3 14_C12 ZBTB10 - - - 4VW 
PFB 2 3 14_F02 ZIC3 - 4VW - - 
PFB 2 3 15_D07 REL - 4VW - 4W 
PFB 2 3 19_E01 ZIC3 4W 4VS 4VS 4VS 
PFB 3 3 01_F05 LBX2 - - 4VW 4VW 
PFB 3 3 02_G12 MAX - - 2VW - 
PFB 3 3 04_A07 TEAD4 - - 4VW - 
PFB 3 3 05_A09 ESRRG - - 4VW - 
PFB 3 3 05_D03 DLX4 - - 3VW 4VW 
PFB 3 3 05_F01 RXRG - 4W 4W 4W 
PFB 3 3 05_F06 ZNF471 - 4W 4W 4M 
PFB 3 3 10_E03 MIXED(ERR0R) - 4W 2VS 2VS 
PFB 3 3 10_E08 NR1I2 - 4W 4S 4M 
PFB 3 3 11_G10 MAFG - - 4VW - 
PFB 3 3 13_D06 KLF3 - 4VW 4W 4W 
PFB 3 3 14_F02 ZIC3 - 4S 4VS 4VS 
PFB 3 3 15_D07 REL - 4S 4VS 4VS 
PFB 3 3 19_A04 ZNF710 - 4VW 4W 4VW 
PFB 3 3 19_B11 GCM1 - - 4M 4M 
PFB 3 3 19_E01 ZIC3 4W 4VS 4VS 4VS 
PFB 3 3 20_D02 
 
- - 4W 4VW 
         PFC 1 2 10_C06 SMAD4 4VW 4S 4M 4S 
PFC 1 2 10_C07 TEAD2 - - 4W 4W 
PFC 1 2 10_E03 
MIXED 
(ERROR) - 3VS 3VS 3VS 
PFC 1 2 11_C03 TEAD2 - - 4W 4W 
PFC 1 2 12_A11 EBF1 - 4VW - 4VW 
PFC 1 2 14_B09 GCM1 4VW 4W 4W 4M 
PFC 1 2 14_F02 ZIC3 - 4W 4M 4S 
PFC 1 2 15_F01 GRHL2 - - 2M 2S 
PFC 1 2 15_H04 GRHL2 - 4M 4M 4S 
PFC 1 2 19_A03 TFEB - - - 4W 
PFC 1 2 19_B10 ZIC1 - 3M 3M 3W 
PFC 1 2 19_B11 GCM1 - 4VW 4W 4W 
PFC 1 2 19_E01 ZIC3 4VW 4VS 4VS 4VS 
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PFC 2 2 1_A08 HES5 - 4W 4W 4W 
PFC 2 2 1_A09 LHX1 - 4W 4W 4W 
PFC 2 2 3_C10 ZDHHC7 - 4VW 4W 4W 
PFC 2 2 4_C09 TFAM - 4VW 4W 4W 
PFC 2 2 5_A07 SATB2 - 4W 4M 4M 
PFC 2 2 5_B12 ELK4 - 4VW 4M 3M 
PFC 2 2 5_E05 ZNF207 - - 4VW 4W 
PFC 2 2 5_H12 SNAI1 - 4VW 4M 4M 
PFC 2 2 6_C09 RFX4 - 4W 4S 4S 
PFC 2 2 7_H03 KLF17 - - 3W 3W 
PFC 2 2 9_H10 HEY2 - 4VW - 4W 
PFC 2 2 10_C06 SMAD4 4W 4S 4S 4S 
PFC 2 2 10_C07 TEAD2 - 4VW 4M 4M 
PFC 2 2 10_E08 NR1I2 
    PFC 2 2 11_C03 TEAD2 - - 4M 4W 
PFC 2 2 12_A11 EBF1 - 4VW 4W 4W 
PFC 2 2 13_D04 TEAD2 - - 4VW 4W 
PFC 2 2 14_B09 GCM1 4VW 4W 4M 4M 
PFC 2 2 14_F02 ZIC3 - 4S 4VS 4VS 
PFC 2 2 15_F01 GRHL2 - 2W 2VS 2S 
PFC 2 2 15_H04 GRHL2 - 3VW 3M 3M 
PFC 2 2 19_B10 ZIC1 - - 2W 2W 
PFC 2 2 19_B11 GCM1 - - - 4VW 
PFC 2 2 19_E01 ZIC3 4VW 4S 4VS 4S 
PFC 3 3 01_A04 DLX5 - - - 4VW 
PFC 3 3 01_A07 IRX5 - - 4W 4VW 
PFC 3 3 01_A08 HES5 - 4VW 4W 4W 
PFC 3 3 01_A09 LHX1 - 4VW 4W 4W 
PFC 3 3 01_C10 BHLHB2 - - - 4VW 
PFC 3 3 02_H07 GABPA - - - 4VW 
PFC 3 3 03_A02 ERF - - 4W - 
PFC 3 3 03_A11 ZNF18 - - 4VW - 
PFC 3 3 03_C10 ZDHHC7 - - 4VW 4VW 
PFC 3 3 03_F01 ZBTB7B - - 4VW 4VW 
PFC 3 3 04_A01 SPIB - - 4W 4W 
PFC 3 3 04_C09 TFAM - - - 4VW 
PFC 3 3 04_H04 PRRX1 - 3VW 4VW 4W 
PFC 3 3 05_A07 SATB2 - 4VW 4VS 4VS 
PFC 3 3 05_A09 ESRRG - - 4W 4VW 
PFC 3 3 05_B07 MXD1 - - 4VW 4VW 
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PFC 3 3 05_F02 USF2 - - 4VW 4VW 
PFC 3 3 05_G01 PAX5 - - 4W 4VW 
PFC 3 3 06_C09 RFX4 - 4W 4VS 4VS 
PFC 3 3 06_G01 ZNF221 - - - 4VW 
PFC 3 3 07_G01 ALX1 - - 4W - 
PFC 3 3 07_H03 KLF17 - - 4W 4W 
PFC 3 3 10_B10 WT1 - - 4W 4W 
PFC 3 3 10_C06 SMAD4 4VW 4M 4VS 4VS 
PFC 3 3 10_C07 TEAD2 - - 4W 4M 
PFC 3 3 10_E03 
MIXED 
(ERROR) 3VW 4S - - 
PFC 3 3 11_C03 TEAD2 - - 4W 4M 
PFC 3 3 14_B09 GCM1 4VW 4W 4M 4M 
PFC 3 3 14_C12 ZBTB10 - - - 4VW 
PFC 3 3 14_F02 ZIC3 2VW 4W 4VS 4VS 
PFC 3 3 15_F01 GRHL2 - 4VW 4VS 4VS 
PFC 3 3 15_H04 GRHL2 - 2W 3S 3VS 
PFC 3 3 17_D12 RUVBL1 - - - 4VW 
PFC 3 3 17_H10 TGIF1 - - - 4VW 
PFC 3 3 19_A03 TFEB - - 4W 4W 
PFC 3 3 19_B10 ZIC1 3VW 4W 4VS 3VS 
PFC 3 3 19_B11 GCM1 4VW 4W 4S 4S 
PFC 3 3 19_D11 TFAP4 - - - 4W 
PFC 3 3 19_E01 ZIC3 4M 4VS 4VS 4VS 
PFC 3 3 19_E05 ZNF3 - 3VS - - 
PFC 3 3 19_G02 NR1H4 - - - 4VW 
PFC 3 3 20_B06 
 
- - 4VW - 
PFC 3 3 20_B08 
 
- - 4W - 
         PFD 1 3 01_A04 DLX5 - 4VW - - 
PFD 1 3 01_A05 POU4F1 - 4VW - - 
PFD 1 3 01_A06 LHX5 - 4VW - - 
PFD 1 3 01_A07 IRX5 - 4VW - - 
PFD 1 3 01_B07 CDX2 - 4VW - - 
PFD 1 3 01_B12 HOXD9 - 4VW 4W - 
PFD 1 3 01_C06 SOX21 - 4M - 4M 
PFD 1 3 01_E03 NR2F2 - 4M 4S 4S 
PFD 1 3 01_F07 TGIF2LX - - - 4W 
PFD 1 3 02_C06 THAP10 - - 4M - 
PFD 1 3 02_D07 MYOG - 4W 4W 4W 
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PFD 1 3 02_D08 SPIC - 4W 4W 4W 
PFD 1 3 02_E08 NFIA - 4W 4M 4M 
PFD 1 3 02_G02 ZNF581 - 4W 4M 4M 
PFD 1 3 02_H03 ZNF670 - 4W 4M - 
PFD 1 3 02_H07 GABPA - - - 4W 
PFD 1 3 03_B02 MAZ - 4M 4S 4S 
PFD 1 3 03_A05 ZNF20 - 4VW - - 
PFD 1 3 03_A11 ZNF18 - 4VW - - 
PFD 1 3 03_C08 SOX6 - 4W 4VW 4VW 
PFD 1 3 03_F01 ZBTB7B - 4W - - 
PFD 1 3 04_A01 SPIB - 4VW - 4M 
PFD 1 3 04_F01 MEIS3 - - 4M - 
PFD 1 3 05_A07 SATB2 - 4S 4VS 4VS 
PFD 1 3 05_B04 POU4F3 - 2S 4W 4M 
PFD 1 3 05_C08 FOXA3 - 4W 4VW 4W 
PFD 1 3 05_C10 PLAGL1 - 4W - 4W 
PFD 1 3 05_D05 ZNF398 - - 4W 4W 
PFD 1 3 05_E04 CEBPB - 4W 4W 4W 
PFD 1 3 05_G01 PAX5 - 4M 4W - 
PFD 1 3 06_B06 HOXC8 - 4W 4VW - 
PFD 1 3 06_C09 RFX4 - - - 4W 
PFD 1 3 10_B08 KLF4 - 4M 4M 4M 
PFD 1 3 10_B10 WT1 - 4S 4S 4S 
PFD 1 3 10_D04 RFX2 - 4W 4M 4VW 
PFD 1 3 10_D09 PLAGL1 - 4M 4M 4M 
PFD 1 3 10_E03 MIXED - 4M 4M 4S 
PFD 1 3 10_G06 PURA - 4VW 4W 4W 
PFD 1 3 11_D04 MYCL1 - 4W - - 
PFD 1 3 12_D04 KLF4 - - 4M 4VW 
PFD 1 3 13_D06 KLF3 4W 4M 4S 4S 
PFD 1 3 14_C12 ZBTB10 4M 4VS 4VS 4VS 
PFD 1 3 14_E06 SP3 4W 4M 4S 4S 
PFD 1 3 14_H05 SP4 4W 4M 4M 4M 
PFD 1 3 15_A10 NFATC4 - - - 4W 
PFD 1 3 15_B11 DLX1 - 4W 4W 4M 
PFD 1 3 15_B12 SPI1 - 4W 4W 4VW 
PFD 1 3 15_D03 HP1BP3 - - 4M - 
PFD 1 3 15_F10 ZNF653 - - 4VW - 
PFD 1 3 16_B10 RBMS1 - 4W 4W 4M 
PFD 1 3 16_D03 DAZAP1 - 4M - 4S 
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PFD 1 3 16_E11 AKAP10 - - 4VW - 
PFD 1 3 16_E12 DDX43 4W - - - 
PFD 1 3 17_B10 PTPMT1 - 4W 4VW 4VW 
PFD 1 3 18_B02 RBMS2 - 4S 4S 4S 
PFD 1 3 18_D05 PDE6H - 4M 4W 4S 
PFD 1 3 19_B04 SIX3 - 4W 4W 4VW 
PFD 1 3 19_B07 HOXA6 - 4W 4VW - 
PFD 1 3 19_B08 POU1F1 - 4W 4VW - 
PFD 1 3 19_B09 ELF2 - - 4VW - 
PFD 1 3 19_B11 GCM1 - 4W 4VW 4VW 
PFD 1 3 19_E01 ZIC3 4S 4VS 4VS 4VS 
PFD 2 3 01_A04 DLX5 - 4W - - 
PFD 2 3 01_A05 POU4F1 - 4W - - 
PFD 2 3 01_A06 LHX5 - 4W - - 
PFD 2 3 01_A07 IRX5 - 4W - - 
PFD 2 3 01_B07 CDX2 - - 4W - 
PFD 2 3 01_B12 HOXD9 - 4M - - 
PFD 2 3 01_C04 FOXH1 - 4M 4M 4W 
PFD 2 3 01_C06 SOX21 - 4M 4M 4S 
PFD 2 3 01_E03 NR2F2 - 4M 4S 4S 
PFD 2 3 01_F07 TGIF2LX - - 4W - 
PFD 2 3 02_B10 ZNF174 - 4M - - 
PFD 2 3 02_C07 ZNF10 - - - 4W 
PFD 2 3 02_D07 MYOG - 4W 4W - 
PFD 2 3 02_D08 SPIC - 4M 4W - 
PFD 2 3 02_D09 ELF5 - - - 4S 
PFD 2 3 02_E08 NFIA - 4M 4S 4S 
PFD 2 3 02_G02 ZNF581 - - 4W - 
PFD 2 3 02_H03 ZNF670 - 4M 4W - 
PFD 2 3 02_H07 GABPA - - 4W - 
PFD 2 3 03_B02 MAZ 4W 4M 4S 4S 
PFD 2 3 03_B10 ZNF322A - 4M - - 
PFD 2 3 03_C08 SOX6 - - - 4W 
PFD 2 3 03_F01 ZBTB7B - 4M - - 
PFD 2 3 04_H04 PRRX1 3W 3M - - 
PFD 2 3 05_A07 SATB2 - 4W - 4S 
PFD 2 3 05_A09 ESRRG - 4W - - 
PFD 2 3 05_B04 POU4F3 - 4M - - 
PFD 2 3 05_C08 FOXA3 - - 4W 4W 
PFD 2 3 05_D03 DLX4 4VW 4M 4W 4S 
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PFD 2 3 05_D05 ZNF398 4VW 4M 4W 4S 
PFD 2 3 05_E04 CEBPB - - 4W 4W 
PFD 2 3 05_F07 ZNF16 - 4M - 4W 
PFD 2 3 05_G01 PAX5 - 4W - - 
PFD 2 3 07_F12 CAMTA2 - 4M - - 
PFD 2 3 08_E09 FOXD4L6 - - 4W - 
PFD 2 3 08_H03 ZBTB10 - 4W - - 
PFD 2 3 10_B08 KLF4 4VW 4M 4S 4M 
PFD 2 3 10_B10 WT1 4VW 4M 4S 4VS 
PFD 2 3 10_D04 RFX2 - 4M 4S 4M 
PFD 2 3 10_D09 PLAGL1 - 4M 4S 4S 
PFD 2 3 10_F02 KLF7 4VW 4M 4S 4M 
PFD 2 3 12_C01 WT1 4VW - 4S 4S 
PFD 2 3 12_D04 KLF4 - 4M 4S 4M 
PFD 2 3 12_E02 KLF12 - - 4S 4M 
PFD 2 3 12_E03 ZBTB25 - 4M - - 
PFD 2 3 13_D06 KLF3 4VW 4M 4M 4S 
PFD 2 3 13_G03 KLF4 - 4VW - - 
PFD 2 3 14_C12 ZBTB10 4VW 4S 4VS 4VS 
PFD 2 3 14_E06 SP3 4VW 4M 4M 4S 
PFD 2 3 14_H05 SP4 4VW 4M 4M 4S 
PFD 2 3 15_B12 SPI1 - 4VW - - 
PFD 2 3 16_B10 RBMS1 - 4M 4M 4W 
PFD 2 3 16_D03 DAZAP1 - 4W 4W 4W 
PFD 2 3 16_E12 DDX43 4VW - - - 
PFD 2 3 18_B02 RBMS2 - 4M 4M 4S 
PFD 2 3 18_B05 BAX - 4W - - 
PFD 2 3 19_B04 SIX6 - 4M 4VW 4M 
PFD 2 3 19_B07 HOXA6 - 4W 4VW 4W 
PFD 2 3 19_B08 POU1F1 - 4W 4VW 4W 
PFD 2 3 19_B09 ELF2 - 4W 4VW 4W 
PFD 2 3 19_B11 GCM1 4W - 4VW - 
PFD 2 3 19_D05 ZNF707 - - - 4W 
PFD 2 3 19_E01 ZIC3 4W 4VS 4VS 4VS 
PFD 2 3 19_G08 
 
4VW - - - 
PFD 2 3 19_H08 
 
- - 4VW 4W 
PFD 2 3 20_B01 
 
- 4M 4W - 
PFD 2 3 20_D03 
 
4VW - - - 
PFD 2 3 20_D06 
 
- - - 4W 
PFD 3 3 01_B07 CDX2 - 4VW - - 
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PFD 3 3 01_D05 ZNF498 - 4VW - - 
PFD 3 3 01_E03 NR2F2 - 4S 4VS 4S 
PFD 3 3 01_E09 STAT4 - 4W - - 
PFD 3 3 01_F07 TGIF2LX - 4M - 4W 
PFD 3 3 02_D07 MYOG - 4W - - 
PFD 3 3 02_D08 SPIC - 4W - - 
PFD 3 3 02_E08 NF1A - 4S 4S 4S 
PFD 3 3 02_G02 ZNF581 - 4W 4M - 
PFD 3 3 02_H07 GABPA - 4M 4M - 
PFD 3 3 03_B02 MAZ - 4S 4M 4S 
PFD 3 3 03_D06 NFKB1 - 4VW - - 
PFD 3 3 03_F01 ZBTB7B - 4W - - 
PFD 3 3 04_D05 HNF4A - 4VW - - 
PFD 3 3 04_H04 PRRX1 4VW - - - 
PFD 3 3 05_A07 SATB2 - 4VS 4VS 4VS 
PFD 3 3 05_A09 ESRRG - 4M 4S 4M 
PFD 3 3 05_B04 POU4F3 - 4W 4M 4M 
PFD 3 3 05_C08 FOXA3 - - 4W - 
PFD 3 3 05_D03 DLX4 - 4W 4W 4W 
PFD 3 3 05_D09 USF1 - - - 4M 
PFD 3 3 05_E04 CEBPB - 4W 4W 4W 
PFD 3 3 05_G01 PAX5 - 4M 4M 4M 
PFD 3 3 10_B08 KLF4 4VW 4M 4S 4M 
PFD 3 3 10_B10 WT1 4VW 4M 4S 4S 
PFD 3 3 10_C01 ZBTB1 4VW - - - 
PFD 3 3 10_D02 ZNF205 - - - 4W 
PFD 3 3 10_D04 RFX2 - 4W 4M - 
PFD 3 3 10_D09 PLAGL1 - 4M 4M 4M 
PFD 3 3 10_E03 MIXED - 4S 4S 4S 
PFD 3 3 10_F02 KLF7 4VW 4M - 4M 
PFD 3 3 12_C01 WT1 - 4S - 4S 
PFD 3 3 12_D04 KLF4 - 4W 4M 4W 
PFD 3 3 12_E02 KLF12 - - 4W - 
PFD 3 3 12_G01 HEY2 - - 4W - 
PFD 3 3 13_D06 KLF3 4VW 4S 4VS 4VS 
PFD 3 3 14_C12 ZBTB10 4VW 4M 4VS 4S 
PFD 3 3 14_E06 SP3 4VW 4S 4VS 4VS 
PFD 3 3 14_H05 SP4 4VW 4M 4M 4S 
PFD 3 3 16_D03 DAZAP1 - 4M 4M 4S 
PFD 3 3 16_E12 DDX43 4VW - - - 
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PFD 3 3 18_B02 RBMS2 - - 4S 4M 
PFD 3 3 18_B05 BAX - - - 4M 
PFD 3 3 18_D05 PDE6H - - 4M - 
PFD 3 3 19_A03 TFEB - 4W 4W - 
PFD 3 3 19_B04 SIX6 - 4W 4M 4W 
PFD 3 3 19_B07 HOXA6 - 4W 4M 4W 
PFD 3 3 19_B08 POU1F1 - 4W 4M 4W 
PFD 3 3 19_B09 ELF2 - 4W 4M 4W 
PFD 3 3 19_D05 ZNF707 - 4W - - 
PFD 3 3 19_E01 ZIC3 4M 4VS 4VS 4VS 
PFD 3 3 19_F01 IKZF3 - 4VW 4W 4W 
PFD 3 3 19_H08 
 
- 4W 4W 4W 
PFD 3 3 20_B01 
 
- - 4S 4M 
PFD 3 3 20_D06 
 
- 4M 4M - 
         PFE 1 3 - 
     PFE 2 3 - 
     PFE 3 3 - 
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Table A.5: Name, Location and Sequence of all 5C Probes. Probe names are 
listed on the left with their chromosomal positon (hg18). The sequence of each 
probe is given on the right. 
5C Primer List 
PRIMER_NAME, LOCATION (hg18) 
 
SEQUENCE 
FOR_1 chr7:115597757-115598282 GTCTGGATAAGGAGAAAGTTAATTTACATACAGCACAAAG 
FOR_2 chr7:115598283-115604576 ATGTTTGCCTTTATCAGTGACGGATATCAACATCATGAAG 
FOR_5 chr7:115608801-115614962 GGGCAAATGATAGGCTAACCTGTAAACTTAAAAGGAGAAG 
FOR_7 chr7:115623541-115625042 ACTCAAAGTGCCTTGCGATACTATTTGAAAGTTTATCAAG 
FOR_8 chr7:115625043-115633971 AACTGGCACCAGCTTCAGCTAATTGAATCAGAAGTTTAAG 
FOR_11 chr7:115644335-115646444 ATTATTTTATCAAGGAAACACCTCCTATAGAATAAAGAAG 
FOR_12 chr7:115646445-115648831 GATCAGTAGAATGTGGTAGAAGTGGTGTGTGAATCCTAAG 
FOR_15 chr7:115660029-115660112 TTTGAAAATTGGTAATATGGACATGGCAAAGATGATAAAG 
FOR_19 chr7:115681634-115684212 ATGTGTCATAGGTAAGACAGGTAAAATTACCACTTCAAAG 
FOR_20 chr7:115684213-115685035 TCTTTCCATAGCTTTTCAAATGTGAAATCATTTTTGGAAG 
FOR_21 chr7:115685036-115687308 TGATTCATTCTCAAGGAATTTCCAACACATAGCGTTTAAG 
FOR_22 chr7:115687309-115691270 TCTGGTAATGAGATCCATGACCCTTCCACACCCCCTCAAG 
FOR_24chr7:115692343-115693067 TGGGGATAGCATGGCAGACACTGGCTAGATGATCTCTAAG 
FOR_25 chr7:115693068-115699683 AATAGGGAAAAAATCACCATGTCTCTCCTGCTACGGAAAG 
FOR_27 chr7:115711032-115711862 GAAATTGTGGTATGTCCTTGATCCTGGAGCATTCAGGAAG 
FOR_32 chr7:115725060-115730982 GAGCAAGCAAATGAAGCTGAATTCAATATGGATTATAAAG 
FOR_33 chr7:115730983-115733617 TCACGCAATCAGGGCAGGCAGTGAAAGAGAATTTCAGAAG 
FOR_35 chr7:115734616-115736008 AAATTTTTGAGCAGTTATGTGATATAGTGAATACATTAAG 
FOR_36 chr7:115736009-115736220 TCAATAAATCTTGTAGTTTTCTTGGACCAGAGGAAATAAG 
FOR_37 chr7:115736221-115739597 TTTTCGTTATTTCACAATCTTTATCTTGATCATCAGGAAG 
FOR_38 chr7:115739598-115745973 CAGGAGGAAACCTTGAAAAAGGGGTACATGTTAGGGAAAG 
FOR_39 chr7:115745974-115750038 ACATCATAAGGAATGTGGCTTTTCAGGGTGAGATAAGAAG 
FOR_41 chr7:115750990-115751652 TGACTATTGTAGCTAGAGAGGAGAAGCCAATGCCTGTAAG 
FOR_42 chr7:115751653-115754768 TTGCTTATCTCAGTAAATTGTTAACATGTAGAAATGAAAG 
FOR_43 chr7:115754769-115756853 GTAGAAAAGATATTAGTGAAGATAGACTAGCCTTGAGAAG 
FOR_45 chr7:115758299-115759208 TAGAAAGATAGTTGCGCTGATACAAAGAAAATACAAGAAG 
FOR_47 chr7:115760111-115764976 CTAATTAAATTGTTTGAGATAGATCTGAAGACAGCAGAAG 
FOR_48 chr7:115764977-115766732 CAGTGCTTTATGTTATTGGGATTAAAAGAATTAGTTAAAG 
FOR_49 chr7:115766733-115766920 TTAAATACTAACACTCAAACCTGAAAGTTGTCTTTAAAAG 
FOR_50 chr7:115766921-115767784 AGCACAGCAATTAAATGGAATTCCACATTTTTAAGGAAAG 
FOR_51 chr7:115767785-115770527 TCAAGTCCAAGAAGTCATTGCCAAGTCCAATGTCATAAAG 
FOR_52 chr7:115770528-115771572 GGTGAAAGGACATGCTTGTGTTTTGATCTCAGAGCAAAAG 
FOR_54 chr7:115775576-115782157 GCTAATGTGAGGGAGCAAGACTTGTCAGGTTCTGACTAAG 
FOR_55 chr7:115782158-115787377 ACTTATATGATTTATGAGTTTTGCGTATTGCTTAGGAAAG 
FOR_56 chr7:115787378-115792901 AGCTGCAAAATCAGGGAAACCATTAGTAACAACGTGAAAG 
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FOR_57 chr7:115792902-115797499 GTCTCTCTGGCTGTTAGGATCAGTTATGCTGGGGTTGAAG 
FOR_60 chr7:115802318-115805492 GCATAATATCAGATTTAGGTAGAGATTAAGGAGATAAAAG 
FOR_61 chr7:115805493-115806404 TTTTCTCATGAGTGTCTAGAAACCAGTCATGTGATTAAAG 
FOR_62 chr7:115806405-115807508 GGGACTCTGAGTAATCTAAAATAAGAGCTGGCAACAGAAG 
FOR_63 chr7:115807509-115807867 AGCTAATGGCACATTTGTACTTTTCCATTTTTATGTCAAG 
FOR_65 chr7:115808565-115809866 TTTTAAACTAGAAGAAACTAAGATAATGCAAATTAACAAG 
FOR_66 chr7:115809867-115810396 TCCTCAATGCTATGTAGCAGTGTCTAGCACATAGGAAAAG 
FOR_67 chr7:115810397-115811132 AGGTGACTTCAGTCATGTCTTTTAATCAGGAAAACAAAAG 
FOR_68 chr7:115811133-115812539 GATCCTTTAAAAATTCTTCACAAGAGGAGTCAAAGGAAAG 
FOR_69 chr7:115812540-115813432 TTACAGTTGTTCATTCTCCAGCATCTTGATCTTGACAAAG 
FOR_70 chr7:115813433-115819798 CAGATGACAAGTGGAAGGATTGACTTTGAATGGGAAGAAG 
FOR_71 chr7:115819799-115835164 GTATGAACACTTAAAGTTTTTGAAATTGCCTTCCAGAAAG 
FOR_73 chr7:115835642-115836064 AACTCCCTAGATTTGCAAAATGCTTATACCCCAGAGGAAG 
FOR_74 chr7:115836065-115836107 TTCCTGGAGATGTGATAATTTCTTTTTTAGGATAATAAAG 
FOR_75 chr7:115836108-115836457 GCCTTCTACTACCACCCGAATACCGCACTTTTCCGACAAG 
FOR_78 chr7:115839804-115843700 TAGATCATACTAAGCAGTACTGTTCAGAATATTAACAAAG 
FOR_79 chr7:115843701-115851768 TTTTTCTATTATCCGCATCTCTAAGATGGGGAAATTAAAG 
FOR_81 chr7:115858762-115865543 AGACAGGAGGAGATATTTGTAGGCACTCCTTTGAAACAAG 
FOR_83 chr7:115866339-115870647 AGTAAAACAATGCCTTTTCCAAGTTTTAGTATTTGGAAAG 
FOR_86 chr7:115875358-115877543 GGTCTGGAGTGGAAGAATGGACTGTGTTTTTCGTAAAAAG 
FOR_87 chr7:115877544-115878831 ATTCGTGGCCAGCACAGCTCCCATAGACATGGCACACAAG 
FOR_88 chr7:115878832-115881206 TTATTTTAAGCTGCAATAAGCCTACTCTTCCCACCAGAAG 
FOR_89 chr7:115881207-115893184 AGCCAAAGATGTGTCAGTTGAGTTATTCATTTATAGTAAG 
FOR_90 chr7:115893185-115899194 AAGCATTGTGTGCATCTATCCTGTTTGGGGTCCATTTAAG 
FOR_91 chr7:115899195-115905376 AAAATTTATAACAATATATTTCCTCTTAAATGTGAGTAAG 
FOR_92 chr7:115905377-115905816 AATAGTTCCCTTAAACTTTTCAAGACTTTCCTTCACCAAG 
FOR_93 chr7:115905817-115908286 TTGCTAGTTTTTAAATTGTGTTCCCAGTCCTTTTCTCAAG 
FOR_96 chr7:115912494-115917040 AAAAAGAAGATTTTCTTTAAGTTTATGTAGTTAGACTAAG 
FOR_97 chr7:115917041-115918624 TGAGATGTCAAAGTTGTCAGCATGATATATCAATTTGAAG 
FOR_98 chr7:115918625-115922291 ACTTATGCCAGAAACAGCAGGTCCTTCCAAATTTCTCAAG 
FOR_100 chr7:115929440-115929873 GTGGACAGACCTTACAGAATTGCAAACCCATTTGGGCAAG 
FOR_101 chr7:115929874-115931946 AGCAGCCTACTCCCTTATGCCCACCCAGGTAATAATAAAG 
FOR_102 chr7:115931947-115932837 TTTTGCGCCAGCATCTACTTTAGGCAAGGACCTCAGGAAG 
FOR_105 chr7:115937791-115944343 CCACTTGACCATAATTTTTCTGAAAATTGCTAAGCTCAAG 
FOR_106 chr7:115944344-115945834 TACCAACTGTTTAATGGAAATTTTAATATACTGTATAAAG 
FOR_107 chr7:115945835-115946603 AAAAAATTGCACTTTCAACATAGGATTTGCTACTCAAAAG 
FOR_108 chr7:115946604-115948246 ATTTAAAATACTCAAAGTGGAAAAGCCCAATCCACAGAAG 
FOR_109 chr7:115948247-115950557 AGGAAGGAAGACCCTAATTATTTGTTTACTCATAAATAAG 
FOR_113 chr7:115957048-115959437 TTAAGGCAAGGTGCACCAAGTACCCTTGAATTATGAAAAG 
FOR_114 chr7:115959438-115962331 AGTGCCCTTCAGGCTACTTGGGCTTAAAGCCAACTGCAAG 
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FOR_117 chr7:115970061-115980026 ATGCCATATGCCTCTGTCTCTTTTCATAAGGAAGACAAAG 
FOR_118 chr7:115980027-115983146 CTAATTACTGCTGTGTAAATGGAGGTAGAAAGAAACTAAG 
FOR_119 chr7:115983147-115987971 ACACTGAGTCGTACAGAAAGCTGCCTGGTATATCCAAAAG 
FOR_120 chr7:115987972-115988758 CCAATGTTTTATATGTCATCTAATTTGAGCCCCCAGCAAG 
FOR_121 chr7:115988759-115991418 ACTCGTTTCTGAGCCCTAAGCCTTTCTCCTCTTCATGAAG 
FOR_122 chr7:115991419-115997316 ATCATTTTTAATTGTTCAATCATCCACATAGCTACCCAAG 
FOR_123 chr7:115997317-116000429 CCAGAACAGTTTCTTTAGATCTTCTTATTTCTCTTTCAAG 
FOR_124 chr7:116000430-116004316 GTTCTGACATGGCACCAAGAGGAGAACCATCCAGACAAAG 
FOR_125 chr7:116004317-116009839 CACATGTGGGAGACACAGGAGATGTTTCTCAAGGGAAAAG 
FOR_126 chr7:116009840-116014022 AGTCCCTAGCAGTCGCCATTCTAATTTCTGTTTCTATAAG 
FOR_127 chr7:116014023-116014342 GAATCTGATGGTTCTACAAGGGAGAGTTCTCCTACACAAG 
FOR_128 chr7:116014343-116018855 CTGTTTCATTTTCTGGTTTATTGGGTGAACATATTCCAAG 
FOR_129 chr7:116018856-116019939 ATGAACGTTCCTGGAGCTAAGGGCAGAGTGAAGAGGGAAG 
FOR_130 chr7:116019940-116021980 GTTAGAAGCATATATTCAGGATTTCCAGCTTCAATGGAAG 
FOR_131 chr7:116021981-116028864 TCATGTTAATTCTTGCATGATTTATGTGTTATGATTAAAG 
FOR_132 chr7:116028865-116030916 CCGTTTGGAGGCCTTACAGAAGTCATCTCACCTCTCTAAG 
FOR_133 chr7:116030917-116033015 TTTTAAATTTTCTATGAGGAATCTGCATCTTTTGAAAAAG 
FOR_134 chr7:116033016-116046180 TCCCCTCTGAGCTATTTTCTCAGCTACTCTCCAATTAAAG 
FOR_135 chr7:116046181-116047724 TTATAAATATTTCTCCTCTGCCAGCCAGCCCAAAGTGAAG 
FOR_136 chr7:116047725-116052329 GGCATCACAGTAGCCTGCAGTTTGCTTACTACTCTCCAAG 
FOR_137 chr7:116052330-116055533 AAAGCAGTGGGCATATGGGAGGAATTATTAAGGTAATAAG 
FOR_138 chr7:116055534-116058179 ATCATTCAGGGTCCATTTTCCATGCATTGCTTATGCAAAG 
FOR_139 chr7:116058180-116058542 CGTACTCTCCCTTTTCCACCAGTCATTTCAGAGTCTCAAG 
FOR_140 chr7:116058543-116058738 CCTTTCATTTTGTAAAAGAAGAAACCGGGGCCCAGAGAAG 
FOR_141 chr7:116058739-116060423 TGCACATACACAACAAATAACTATACATAAGCGGTGCAAG 
FOR_142 chr7:116060424-116062230 ATATTTTTGAACATTGCAACCCATTTCCTAATTCAGGAAG 
FOR_144 chr7:116062714-116066773 ATATTTGTTAAACTTCCCTATTCGAGATTTTGTTATTAAG 
FOR_147 chr7:116071401-116071748 GAGTTTTCATTTCACTTACTATATGTGCTTTATAACTAAG 
FOR_148 chr7:116071749-116079800 GTTAGGGTATAAGTGGAACCCTCTAGGTCTGGTATGAAAG 
FOR_149 chr7:116079801-116084239 TTAACTCATGTAACATCTTTCAGCAGAAAATCTCAAGAAG 
FOR_150 chr7:116084240-116084622 AATTGGAAAGATTTTCATCAGATAGACTTTTAACACCAAG 
FOR_153 chr7:116087402-116089954 CTGCTCTGAGACACCCCAGGGAGAGGACCAGTGGTGGAAG 
FOR_154 chr7:116089955-116091794 GATTCAAGCTGTGTCCCAGCAGTCTCTGCCTTCTATCAAG 
FOR_155 chr7:116091795-116092881 CAGCGTACCACAACAGATGGACCAGACACTTCAGGGAAAG 
FOR_158 chr7:116108496-116108907 AAATACGAATTTAGACAGTGATATAAAGATTCAAGGAAAG 
FOR_159 chr7:116108908-116116288 AACATTAATTATAACACATGCAAATCATTCCTGTACAAAG 
FOR_160 chr7:116116289-116116599 AATGCTATGCAGTTTTGCAATACATATATACCACAGAAAG 
FOR_161 chr7:116116600-116126267 AGTTTTTGTTTTCCTTCTATGTAAAAGTCCAGTTGGGAAG 
FOR_162 chr7:116126268-116127854 GTGACATTTCAGATTATATTAAAGTTATTTCCCATATAAG 
FOR_163 chr7:116127855-116134507 AGAAAAATGTCTAGCAATTGCATGCTAATTTAGACCAAAG 
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FOR_164 chr7:116134508-116135577 AGGCTGTCCTGAGGAGGTGAAAGCTAACCTTTATATAAAG 
FOR_165 chr7:116135578-116135668 ACTAAATATATAAACTAATAGTCATTACTTATTTCACAAG 
FOR_166 chr7:116135669-116138207 AGTAAATATTAATTATTTGTGTGATCTTTAGATATGAAAG 
FOR_167 chr7:116138208-116138430 TTGGCATGGCTTCATTTTACCTTTCTTGCTATTAGCAAAG 
FOR_168 chr7:116138431-116138839 TTCAAAATAAAGCCTGGTTTCATTCATAGTAAATATGAAG 
FOR_169 chr7:116138840-116140816 GGAGGAAAGGCACCAAGTACGTGCTTGGTACAGAGAGAAG 
FOR_173 chr7:116151992-116154098 CCTGAGACTTTTCCTGCAGGCCTTTGGGAAGCAACTGAAG 
FOR_174 chr7:116154099-116155205 GTCATATTTGCACAATGCTTTACATCTGAGATACTGAAAG 
FOR_175 chr7:116155206-116157096 AAACTCTTTTAACTTCCCCAATTTCTGGAAAAACAAAAAG 
FOR_176 chr7:116157097-116159349 TCTGTTAAATGTGTGGTCTCTTTTTATTAAGTTCTTGAAG 
FOR_177 chr7:116159350-116160026 TCAGACAATAACCTCTAGTAAACCAACTGAGAATGATAAG 
FOR_178 chr7:116160027-116160694 ATCGTCCATTACCTCACCAATCCAGTTTTGTATGAATAAG 
FOR_179 chr7:116160695-116162927 CGTTTTTGTGAACATCTGGCAGAGACACAGCTGAAGGAAG 
FOR_180 chr7:116162928-116164732 GGGATGGTATGGAGTGGCTCTTGGGAGCTCAGAGTTGAAG 
FOR_181 chr7:116164733-116165014 TGTTATGAAAGTACAAACATTTGGTGCTTTTCAGACAAAG 
FOR_182 chr7:116165015-116165638 AAAATTGGGTAACCAAAATCTGGAGAATTTGTAATAGAAG 
FOR_186 chr7:116176540-116180390 GTGTAATGGATTTTTATGGGTAAAATGGCTATCATAAAAG 
FOR_187 chr7:116180391-116180693 CATTTCCTTTCTCAATTGTCACAAAGCTGCTGAGAAGAAG 
FOR_188 chr7:116180694-116183535 GTGCTAGTTCTACTGTATTCTACATGTACCCTTCTACAAG 
FOR_190 chr7:116185922-116186482 TGTGTAATTCGGTGAATAAAATACAAATGCATTTCTTAAG 
FOR_191 chr7:116186483-116187729 GTCACATTAAAGTGGTAGTTTTAGTTTAGACCTTAGAAAG 
FOR_192 chr7:116187730-116191665 CATCTGCTTCTTTAATTAGTTTTAGAAAGGGAGAAATAAG 
FOR_193 chr7:116191666-116201664 CATCACTGCACAGTGGAGAATTTACCACTAATGTGAAAAG 
FOR_194 chr7:116201665-116201971 TGATAAAGAGAGAAATGTCTAAGGAAATGAGGGTAAAAAG 
FOR_196 chr7:116203379-116205630 TAACCAGCTCTACTACAAACTTTATATGGGACTTAATAAG 
FOR_197 chr7:116205631-116206264 ATTTCATTCGAAATGAGACTCATGTAAGTTGACTGCCAAG 
FOR_198 chr7:116206265-116212750 AGGTGTATTCGGGCAGGAGCAGGACCAAGGTGGTGACAAG 
FOR_199 chr7:116212751-116215727 TGAAATTTTGGATGTTTAGGGCAAGTGTTGGGATTCTAAG 
FOR_201 chr7:116217701-116220386 GCCTCCATATTGTGAATCAGCTTCTCCTTTCTGTTCTAAG 
FOR_202 chr7:116220387-116221965 TTGCCGAGCTGTCTGGTGTGGATTTTCCTTCTGCTCCAAG 
FOR_204 chr7:116241645-116247085 TTTCTATCCCCCTTCACCAGTCTTCCTTCTTTCTGCTAAG 
FOR_208 chr7:116259833-116263562 CAATGACTTAACTGCCTGCCAGAGATAGGAGAGCATCAAG 
FOR_209 chr7:116263563-116268283 GGTTCTCAAATCTAGTTATACTTTAGGATCACCTGAGAAG 
FOR_211 chr7:116276679-116279948 TTATTTTACAAAGCACCTTTCATGCATTATTTCATGGAAG 
FOR_213 chr7:116284006-116284370 AAATAAAAGTGTCGTTTAATCAATATGCATTCCAACAAAG 
FOR_214 chr7:116284371-116284829 AGAATTTTAAAGGATAGGTAGCAAACAACATTCCAGAAAG 
FOR_215 chr7:116284830-116288190 GCAGCTTTGATTACATGTTTAATCTCTCATAAACTTCAAG 
FOR_217 chr7:116290572-116291465 GAGTGCACAAACATATTTAAAATTGAGGCGTGCTAAAAAG 
FOR_218 chr7:116291466-116291670 TAGAAGATGCCTTATTATCTGGCACTCTCAGGGCACTAAG 
FOR_220 chr7:116292370-116293242 TTAGGTTCTAAATTTTTGTCTTGATGATTTTAGAATAAAG 
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FOR_221 chr7:116293243-116298412 TGGTTAAAGCGAGATGGGATAAGCCCTTTAGGACAAAAAG 
FOR_223 chr7:116299307-116300309 CGGTCTGGAATAGAGGGTGGGAATCTGTATTTTTTCCAAG 
FOR_224 chr7:116300310-116301217 ACACAGTCAAGGATTGCAAGGCAGAAAGATACATGTGAAG 
FOR_225 chr7:116301218-116304290 CTTCCCCTGGACCTCCGCAAGGGCTGGCCGGGACCCAAAG 
FOR_227 chr7:116320019-116322321 TTTATGAGTAAATGACCACTTGCTCCTAAATATTTTAAAG 
FOR_228 chr7:116322322-116322448 GGAAACATACAGCGTTTTTGAACAATACTTTCAAAGTAAG 
FOR_229 chr7:116322449-116323266 TTACCTATCATTGAGGCCATCCAAAACTACGTAACAAAAG 
FOR_230 chr7:116323267-116325245 CTTCTTTAGAAGTACTTCTGTGTTCTCCTTTCTCAAAAAG 
FOR_231 chr7:116325246-116326755 GAACATAAGAGAAAGTTCTTAGTGGCTAATCATGTCAAAG 
FOR_232 chr7:116326756-116326857 TAGGCTAGAAGGTGACTTGTAACTGAAGGGAAATTTTAAG 
FOR_233 chr7:116326858-116327883 CAATTTAAAATGATGGTAAAAGTTACAGATTAGGAATAAG 
FOR_237 chr7:116334861-116338483 TTACAGCAGTTTTAAAATGGTGCCCCTTGTAGGACCAAAG 
FOR_240 chr7:116344062-116344149 TTGCCTTTGAGTGTCATGTTGATGCTCAAAATGTTTCAAG 
FOR_241 chr7:116344150-116345302 TAAAATCACTGTAATTAATTAGTTTGATTAGAGCACAAAG 
FOR_242 chr7:116345303-116346713 TTTGATGATGGTGAACTAAATACTAGATCTAATTGACAAG 
FOR_243 chr7:116346714-116350123 AGACATATCCAAATTTGACATTCTGAGTATTATGCAAAAG 
FOR_244 chr7:116350124-116353124 AGAAAAAGATAGATATCATTTTATGAGACTTATTTATAAG 
FOR_245 chr7:116353125-116355838 GACGTGCAATCTCATCTGAGGCTTGGATTCCTCTTCCAAG 
FOR_246 chr7:116355839-116361566 TCAGTTCTCATGGTCACAAAATGGCGGTGATAGCTCCAAG 
FOR_248 chr7:116361593-116367841 CAAAATGTATGTTAATCAACTGTGTATGTTATTGGCAAAG 
FOR_249 chr7:116367842-116372955 CTAGGAGTAAATGCTCTGTGTCAATAGAAACAAATTTAAG 
FOR_250 chr7:116372956-116374893 TATACATGCAGAATTATATCTTAGAGAACTTCTCCCCAAG 
FOR_252 chr7:116386571-116391563 GACAGGTAATAGTAGAATGCTTACAGTTCTCTTTGTTAAG 
FOR_255 chr7:116396053-116396912 CTTCAGTTCGCTTTGCACAGGCTGCACTTAAGGAATGAAG 
FOR_257 chr7:116397833-116406683 TACAGCAGTCTTCTTGTCTTATGCTGTATCTTTCAATAAG 
FOR_258 chr7:116406684-116412712 CACATAATTTCCTCTTGATTTTTCAATATGAACAGAAAAG 
FOR_259 chr7:116412713-116418208 AACATTCATACAGAAAAGAGCAGATATTCTAAGTTTAAAG 
FOR_265 chr7:116427183-116427933 CTTCTGTAGTCTATCAAAGTAATTGCATTATTAGGAGAAG 
FOR_266 chr7:116427934-116428247 TCTCTGAAAAACCCAGACATCTGGTAGACATTCTCTGAAG 
FOR_267 chr7:116428248-116433502 TTGAAAGAACAGTGTCCATATCTTATTGGAAATAGTAAAG 
FOR_271 chr7:116434982-116436704 TAAAAACCACACAGGAAGGTCTGTGGTTTGCCTAAAGAAG 
FOR_272 chr7:116436705-116438260 AGGCATATGTCTCAGCCCCTGAGCTGTCCTCTATGAAAAG 
FOR_273 chr7:116438261-116438320 CCTCTCAATCAAGTCCTGGAAGAATGGTCTCCTTCAGAAG 
FOR_275 chr7:116444568-116447115 GATTGAGTGTACAATCCTTGATCTGTCAATCTACCATAAG 
FOR_277 chr7:116449020-116451967 ATGTGGAGGGGGAAAATAAATCACCAGAGAACCAACAAAG 
FOR_278 chr7:116451968-116453989 GTACCGTGTACTACCAGGGTTTAACCATCTACCATCTAAG 
FOR_280 chr7:116462009-116463443 TTTAATAAATCTCCCGAATTGTTTGGTACTGTTTGGCAAG 
FOR_281 chr7:116463444-116464263 ATTCCGCTTACAGAATTCAGCAGGTGTGCTTCCTAATAAG 
FOR_282 chr7:116464264-116464575 TTTTATGTTATGCCCTTAATGCACAGCCCTACCACAAAAG 
FOR_283 chr7:116464576-116467915 TGCTTCATAGTAATTCTTTAGGGGATGGTCATGGGTAAAG 
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FOR_284 chr7:116467916-116470897 GAGTTTCCTATATTGTTTAATTGCCTTTAACCAATGGAAG 
FOR_285 chr7:116470898-116479290 GTTTTTATTCCCATTCTCTTGCTTCTTACCAAAATAAAAG 
FOR_286 chr7:116479291-116480731 CGAACAGGAGGACGGGGATCTTTGCCCTCCTCCTTTGAAG 
FOR_289 chr7:116485626-116489121 ATATTGGTTGTCACTTGGAAAATTAATATGTAGGATGAAG 
FOR_290 chr7:116489122-116490630 AAGCCCAGGACAAAGATTAAATGTTTTCACAATGATAAAG 
FOR_291 chr7:116490631-116492029 CGTCTGTACATTGCCTGGTCTGGGCTTCTTTAAGGAAAAG 
FOR_292 chr7:116492030-116496463 ATATATTTTGTATTTGAAAATCTGCTGGTAATTTCAAAAG 
FOR_293 chr7:116496464-116505959 ATAGATGCTTTGCATCAGGGTCATTTCTACTATTATAAAG 
FOR_294 chr7:116505960-116511717 CGCAACTGGAAATACCTGTGAACACATGCTTGGGTACAAG 
FOR_298 chr7:116528256-116528326 AGAGCATAAATGGACCTAGAATAATGGTGGATTTCAGAAG 
FOR_299 chr7:116528327-116532214 CTACAGAGTGATTACCCAATATCTCAGTGGGGTTAAGAAG 
FOR_302 chr7:116535371-116541890 GTCTACTTTAATTCTTAAGAAGCACTTAGCCAGTTTCAAG 
FOR_303 chr7:116541891-116541946 TTTCCCATGGGTTTAATGGTGTTGGTGTGGAATTACTAAG 
FOR_304 chr7:116541947-116542198 ATTTTTGTTCCCTGCAGGTAAATATGAGACAAGTTTGAAG 
FOR_306 chr7:116552834-116554112 TAAACATTATTCTTTAGGTTCTTTGTCTCTCACAAAGAAG 
FOR_307 chr7:116554113-116555471 TTATTTTGTGCTAGATACAGATCTTGCAATATTCATGAAG 
FOR_309 chr7:116557409-116558709 CAGGTAAATTTGGGATATAAGTACACATGTTAAGCAAAAG 
FOR_312 chr7:116566112-116567132 AAAAGGAGATTTCTGCCGAGATATGAACTTGCTCTCAAAG 
FOR_314 chr7:116569718-116575669 TATTTAACTGGTTTATTGTTGTCTAAATTTTATAATCAAG 
FOR_315 chr7:116575670-116576527 CGGCTTTCTGGGACCTCCCACTGAGCCATTTAAATACAAG 
FOR_316 chr7:116576528-116577105 CTTGGCTAAATGTTAACATTTAAAACCAAGCACCAAAAAG 
FOR_317 chr7:116577106-116577644 GTTGTCCACTCTTTTCATGCAGTTACCCATATTCCATAAG 
FOR_318 chr7:116577645-116578660 AATCTGGACTCACACTGGATTTCTTTTTGAGTGTGCCAAG 
FOR_319 chr7:116578661-116581134 GGTAAGATGTCTACTGGAGTAGTAGAACTCTTGCAATAAG 
FOR_320 chr7:116581135-116582676 GTGTAAGGCATTTAGATTTCATTGTAAGTACAATGGGAAG 
FOR_321 chr7:116582677-116583219 GTTACTCATTCCCACCTCAGAAACTTTACACTGCTGGAAG 
FOR_322 chr7:116583220-116585607 CACTGAAAACATTTTTGTTGGGCTGTGCATAAATGCAAAG 
FOR_324 chr7:116585641-116586244 ATGATACAGGCCAAATTCTATAAACTTTAATTAGCCCAAG 
FOR_325 chr7:116586245-116586892 TGATAGAAAACAGGCCTTTATCATATGCTTTCATTCAAAG 
FOR_326 chr7:116586893-116595480 ATTGGTGATTTGTTTTTGGACACAGTATACTCTGTCCAAG 
FOR_327 chr7:116595481-116595603 ATGCGGTCTCACTGAGTTTTAGTAAGACTCAGTTTTTAAG 
FOR_328 chr7:116595604-116597168 GCACTGTGTGGCTGTTTTTCACTTTCACCCCATCTTTAAG 
FOR_329 chr7:116597169-116599916 CTAAAATCTTACTCATGGTTCAGCTAAACAGTGGTCCAAG 
FOR_331 chr7:116602593-116607025 TCGGCTAATTGGGGGTAGGGGGACTGGATTAAAATCCAAG 
FOR_332 chr7:116607026-116607805 AATAATACCATGGATTTAATTCTTACCGAAAAGGAAGAAG 
FOR_334 chr7:116614251-116616617 CTTATGTGTTCCTACTTTCTTTTTCTCCAACAGATATAAG 
FOR_335 chr7:116616618-116621728 GGATGGCCCTTCACCACCCCCATTAAGAGTCATTAGGAAG 
FOR_336 chr7:116621729-116626310 AATGTTTCCAGATTCTATTAAGTTTTCGCTCTTTCCAAAG 
FOR_337 chr7:116626311-116628522 ATATAAGTTTCTTTGAATTGAGTCATATTTTGTTCCAAAG 
FOR_339 chr7:116630906-116635745 GCGGAACACTTCCCTACTCTTCCTGCTTTGAGGCCAGAAG 
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FOR_340 chr7:116635746-116635878 AGTGGGGCATGCACACCAACCGTGCCAATGGGAGAGGAAG 
FOR_341 chr7:116635879-116637096 GTCCTGCTTTTTTATTTCAGTACCTACTAGAAATGAAAAG 
FOR_343 chr7:116652179-116652539 GAGGACAGGACTCAACTCGCCTCATTTCATGTTTTCAAAG 
FOR_344 chr7:116652540-116653236 AGGACTAACTCTTCCTAGAATGTTTAGTTACAAAGATAAG 
FOR_345 chr7:116653237-116654311 TCGGAAAAGGGAGCATTTATGGACATCAACCAGGATGAAG 
FOR_346 chr7:116654312-116658005 CTGAACCAAAGTGATCATTTGTCCTCACCACCTTTAAAAG 
FOR_349 chr7:116662874-116666084 CGAAATTTCGTGAGGCGCCCCCACCTCCGACAGCCACAAG 
FOR_350 chr7:116666085-116670645 TACATCAGTTTTCTGCCACAGGAGAGAAAACTGAACTAAG 
FOR_353 chr7:116678790-116681537 TAGTGAATAGGATATGTATTCCTATAAAATTCTAGTAAAG 
FOR_354 chr7:116681538-116702196 TGTCATGGCCTGGAAAAAGCCACTGCCCTTGATCACCAAG 
FOR_355 chr7:116702197-116707011 AACGTTTGAGTTCCTAGAGACTCTGTATCCTTATAAGAAG 
FOR_357 chr7:116707989-116711010 GAGAGAGAGGAGCAGACAAAGCTATGACCATTGACAAAAG 
FOR_358 chr7:116711011-116712084 TAAGCATTTTGCCTGCATTGTCTAATTTAATTCTCATAAG 
FOR_359 chr7:116712085-116715789 AAAGATATTTACCAGTACAAAATAGGTGTCATGGGGAAAG 
FOR_360 chr7:116715790-116716759 TGCGCCTGAATATGAGGAAAAATTCCATTGAACACTTAAG 
FOR_361 chr7:116716760-116719057 GTTCTTGCCATAATAATATCTTCCTTAATTGGTTTTTAAG 
FOR_362 chr7:116719058-116719473 TAAGGGGCTTCAAGGCAACCTAACCAAAATGTGGGTGAAG 
FOR_363 chr7:116719474-116719968 TTTCTCTAGAGGCTGACTTGGTAACTGCTGTCAGTAAAAG 
FOR_364 chr7:116719969-116725975 TCTTCCTTGAGAACAGGTGGGCCTGAAACTTCCAGGGAAG 
FOR_365 chr7:116725976-116729875 GTATAACCTGGTGATTCCACTCTGGAAACATCTGCACAAG 
FOR_367 chr7:116732656-116733772 TGAGTACTTGCTGCCTCTTGCTAATGTGGGATACCGAAAG 
FOR_368 chr7:116733773-116734834 TATGGGGCTCATGTTCCTTGGATTCAGTGAGTTCTATAAG 
FOR_370 chr7:116737156-116744332 AAAATACCTTTTCCATAGTTACCCCATTTATCTTCTAAAG 
FOR_371 chr7:116744333-116744401 ATGTTTAGAGAGATCACATAGAGGAGGAAATTCCCAAAAG 
FOR_373 chr7:116752148-116760886 AGAAAAACAACTTGGGAGATTTACATTATGAGATATCAAG 
FOR_378 chr7:116773804-116775029 CAAGACAGCATCAGCTGCCATAGTATAAAGAGGATATAAG 
FOR_379 chr7:116775030-116776390 CTAACCTAAATTTTCAGCATCCTATAACGTTAACTTAAAG 
FOR_380 chr7:116776391-116783913 TGAATTGTATGCTTTCAATGAATGAATTATCTCAAGAAAG 
FOR_383 chr7:116791984-116792346 TCCCTTCAATTATTATTGGTAAACTCTGAAATAATATAAG 
FOR_384 chr7:116792347-116793757 AATGTATAATCTATCCTTCAAATCAGATATTTCACAAAAG 
FOR_385 chr7:116793758-116799657 AAATATGATTGGAAGTTACTGTGTAACTTTTGAACAGAAG 
FOR_386 chr7:116799658-116803602 ATCCTATGACCATTAAATAAATCAAATTGTAATTTAAAAG 
FOR_387 chr7:116803603-116804982 TACCACAATCTCAGAAAGGTTTTTTGTAGACATAGAAAAG 
FOR_388 chr7:116804983-116805860 ATGATTGTGAGGATGGAGAGCAAACTGGATCACTCATAAG 
FOR_389 chr7:116805861-116811442 ACTTGATCCTTGCTTAGAAGTTACAGACTTGTGGCTAAAG 
FOR_390 chr7:116811443-116813217 ATACCACCAGTACTGCTTTGAAAACGAAAAGAAATGAAAG 
FOR_392 chr7:116819026-116821165 TTTTTCTCTTAGTTTCACTCCCACCCACTCCATCTGAAAG 
FOR_393 chr7:116821166-116822556 ATAACTTTATCAAAATATTTTAATAGCTTTGTATCTAAAG 
FOR_394 chr7:116822557-116822904 TTAGACCTTTCACATTTTTAAATCAAATTGTAATCTCAAG 
FOR_395 chr7:116822905-116827129 GCCGTAAATATACTTAAACCATTGAATTCTACACTTTAAG 
253 
 
FOR_396 chr7:116827130-116830002 TGGGCCAAATGGGGAATAAAAGGACTAATACCCTATAAAG 
FOR_397 chr7:116830003-116833414 TATCAGAGTATGCTTGAGTTAATGCTGTCGGGCATAGAAG 
FOR_398 chr7:116833415-116837623 AAATAAAAGTTCAGTTTCAGAAGTTAGCAAGGTCATGAAG 
FOR_399 chr7:116837624-116844404 ATGCTACTTTACACATGGAAACTGAGACTTCAATCTCAAG 
FOR_400 chr7:116844405-116849537 AATCATTTAAGTTATCTAAAACATCTTACCCTTCTCAAAG 
FOR_401 chr7:116849538-116849668 AGTTGGAATCTACACTAATGCCTGTCAATATAAAAACAAG 
FOR_402 chr7:116849669-116850742 CTCTAACAAATCTTCCTCTTTGAACTGCTTTGATTGAAAG 
FOR_403 chr7:116850743-116852285 GATATAATAATCCTCATTTTAAAACGGGCAGAAATTGAAG 
FOR_407 chr7:116859106-116862886 CTCAGAATGAGCTATGATTCATTTACAGGTAAGTCACAAG 
FOR_408 chr7:116862887-116863142 GGCTCTTCTTCCTAGTTCCTGAGTTTTTTTAACTTTCAAG 
FOR_409 chr7:116863143-116865693 ACCTGGGTACATCTGTCTCTTTTTATCAGGAAAGCCAAAG 
FOR_410 chr7:116865694-116866419 GTGATTATTTGCATTTGATAGTTGGGAATATGAGATCAAG 
FOR_411 chr7:116866420-116870064 TTATTAAACTGTAATGAGCTAAAGAATAGATTTTCTGAAG 
FOR_412 chr7:116870065-116870540 GGTCGAAGATACCTATAAGAAACATACAAGCCTTGTTAAG 
FOR_414 chr7:116881628-116886437 TTTTGTATAAAAGTGTGCTTTTCCGGGATGTTGTTTGAAG 
FOR_415 chr7:116886438-116887480 GACAAAAATGAACTTCCTCAGGTCACCTAATGAATACAAG 
FOR_416 chr7:116887481-116887586 AGCAAAAAGGAAATTCTTCCAATTAGGCAGAGTGATGAAG 
FOR_418 chr7:116899363-116900042 GGAATCACCTAGCACCTAAGGATGGGTGAGTAAAGACAAG 
FOR_419 chr7:116900043-116901864 AATTTAATCTGTGTTATGAATTCCCTTGTTTCTAGAAAAG 
FOR_422 chr7:116908132-116912912 ATTGTGTCAGCAAAGAGCTTAGGCTTCTTTTAGCAAGAAG 
FOR_423 chr7:116912913-116916998 ATAACAGGTTTAAATATGTGCAAGGAGATGTCAGCAGAAG 
FOR_424 chr7:116916999-116920846 AAGCAATCTGAGGATGCTGTCCAATCCTGCCTCTCTCAAG 
FOR_426 chr7:116920882-116922275 TGATGACGTTTTGACAGTTGCACAAGTTTCTTTCTTTAAG 
FOR_427 chr7:116922276-116924466 TAAAATTCTGACTCTGCCCTTGACAAATTAACTAATTAAG 
FOR_428 chr7:116924467-116926564 TTAATAAAAGGCAAAAGTCAGATCGAAAAATGAGTATAAG 
FOR_429 chr7:116926565-116926608 AATTATATGACTTTAGGAGGATATGTTATGAAAATCAAAG 
FOR_430 chr7:116926609-116927976 GGCTTAAGATGACTCTGTGGTCATTGTTGGGCAGCATAAG 
FOR_431 chr7:116927977-116928226 TAACATAACTTATTAAAATGGGCACAGATAACACAGGAAG 
FOR_432 chr7:116928227-116934991 AAAGGTAATTAGGCTTTATAGAAGGGCTCTCATTAGCAAG 
FOR_433 chr7:116934992-116938677 ATGTATGGAGAAAGACTAAATTGTTCTTAAACTTCTCAAG 
FOR_434 chr7:116938678-116940500 AGCGAGGATGAAGACCTACCCTCTCAGTGCAGTATGGAAG 
FOR_439 chr7:116954445-116959635 TGTTATCATAATGATAATAGCTCAGGATGTGCATGACAAG 
FOR_440 chr7:116959636-116966785 TCTACTGAGACTCATTCAGTCAGTATCTCTAAGAGGCAAG 
FOR_441 chr7:116966786-116969901 AATAAAAAGAAGTGGAGGAATATTAAATGCAATATAAAAG 
FOR_442 chr7:116969902-116971187 TGTACTTAGAACTTATATTTTGTAGTGACTTCTTTAAAAG 
FOR_443 chr7:116971188-116971935 CAGTAGAACAGGGGACCAGCAATTATTCTTCCTCCAGAAG 
FOR_444 chr7:116971936-116972824 TGTCCGTGTACCTCAAGGTTCTTGTTCATCACTTCCCAAG 
FOR_445 chr7:116972825-116975278 TAGGACTGTTTACTTTGATTTGAAGACCACTATGCTAAAG 
FOR_446 chr7:116975279-116977027 TTTGTAGAAATGTGAGAAAAAGTTTAGTGGTCTCTTGAAG 
FOR_447 chr7:116977028-116978335 TCTTACCCACTCAATACAATTTGGTAATTTGTATCAGAAG 
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FOR_448 chr7:116978336-116981205 CCTAAGAGTCTTCCAAGTAGCAGGTGAAGCAAGTGCAAAG 
FOR_449 chr7:116981206-116981669 ATATGAGAAAAGTCACAGAGGAGTCAAAGATGATTCCAAG 
FOR_450 chr7:116981670-116984191 ACTTTTCTTCCTGATTAGGTTTCTACTAAAACCAAACAAG 
FOR_451 chr7:116984192-116987118 TGGATCAATTAATAAAACACATGACCTATGCTTTAAGAAG 
FOR_453 chr7:116988885-116990395 TGATAGTGAGGAGCAGAATTAAGGTGGACGTGATTAGAAG 
FOR_454 chr7:116990396-116993153 AAAATACTTGGGAGGGAAATTGGCAAGAAGTATGAAAAAG 
FOR_455 chr7:116993154-116993843 CCTTGAACTACCTGTAATTTTCTCCTGATAGGTAATTAAG 
FOR_456 chr7:116993844-116998434 AATTCCCTGGTGGACAGTCAGCAAAGGGGAAGATGAGAAG 
FOR_457 chr7:116998435-116998790 GCCAATTCTTAGACCAGTTGAATCAAAATCATCTAAAAAG 
FOR_458 chr7:116998791-117000144 GCATTACCTCTAAAGTTCATGTTTCCTTTACCCAACCAAG 
FOR_459 chr7:117000145-117000426 ATATCATTGCCCTTTGTATGTGCAAATCAGAGTTAATAAG 
FOR_460 chr7:117000427-117004204 TCCACTCACTGCTTGGAACATATTGCCTGCAATAATTAAG 
FOR_461 chr7:117004205-117007965 TCACATAGCATCTAATAAACGTATTTATGAACTACAAAAG 
FOR_462 chr7:117007966-117010107 CCTCATTTTCTTAAAGCATTTTCTCCTTTTCCTCAACAAG 
FOR_464 chr7:117011453-117015792 AAACAATTATTGGTGACTCTGATGTCAAATGTTTCTCAAG 
FOR_465 chr7:117015793-117020511 TGGGTTTCTGAAAAGATTTCTTTTAGAGAATGTATATAAG 
FOR_466 chr7:117020512-117024397 TCTCGGTGTGAAAGTGGCAACCTGCTGGGGTCTGTAGAAG 
FOR_467 chr7:117024398-117033085 CTACCAGTTTGGCTGAAACAGGATATTTGAGCAGAGGAAG 
FOR_468 chr7:117033086-117036940 ATATGCTCCGAAAGGTTAGATAGCTTGCCTAAATGACAAG 
FOR_469 chr7:117036941-117038746 ATCATATCTATTCAAAGAATGGCACCAGTGTGAAAAAAAG 
FOR_470 chr7:117038747-117038904 TCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAG 
FOR_472 chr7:117042650-117046025 CCTTTCCAGGGTCTCAGGAGACTATTCAAACAGGACAAAG 
FOR_473 chr7:117046026-117047652 TGAAACAGTTTGATGAGAAGTTTTCTAAGGTTCCTTCAAG 
FOR_475 chr7:117051319-117051809 CTGCACCCTACTGCTCCCATGTCATGCAAGGCACAGGAAG 
FOR_476 chr7:117051810-117057401 CACTGAAACCTGAGGCAGATTTATTGTGGCAATAACAAAG 
FOR_477 chr7:117057402-117057519 TCTTTATTCTTGAAAAGAGCCCTCCCTCCAAATTTACAAG 
FOR_478 chr7:117057520-117057672 AAGAGAAGGTTTTATATAGGAAGTGGCATTTAGAATGAAG 
FOR_479 chr7:117057673-117060421 AATGGAGTTGGGAAGGACTGACATCTTGACAATGTTGAAG 
FOR_480 chr7:117060422-117061837 TTTAATTTGATCTTCTTTTGCTAGTTATCCAAGGTGGAAG 
FOR_482 chr7:117062193-117067435 TTAGAAAACACTGACTTAGATTTAGGGTATGTCTTAAAAG 
FOR_483 chr7:117067436-117070752 CTCCAGGTAGACTGACTATAAATCTAGACTGAAAAAAAAG 
FOR_484 chr7:117070753-117070878 TTTTAATTTATTTGTCTAGACTTTGTCATGTTGCCAGAAG 
FOR_485 chr7:117070879-117073682 AGAAAGTGATAATTAAGGCGGTTCATAAAGGGTCATAAAG 
FOR_487 chr7:117083344-117088524 ACTATGTTGACTTTTCTCTAATGAAGATGATTCTAAAAAG 
FOR_488 chr7:117088525-117089649 ATAACACAGAGCTGAAGAGCACGTTTTTACCCTCAAGAAG 
FOR_489 chr7:117089650-117091888 AAGGTAGTGGGGGTAGAGGGATTGGTATGAAAAACATAAG 
FOR_490 chr7:117091889-117092016 TTACGGGCTCAGATCTGTGATAGAACAGTTTCCTGGGAAG 
FOR_491 chr7:117092017-117092396 TTTCATACAAACTCTTCCCCCTTGTCAACACATGATGAAG 
FOR_492 chr7:117092397-117093667 TCCTTACTGAAGGCTTGTTATTACCATGATTATCACTAAG 
FOR_493 chr7:117093668-117093837 TTAAACTCAGGCACATCCTGACCAATTTGGAATTCTTAAG 
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FOR_494 chr7:117093838-117094852 TTAAGTAATGATAACTGGAAACTTCAGCGGTTTATATAAG 
FOR_495 chr7:117094853-117096018 ACTTGTCATGTTTCATCAGTCTCTCACTCCAATTTCTAAG 
FOR_496 chr7:117096019-117097027 AGATTTATATTCTGCAAGTGTCCATCTATTTCTTTTAAAG 
FOR_497 chr7:117097028-117097560 GCGTGGACCCCAAGCTCACTATGCCAAAGGGCAAGTTAAG 
FOR_498 chr7:117097561-117113770 GAACAAAAGGAAGGCAATATTGAGTAATTCAGCTCTGAAG 
FOR_499 chr7:117113771-117119446 GCTACAAGCCCACTATACAATATTGTTGTGATCTGATAAG 
FOR_500 chr7:117119447-117124005 AACTAGTTGAGTTATAACCTTGGGTAGGAAATTACATAAG 
FOR_501 chr7:117124006-117125194 TGAGAACACTTTTTCCATTCTCCATAAGTCTAACTCTAAG 
FOR_502 chr7:117125195-117128742 TTTTGTGTCCTAAGACATCTTGTCTAATCTGAGGTAAAAG 
FOR_503 chr7:117128743-117144189 TATTGCCCCACGCCCAGTGCCGCTAGGTGATCAGATAAAG 
FOR_504 chr7:117144190-117149507 CAGGAAAGAAATGGGCTGTCTCTTTATCAAATTTGATAAG 
FOR_506 chr7:117150627-117150962 AAGATACAGACGTGTTACATCTTCTTTGTTAGAATGAAAG 
FOR_507 chr7:117150963-117153567 AAACAAAACCACATCTCCCAGGTTAGGAATGTTTTCAAAG 
FOR_508 chr7:117153568-117155028 AAACAGTAAGTACTGAACATATGTCTCAATAAAGGGAAAG 
FOR_509 chr7:117155029-117158580 ATTGTTAAATTTTGCTAGATTTATACACAGAAAGATAAAG 
FOR_510 chr7:117158581-117160639 CCCACTCTCAAACGCAATGGAAAAGAGAGTGAACCTGAAG 
FOR_511 chr7:117160640-117162523 TGGTACTCTGGGAAACAGAAAGATTAGAATATTACAGAAG 
FOR_513 chr7:117162744-117166350 CCAAAAAGGGTCAAACAGCACAGCTTTCTTTGGGGGAAAG 
FOR_514 chr7:117166351-117170501 GACCTTGTTCATTGCACTCCAGTTTTCTTAGCTCTCTAAG 
FOR_515 chr7:117170502-117173345 CGGGCAGAGTGCAAGCTGATGTACTATGTAGTCTTGCAAG 
FOR_516 chr7:117173346-117174358 AAACGCGTTATATCTGCCCAGCACACATGCTTGGGAGAAG 
FOR_517 chr7:117174359-117177986 CTGACTGTTACTCTATCAGAACCGGGTCGAACATGCAAAG 
FOR_518 chr7:117177987-117184316 TAAGTAAAAGTTATCATAGATCATTGCAATCCTCAGAAAG 
FOR_521 chr7:117185609-117186934 ACCTTTCTTTTCCAATACGGTGCTGTTGAAAGTACACAAG 
FOR_522 chr7:117186935-117187620 GATACGAAGTTTTTCAGCACCGGCAGCTGCCACAAGTAAG 
FOR_524 chr7:117190233-117190464 TATTTATTGTTCATTTTATCTCTTAATGTTAGACTATAAG 
FOR_525 chr7:117190465-117196776 ATGACCTGGCCCTGTTCAGGTTAGAGGGATCTCTCTAAAG 
FOR_526 chr7:117196777-117200917 TAAGCTCTTAGAAAATAGGAGTAGGCAGCTGAGAATAAAG 
FOR_527 chr7:117200918-117204998 AAGAATTTCCATGAGCTGGTATTCTATGGTACATAAGAAG 
FOR_528 chr7:117204999-117205660 GAGTGTTTTGTGACTGCAGAGGGATACTGATCATTATAAG 
FOR_529 chr7:117205661-117214375 ATCTTCACTAACATTTCCAATGTTGTCTAGCATAGACAAG 
FOR_530 chr7:117214376-117215135 CTTGGGGCTCTAACTTAGTCATAATTTTTATAGATAAAAG 
FOR_531 chr7:117215136-117216509 TTGACAAAATGTTCCTCAGTCATAGATCCTGGTTTTAAAG 
FOR_532 chr7:117216510-117220056 GGATGTTCTTGTGCTCTTGCTCAAGGGCTTGTAGCTGAAG 
FOR_534 chr7:117222053-117223390 AGTACTCACTTCCCCTCTTCATCCTATCTCCTCCTTTAAG 
FOR_535 chr7:117223391-117228413 CACTGATGTAATAAACAAGTAAACAGGGGAGAAAGAAAAG 
FOR_536 chr7:117228414-117229567 TAGTAATCACTTGAATATGAGGAAGGATTTCTTTTAAAAG 
FOR_539 chr7:117230846-117234904 TGTCCAGTAGTTGCTTTCCTGGTCTTCTGTGTAGTCTAAG 
FOR_541 chr7:117239628-117242516 CAATTAAAATGTGCTTTTCGGTCTACAGTTTTCTATCAAG 
FOR_542 chr7:117242517-117244976 ACATTATAAAACACTACCAATTTCAAAACATACTGACAAG 
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FOR_544 chr7:117244985-117246173 AATTATGGCTAATATAATAAAGAATTTTTAAGGGTCAAAG 
FOR_545 chr7:117246174-117247010 ATTTTCTGTGCAATGCTGAGAATGTCAGAGAAGAGGTAAG 
FOR_547 chr7:117248239-117253247 CTCTGGATCCAAAATGGGAAGCCACGTGCCAGTGCCAAAG 
FOR_548 chr7:117253248-117253903 ACTTACTGAAGTTCTAAATCATATCCTTTGTTTTCTCAAG 
FOR_550 chr7:117254794-117259229 TAATTCTATCTGTGCTGCCTTCTCCACTTCCTTTTCTAAG 
FOR_551 chr7:117259230-117259873 TCCGATACTACCACTCATCTCCTCCTTTCTCCCTGTGAAG 
FOR_552 chr7:117259874-117278412 CTATTTGCTGTCACCAGTTAGAAAATAATGCACTCTTAAG 
FOR_553 chr7:117278413-117279850 ATCCTATTAGAATCATACCCTAATTACAGAAAAGCACAAG 
FOR_554 chr7:117279851-117280370 TGAAGTGCCGGACATATAACGAAAACCTAACAATATTAAG 
FOR_555 chr7:117280371-117284325 TACGCAGATTTTGAATAGCCAATTAAATTTAATTCAAAAG 
FOR_556 chr7:117284326-117284782 TTCAATGATGTATGCAATTTTTAATAACTTGAAATCAAAG 
FOR_557 chr7:117284783-117285361 AAATAAAGAAATCACAATTCTCAATTTTAAACCAAAAAAG 
FOR_559 chr7:117291311-117293839 TTTAAAATCCAGCAGGTTGTGCCTATTTTCCATCAGTAAG 
FOR_560 chr7:117293840-117295506 GCAAGCAGACATTCAAATGTAATAACCATCCTTTAAGAAG 
FOR_561 chr7:117295507-117295997 TACCAACAGAAAAGACAAATCTTTTTCCATGTTACATAAG 
FOR_565 chr7:117301977-117310829 GACAGGCTCCACCTCACCACAGATCTCCAAGAAGGAGAAG 
FOR_566 chr7:117310830-117311855 TGTCGAGATTCACAGCCAGCCCATCATGAATTGTGCAAAG 
FOR_567 chr7:117311856-117316255 CTGCGGAAGTGAAGTATCCTTGGTGTCCCTACTGACAAAG 
FOR_568 chr7:117316256-117316630 TCTCTAATTCTCACCTAATTCTTTTGATAATTCATGAAAG 
FOR_569 chr7:117316631-117320129 GTCCTTAAACACTTTACCCCACACCCAGAGCCCAGACAAG 
FOR_570 chr7:117320130-117320250 ATCCCCCACTTTTCTCTCCTTTATGAAGAGGTCATTTAAG 
FOR_571 chr7:117320251-117324194 ATTGGTATGGGAAGTAGCCTGGGAATCAGGATTTTTAAAG 
FOR_572 chr7:117324195-117324983 AATTCAGGATGATAAAAGCAAAATTATAAGTGTGTAGAAG 
FOR_573 chr7:117324984-117329171 CATGAGAAGGCACTCTGTATAAACAAAACATCATCCAAAG 
FOR_574 chr7:117329172-117329423 ACCTGAGGGGCTCCTGGAAAGAATAAAAGTTTTCTAGAAG 
FOR_575 chr7:117329424-117332188 GCAAAGACCTTTTATACTTCTTTCTGTTTTCATGATCAAG 
FOR_576 chr7:117332189-117334886 CATTTTTCAAGGATTGTTTAGGAACTATCTGTCTGTGAAG 
FOR_577 chr7:117334887-117336857 CTGGCAATTTATGACATCGAATTGTGAAGTCTTAGAAAAG 
FOR_579 chr7:117342270-117342424 GTGTTTAATTGGCTCTTCTATTAGTTTCATAAGATAGAAG 
FOR_582 chr7:117347944-117356272 TTAGTATATGTGCTTGCTATGTAAATATTCAGTGAGCAAG 
FOR_583 chr7:117356273-117356691 ACTGTGGATCTTTTTCTCAGATGAAGACACAGAGCAGAAG 
FOR_584 chr7:117356692-117364472 CCTACCTTTTCATGATATACTTACTATACAGATCTCAAAG 
FOR_586 chr7:117373712-117382856 TCTAATATTGTTTTGAACTTCAATATATTTTCCCACCAAG 
FOR_587 chr7:117382857-117389863 CATAGTAACGCATGGCAGGAGCAGTCAGAACTCGGCCAAG 
FOR_590 chr7:117397094-117404417 AGGCCAAATCTCATCAAGGTGATAAGCTCTGTTCTGAAAG 
FOR_591 chr7:117404418-117404731 TGCTAGTGCTTGACTATTGTTCTGTTTTCTCCTTCCTAAG 
FOR_592 chr7:117404732-117404962 CTTATTGAGCAGCTGCTGTGTGCTAAAAAAAGTGTTCAAG 
FOR_593 chr7:117404963-117407209 TTTTAAGCTATTGTCATGGCCATTTCATCTTTGGGCCAAG 
FOR_595 chr7:117415206-117418643 ATTGATTTGAGTATGCCTTTTTGGGAGTTGAGAGTTTAAG 
FOR_596 chr7:117418644-117427061 TCCTTCTAAAGATGGAAAGATTCTTCCTTTGATGATTAAG 
257 
 
FOR_597 chr7:117427062-117428039 ACTAATTAGTCTGGCTCCGTGTACTTGAGAAGCTGGAAAG 
FOR_598 chr7:117428040-117428313 GCATTTTTCATACTTGTTTCCGTAGCTGACTGCATACAAG 
FOR_599 chr7:117428314-117428672 TCCGTCCCAAAAGGATGTCAGCTGAGGATACCTGGGTAAG 
FOR_600 chr7:117428673-117433066 GCCATTACAACTTTAAAAAGTTTTCTGTTCAACAGGTAAG 
FOR_601 chr7:117433067-117434754 GCCTGGGAATGTAATAAGGAGAATTTAAATCAGCTAAAAG 
FOR_603 chr7:117438608-117451059 CACAACATGTAACTCTTTGGAAGATACCTGTTAGTATAAG 
FOR_604 chr7:117451060-117451350 ACAAATATTCATATACTGCACAATCTTTGAAGGTGAGAAG 
FOR_605 chr7:117451351-117457028 ACAGCATTCATACTGTTTTGAACCCTTTTCACATAAAAAG 
FOR_606 chr7:117457029-117462764 GTCTTGGCCAAGTCAATGGGGACAGAAATAAAGAGATAAG 
FOR_607 chr7:117462765-117462875 TGTAACTTTGGGATGGGGGTGAAGCTAGGGGTGAGGAAAG 
FOR_608 chr7:117462876-117463473 TGGTTCTCATCTTGGCTGCATGTTGAAATCACCTAGAAAG 
FOR_609 chr7:117463474-117469725 TTATTTATACTGTTTATTGTCTTTTCCACTATAATGCAAG 
FOR_615 chr7:117476669-117480790 AGTGATTCTCATGGTATTATGTAAGATCACCACCAATAAG 
FOR_616 chr7:117480791-117485009 TATGTAAGTGGGTATTGCATACCACTAAGTCTTGGGAAAG 
FOR_617 chr7:117485010-117489451 TAACTGGTGATTGTTAGTATAAGGAATACTCTTGGGAAAG 
FOR_623 chr7:117508289-117518070 TGGGAACATGACATTTTAGAATGTTTAACAGTCAAAAAAG 
FOR_625 chr7:117524320-117532227 CATATTAACAAAATAGCGAATCATTATTTGGATGTATAAG 
FOR_626 chr7:117532228-117537156 CTATCATGAGCCCACTTCATACCTAGGCTTCATGGTAAAG 
FOR_627 chr7:117537157-117537712 TCTGTGTTGCATGTTCTGTTTTTAGTCTCAGCATCTAAAG 
FOR_638 chr7:117565102-117572561 AGAACACTACAAAATAGGTGCTCAATAAGCAAATACCAAG 
FOR_640 chr7:117572736-117574054 GTTAGAGGTTAAAGGCAGGAAAAAAAGAGCTAATACCAAG 
FOR_641 chr7:117574055-117580157 GGTGTCTCTCTAGCCCTTATTTGCCAAGACCAAAATCAAG 
FOR_645 chr7:117589977-117593454 CTCTTAATGATTTGTAAAAAAAGGTTATATTTATCTTAAG 
FOR_646 chr7:117593455-117601132 TCCTCCCTTTGAACACCACTGTCAAACAATCAAACTGAAG 
FOR_650 chr7:117614663-117615273 TTTGTCTTAGTTTATACCTTTAGCTGCTGGTCTACATAAG 
FOR_651 chr7:117615274-117620404 TTTGTTTTTATGAAAGTGCTTAAAAATAGTAGTTGGCAAG 
FOR_652 chr7:117620405-117623511 ACACCTATCGCCAGGGAACAGTATTCTTGTGCTTGTGAAG 
FOR_653 chr7:117623512-117624942 TTATTTTAAAAAATAGCTCTCTGAATCTGACTTGGATAAG 
FOR_654 chr7:117624943-117625814 GTAGCCCGGTAAACTGGTGTTTGAAGGCAATATATAAAAG 
FOR_655 chr7:117625815-117627691 CACAAAAACCTCTCAGCCCTACACAGCATCTTTAAGAAAG 
FOR_656 chr7:117627692-117633539 TAAAAAATGAGAAATTATGGTCTAAAATTCCCTGTATAAG 
FOR_658 chr7:117634323-117636076 CGTACCATCTGGAGATGCAACTCATATCAACATGTTCAAG 
FOR_660 chr7:117639998-117642099 CTGGTCCCGCGCAGGACCCTGAAAGTCTCGTCCCAGTAAG 
FOR_661 chr7:117642100-117643094 TGAAACGAGGAGATGCATTCAAACCCTAGCAGTTAAGAAG 
FOR_662 chr7:117643095-117645597 ATGGTTTAAAGATATACTCAGAACATAGATCATGTAGAAG 
FOR_663 chr7:117645598-117648003 CAGTTTTCGTTATGTAAATACTCCCATTTCTGAGTGTAAG 
FOR_669 chr7:117659169-117660333 AATTTCATCCTTAAGCCAAACTGTAAATGTGAACAGAAAG 
FOR_670 chr7:117660334-117664128 ATAAGAAGCTGTCAGTGGTGAACCACCATGTTTAGTAAAG 
FOR_671 chr7:117664129-117665277 TGTTTCTTTTATGTATGATTTTTTTCCATCACTTAAAAAG 
FOR_672 chr7:117665278-117665764 GGAAAGTGTGTATTTGCCCCTCTTTGCAGTGGGAACTAAG 
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FOR_673 chr7:117665765-117667072 ATTTTCACCAGTCTGTTGACAGAGTTGGCTCAAGAGGAAG 
FOR_674 chr7:117667073-117676995 GTGTATCTAATCAGTAAACACATAAACTCTTGCTGTAAAG 
FOR_675 chr7:117676996-117681530 TCCTTGTGTATTTTCATGTTTCTTAAAAGTTAGTAAGAAG 
FOR_676 chr7:117681531-117683117 CTTCCTTAATTTTAGAGGTATAGTCAGTGAGAAAATAAAG 
FOR_677 chr7:117683118-117691760 GACAATATGTGAATAACCAGCAAACTCTAGCAACAATAAG 
FOR_678 chr7:117691761-117694222 TGTGGAGATTTATAGGTGGATTCATTTTCCAGAGCTTAAG 
FOR_681 chr7:117708238-117711933 ACATTCCTTATAAGTAGTGACCAACATGTTGTAACAGAAG 
FOR_685 chr7:117724096-117725341 CTCTCAGGAAACAATGTGACTTGGATCTTTGAATCCAAAG 
FOR_688 chr7:117733948-117739166 TCCTTGAACAGTTTCTGGCATTTAGTAGGGGAACAATAAG 
FOR_692 chr7:117754462-117755196 ACCCTAGAAAGTAGTTGAGGCTCCAAGAAAATCTAAGAAG 
FOR_693 chr7:117755197-117758934 CCAAACTGAGGAACTTTTTACAAAATACCTGACAGTTAAG 
FOR_694 chr7:117758935-117759925 AGAGCTGTCAAAATTTTTAAAACTTGAAAAGGACTATAAG 
FOR_696 chr7:117763482-117775069 AGTTGTTGATCCTGAGGTGTTTGCCCAAGAAGAGGAAAAG 
FOR_697 chr7:117775070-117780876 ACTAAAAGTATCTGATACAAGCCTCAATCAATTTATGAAG 
FOR_698 chr7:117780877-117785468 CACGTTCAAGTGTGTGAATAGCAGCTGCCTGAGTACAAAG 
FOR_699 chr7:117785469-117787223 TGAGTGTATTGAAACAATTATGACTATTTCATAGGTGAAG 
FOR_702 chr7:117795166-117795912 GAGTAACAGCAGCAATCAAGATGAATCATAATTACCCAAG 
FOR_703 chr7:117795913-117796992 CAATAACAGGTACATGAGACCCAATATGCAGAGGTGAAAG 
FOR_705 chr7:117797013-117800251 AATCTGTTTCTGCTTGTGACAGTAAATCTAGAACTGGAAG 
FOR_707 chr7:117809275-117810127 TGTCATTTGAATTGCTGAGAAAAGAAATTCATTCTACAAG 
FOR_708 chr7:117810128-117813248 TGCATCATTTTACATGTGCTTGTCAAGTATATAGTTTAAG 
FOR_709 chr7:117813249-117815722 TGCCATCAGGAATGTTTGAATATACCATTTTCACCATAAG 
FOR_710 chr7:117815723-117817378 GTTGAACTGGGTAGGTACCAAAAAGACTGTCTGTCACAAG 
FOR_713 chr7:117827230-117831742  AGCCACATTTTGGGTCTTATTTCAAACTAGTAACACAAAG 
FOR_714 chr7:117831743-117833241 CAAACTCATGAGGATATTTAACCATGAAAGTTTCCAGAAG 
FOR_716 chr7:117833369-117845957 GACCAAGGTAGTAGAGCTGTTTTAAGATAACAAATAAAAG 
FOR_717 chr7:117845958-117848439 CACAGAGTAGTTGTGGATCCCAGTGGTTGAATGGTAAAAG 
FOR_718 chr7:117848440-117851061 ATTCACTAGGAATTATGAAAACAAAATCATCCATCTAAAG 
FOR_720 chr7:117856727-117863427 CAAACTCGAAGAAACAAAGAGCCTGAGAGCTACACTCAAG 
FOR_721 chr7:117863428-117865641 CTCATTATCCTCAAGACACGTAATCATTGGATTTTCCAAG 
FOR_724 chr7:117869609-117870489 GTGTATTAATAGAAATTGTATATTTTTGTTGTGTCCCAAG 
FOR_725 chr7:117870490-117873429 TTGTTACAATACCAAAATATATTATTCATAGACTCACAAG 
FOR_726 chr7:117873430-117875326 CTGCATTAGGTCCTAAAAAGAGAGTTAGCCTGTCTTTAAG 
FOR_728 chr7:117875455-117875879 GAGTCGGACTCTTGGCTTTCAACATGCTTTCCTGACCAAG 
FOR_729 chr7:117875880-117883039 TATAGTTAACAGCTTATTATAGAAACTGTATAAAAAGAAG 
FOR_731 chr7:117883765-117892970 GTTATAGTAAAACAGAAATCAGGCTGGTTTCAGCCTGAAG 
FOR_733 chr7:117893193-117904369 TAGTTTACGAGCCACTGAAACTATTTCCAGGGCGAAGAAG 
FOR_734 chr7:117904370-117904798 GGTAATTTATTTCACAATGTGGGAAATTGTATATGGAAAG 
FOR_735 chr7:117904799-117905776 TTGGACCCCTTTGTGGATAAAGCAAGGGAGTCAAGCCAAG 
FOR_737 chr7:117909651-117913178 AAATAGCATTTTGAATACTTATAATGATTTTATAAGTAAG 
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FOR_739 chr7:117914160-117915342 GATTTTGGAAAAGAATAAACATCAAGTGTTTGTAACAAAG 
FOR_741 chr7:117918022-117919004 AGCTATTATACCATGAGGAAAAGCAACATGTTGAGCTAAG 
FOR_742 chr7:117919005-117919940 GTTTACCCAACACTACTTCCTGTCTTGAAGACACGAGAAG 
FOR_743 chr7:117919941-117924925 GATAAATAGAATTTTTGCCATGTCTGCAAGTTCTATAAAG 
FOR_744 chr7:117924926-117927813 CTGGGATATGTGGTAAGAGCATGTTTAGTAGCATAAGAAG 
FOR_745 chr7:117927814-117930607 TAAAATTAAAGGTGTCTCTGTGCTTAGCGAATTTATAAAG 
FOR_746 chr7:117930608-117931069 TAATCTAATTAAGTAACAGTTCACAGAAGAAGACATCAAG 
FOR_748 chr7:117936326-117941888 TTTGATGGATCCATTGCATTCTCTTAAAATGTAGTAGAAG 
FOR_751 chr7:117943862-117946051 AAAGATTTTCTGATTGGCTATTTGGTTGAAAAGAGTTAAG 
FOR_752 chr7:117946052-117947632 ATTACAATTAAAAGCAAAATCTCTTCCCAACTCAGAAAAG 
FOR_756 chr7:117953828-117960889 TTAGAATAAAGACCTTTTGATTGATCATATTTGATTAAAG 
FOR_759 chr7:117961105-117963456 GCCTCTCACACACACAACCTGGATTTCTAGCAAATATAAG 
FOR_760 chr7:117963457-117965130 AATATAAAATATTTTACTATGACTTGTGTTTAAGAAAAAG 
FOR_762 chr7:117973388-117988981 AAAAAAGTACACCTGTGTAGGCTACTTACTGTGAATGAAG 
FOR_765 chr7:117992159-117992442 TAATAACAAAATTGAGAGACATTATACTTTAGTTTCAAAG 
FOR_766 chr7:117992443-117993890 TGGAAAAAAATTTATTTGTTTCATGAAAGTTAAATATAAG 
FOR_767 chr7:117993891-117994842 AGGTATATACTTCTAATCTTACATAATTTTTTACTCTAAG 
FOR_768 chr7:117994843-117997059 AATTGCTTTTTCATTTTGTCGATTTTTTTTTGTACAGAAG 
FOR_770 chr7:118009421-118009816 ACACAAAAATGATGGAAGAGGGAATCCACACTCTGGGAAG 
FOR_771 chr7:118009817-118012221 AAATATTATTTACTCTGTTTTTCATATGAGAACACTAAAG 
FOR_773 chr7:118012383-118015755 GTTCCGGACACCGAAGTGCTTTCTGGAGTGGCAACCCAAG 
FOR_774 chr7:118015756-118017020 ATCAAAAGAGTAACTTAAAAATCTAGAATGAGAATTTAAG 
FOR_775 chr7:118017021-118022505 TTCACTTTATCTCCTAAATTGCATTTTGCCTAGAAAAAAG 
FOR_776 chr7:118022506-118023306 AGTACAAACAAGTAAAAAGCCAAACTGCTTCCACTTGAAG 
FOR_778 chr7:118032257-118037031 AGGGAGAGACGAGCAATGCCATCATACAGTCTCCAGGAAG 
FOR_779 chr7:118037032-118041118 AATTATATTATTCCAGGGCACTGAACGTTTACTTACAAAG 
FOR_780 chr7:118041119-118044577 CACCCATGAGAGCAGTAAAAAGTGAGTTCAGTTATTTAAG 
FOR_781 chr7:118044578-118057842 AATAAGCACAGAATCAAACTTATTTTAGACTTTTTTTAAG 
FOR_783 chr7:118065172-118071565 TAGGGCCTGTGGACTTCTTATCTCAGAATCATCTTAAAAG 
FOR_784 chr7:118071566-118078458 TAGAGAGAGACTTCCACTGTACAGCTGAAACAGGCATAAG 
FOR_785 chr7:118078459-118079156 CCTTTCCTTCTGAAAGAACAGAATGGGCCTGTGCAGAAAG 
FOR_786 chr7:118079157-118080510 TATTCACAACTATTATTTACTAAATTAGCCTCTTCACAAG 
FOR_788 chr7:118080600-118082900 GACACAGGAATTAATTATAAAGAAGTTACGAATGGCCAAG 
FOR_789 chr7:118082901-118086695 GGGCTGAGATCATGCAGCTTATAAGTGAAAAAAGATAAAG 
FOR_790 chr7:118086696-118087830 GTTTCTTATAGATCAGATGTTAGAGTCCTTTGTAATAAAG 
FOR_795 chr7:118110542-118116592 ATGGAAGTTAGAGTCTTTCACATGTTGGCAGAAATCTAAG 
FOR_796 chr7:118116593-118118958 TTCGCTGTATTTGGAAATCGGGTTGGGATTTGAGTTAAAG 
FOR_798 chr7:118118979-118122757 ATGTATTATGAAAAGGCATTCCAAGTTTTTTACAGGTAAG 
FOR_799 chr7:118122758-118123465 GTATATGCTGCATAAACCTGAGCTGTTAACCAGTCTCAAG 
FOR_801 chr7:118123896-118127179 ATCCCTAGTGAGTCCTATTTCAGATGTCTGACTCCAAAAG 
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FOR_802 chr7:118127180-118132591 ATGCCATTCATAAGTGGCTTGAATCTCAACCTTTCAGAAG 
FOR_803 chr7:118132592-118133675 ATAATTGTACATAAAGTGATTCTTATCATGGTGAATAAAG 
FOR_804 chr7:118133676-118134163 TGTAGTAAGGAGTACTTGTCTTTCTTGCTGCTCTATTAAG 
FOR_805 chr7:118134164-118143444 TTTGTTAATATATACTGAAGCTGACCTTTATTGACAAAAG 
FOR_806 chr7:118143445-118145173 CCCTTGGAAAAATCTGGAAGGAATTCACAGAGGAAGTAAG 
FOR_807 chr7:118145174-118145507 TCAGGAAACTAACTATTTTCATGTTTCTACATGGTCAAAG 
FOR_809 chr7:118153941-118170303 TCCTGTCTTCATTGGGGAAGGAGACACAAGACCCACTAAG 
FOR_810 chr7:118170304-118172110 AGGGGTACGTGGAACGGAAGGGCCTTGCTGCAGGCTGAAG 
FOR_811 chr7:118172111-118180123 GTTCAAATAACCCAAATCGAAATTGAACTTCACATTGAAG 
FOR_817 chr7:118185016-118188949 ATGTGCTATTGTGCTGATACAATCATATCTTGTTCTCAAG 
FOR_818 chr7:118188950-118192901 GAAATCACATGTTACAACTAGTAGATGAACTAAAATAAAG 
FOR_820 chr7:118192926-118198234 AATCTTAAAATTGTTTTAATGAGTGAGATAAACTTAAAAG 
FOR_821 chr7:118198235-118202713 ATTTATTTTACAATTATAAACTCAATTTAAAGTTTGAAAG 
FOR_822 chr7:118202714-118208267 CCTCCATAAATGCATAATCCTTCTTATTTAGATTATTAAG 
FOR_823 chr7:118208268-118210988 GGCAAGTGTACTATCTAAAATGATTTCTCGTTTCAATAAG 
FOR_826 chr7:118215209-118221703 ATTTGGGGAATACTGTAAAAGGAAATCAAGCAAAAAGAAG 
FOR_828 chr7:118222405-118222956 ACTCGTCCCCGGTTATCTCAGGGGCCTGGGAGAAGAGAAG 
FOR_829 chr7:118222957-118224989 ACTAATCTGTGTTCCACTATCTGACTGTCTGACAAAGAAG 
FOR_830 chr7:118224990-118225664 CCCTGACAGAGTTTTAAATACAGACAGAGCAGTGGAAAAG 
FOR_832 chr7:118225695-118226169 TCCATTGAGACATTGCATTTCATGATAGAAAATTCTCAAG 
FOR_833 chr7:118226170-118227462 TTTCGGGACAGGCCCCCTCTTAAGAAATTACTGGGTGAAG 
FOR_841 chr7:118256172-118259200 GATAATCTCAAAGACAACCACACGTATACACATACTAAAG 
FOR_842 chr7:118259201-118259827 GTAGGGTATTGTTAAGCACAATTAGGGTATTGTTAGGAAG 
FOR_844 chr7:118262899-118266249 AATAATATCTCCCTATTGTTCATAATGTCTCCCTATTAAG 
FOR_848 chr7:118275081-118276446 ATTAGAAAGGTGTTATGAGCCTTCTTCCAGACATACCAAG 
FOR_849 chr7:118276447-118278095 GTGATCTAAGTCAGAGAGAGGATCAAGTCAGGACACCAAG 
FOR_850 chr7:118278096-118280167 TCATTGCAACAGAAAATTGTTCCAAACTGTTATGATAAAG 
FOR_851 chr7:118280168-118281466 CACATTTTTTAAAGTCGTCACTGTATTGTTGCAATAGAAG 
FOR_859 chr7:118295522-118298023 ACCGGATTGTTTGGCTCAGATGAAGATTGGGTGTGTGAAG 
FOR_860 chr7:118298024-118299632 TCATTACTTATATAATATTTAAACGATTAGCCATATAAAG 
FOR_864 chr7:118305250-118305693 AAATATATAAATATTGTTTACTAAAGAAAACATAGTCAAG 
FOR_871 chr7:118316092-118319933 TTATTTAGGTGATGAAAAATTAAAGTTTTTGCAAGTGAAG 
FOR_872 chr7:118319934-118326087 AGCGGGGAGAGGTCAGAGCCACCCAACCCAGTTGCCAAAG 
FOR_873 chr7:118326088-118326428 ATTAAAATATCACTGCTACTAGGCAGATAACAAATGAAAG 
FOR_874 chr7:118326429-118330577 CATTTGAGTTCTTCCCAGTTTTGAACTATTACAAGTAAAG 
FOR_877 chr7:118336293-118337454 GGTCCATTTCCAGAACTCCAACAAGGTCATCTCTTCAAAG 
FOR_879 chr7:118339972-118341522 CCTTTAAGCCTCAAATTGATTACATAAATCTTGGAGGAAG 
FOR_880 chr7:118341523-118342346 TTTATCAAAGATCACATTGTTAGGAAGTATTCAGATCAAG 
FOR_883 chr7:118342476-118345933 TTAGAACACTGTTATTATCCTCAGAAGAGAAATCTACAAG 
FOR_884 chr7:118345934-118348238 GTTCTGAGGATTGTGATAAGTGCTCTCTTGGATTCTGAAG 
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FOR_885 chr7:118348239-118349166 AAATTATTCTCATCTAGAGATTTGTATTGATATGCAGAAG 
FOR_887 chr7:118349240-118351772 TAAGTCTTCTGACTGGAAAACTGAGTGTCCTTTTTCAAAG 
FOR_890 chr7:118353269-118355818 TATTTATTCTAAGGCCACAGGACAAATTTCTGTCTGGAAG 
FOR_891 chr7:118355819-118356080 TGGCAATGTTAGGCCACTTTTTCTGCAGGACTTTGTAAAG 
FOR_893 chr7:118360340-118371174 TATTATAGTCAGGAGTAGAGATGAGTGGTAGTAGAGAAAG 
FOR_894 chr7:118371175-118374774 AAAAAAACATTTAAGATGCTTTGCATTTCAGGGAGGAAAG 
FOR_896 chr7:118380120-118382070 GGTATCAGTTTTAATATCTCCTGTTTTGTTTCGAATTAAG 
FOR_897 chr7:118382071-118385396 GTTCTCAGCATCAGCTGCAATAATAGAAGGGGGACATAAG 
FOR_900 chr7:118399267-118401405 AGATCAGAACGAGCTGTAATGATGAACAGAAACCAAAAAG 
FOR_901 chr7:118401406-118405450 TTATCAGGAAAATGTAAAGTCTTGGCCTGGAGAGAAAAAG 
REV_10 chr7:115634609-115644334 CTTAAGTTCAGTGTCATTCTTGTTCACAACTATAACCCCA 
REV_13 chr7:115648832-115658204 CTTCGCTGAAGGAGAGGTGCATGAATTACAATGGAAAGTC 
REV_17 chr7:115678230-115679502 CTTGAACTTATGCTATCACTTAGTTTAGTCTAAATCAATC 
REV_28 chr7:115711863-115716752 CTTATTAATATGATAAATAATATATCTTAAGCGTAATGAA 
REV_29 chr7:115716753-115718520 CTTCACTGCCTAGAGTTTGGGAAGGGTGACACAATAATAC 
REV_46 chr7:115759209-115760110 CTTTATTTTTATCACCACCTGACAAATATTATTTCATTTT 
REV_53 chr7:115771573-115775575 CTTTATAATCCATGTCTTTTTAATAATTATTCTATAACAA 
REV_72 chr7:115835165-115835641 CTTGTGTTCATCTTGAGCCAATAAAAACTACAAAAAGGAA 
REV_84 chr7:115870648-115874160 CTTATACAAATTTTTTGTGTATGTGGGGAGAGAGGGAGTG 
REV_99 chr7:115922292-115929439 CTTTGGGAAGCCTAGCTTTGTTGACTATAAATATGGTACT 
REV_111 chr7:115951445-115956484 CTTTGGGTGCTTTTAAGAAGCACCCAAAATTATTGTCATG 
REV_143 chr7:116062231-116062713 CTTAGGCTACCGCGCGGGACTAACAAAAACATAAAAATCA 
REV_157 chr7:116094748-116108495 CTTTCTCTGCTTCTGTGACATATTCCTGCTATTCTTCCTG 
REV_172 chr7:116150033-116151991 CTTCCCTTGCTGATTTTTTTTCCGATTCCAAGGAGTAAAA 
REV_189 chr7:116183536-116185921 CTTCTACTTACCTAATAAAAGATTTGGTTGGATGAATTTC 
REV_203 chr7:116221966-116241644 CTTTATGTCAGGGGCTCACAGACACATTTGGTGTGCCTTA 
REV_216 chr7:116288191-116290571 CTTACTGCTAGAGCCACGAAAGGAAAGAGAGAAGGACAGT 
REV_236 chr7:116331386-116334860 CTTATTGTAACAGCTCCAATGTATTATAAAGAAGAACGTA 
REV_253 chr7:116391564-116395299 CTTATTCATTTAGACCAGGAGTGGAGCTCCTCATGCTAGG 
REV_274 chr7:116438321-116444567 CTTGTATCTTAGTGAGTGAGACAGAGAAACAAACACGTGA 
REV_276 chr7:116447116-116449019 CTTCTACAGTGAAACAAAAGTAATTAACCTTTTTAAAAAG 
REV_296 chr7:116515432-116528143 CTTTTCTAAAACCTTTTTGCCTTAAAGGTCATTTAATTCT 
REV_305 chr7:116542199-116552833 CTTTAACTGTTTCATAACTTCAAAATGTTATTTTGAAACA 
REV_330 chr7:116599917-116602592 CTTGTAAGAACTTTTGCAACGGCTTCTAAAAGAAGGTTCT 
REV_342 chr7:116637097-116652178 CTTCCACCTGAACAGCTGTGATGGCACACCATCCCGATGT 
REV_372 chr7:116744402-116752147 CTTTCGTTTATTCCCCTGCTTCACGGGGGAAGCGGGGCAG 
REV_404 chr7:116852286-116855373 CTTCTAAATCTAAGGTGAGATCTAAGATCACATGAAATGT 
REV_405 chr7:116855374-116855697 CTTTCAAATAATAGTGCATGGCTATTATCTTGAGATACAT 
REV_417 chr7:116887587-116899362 CTTATAGTGTTCCATCTCTGTGCCAGGCAGTGGAGAGTTT 
REV_420 chr7:116901865-116906597 CTTTATTAGTTTCAGGTTTAGGTGAGTGAACTCCAAGGGT 
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REV_421 chr7:116906598-116908131 CTTCTGTGGCTCATCACATTAGGCTATGAATACAATTTAT 
REV_452 chr7:116987119-116988884 CTTATTTAGGCACAAAAAACCCTATTATATTATTTCATTT 
REV_471 chr7:117038905-117042649 CTTCTTTTCATCAAAAGACTCTATAAGCCAAGCCACTGAC 
REV_486 chr7:117073683-117083343 CTTCTGTCCCCCTGCCAAAGTCATATGTTGTTTAGGATTG 
REV_520 chr7:117185297-117185608 CTTTGGAAGAACCCTGAAACAGTTTTAGATTATGGACAGC 
REV_523 chr7:117187621-117190232 CTTTAGCACGAGTTGGACAGAGGCCTGAGGTAGGTGGTTA 
REV_533 chr7:117220057-117222052 CTTGAGGAATAATCTATATTCCTGATTATCTATTTATGGG 
REV_549 chr7:117253904-117254793 CTTAATATTGGGAATTTTTTTTCTGTTATGAGTTGAAATG 
REV_564 chr7:117298280-117301976 CTTTGATCTGTAACCCTTGGACTGAACATTCTAGTCATTC 
REV_594 chr7:117407210-117415205 CTTCAAAAAAAAAGTCACTTGGGGCAGTCATTAAAATACA 
REV_613 chr7:117472370-117476601 CTTCCTCTAGTTGGAGGCATGTCTTCATGTCTGGGTTTAC 
REV_618 chr7:117489452-117495550 CTTTCATTTAGCAATCATCAGTATCCACTAAGCACCATGT 
REV_624 chr7:117518071-117524319 CTTGTTACTATAAGCAAATGAGAACGATTATAAGAAAAAA 
REV_647 chr7:117601133-117608227 CTTATTCCAATACGGTGTTTTGTTCATGGCCATTTTTTAT 
REV_648 chr7:117608228-117612532 CTTCTGTTTTTGTCTTTGTGATAATTACATGATTAAAAAA 
REV_649 chr7:117612533-117614662 CTTAGTATTGAATAAAAGAAGACATGGGTCTAGCATAACA 
REV_665 chr7:117648602-117650010 CTTTGATGTCATCCTTGACTCTTCTCTTTCTCAAAGGCGT 
REV_666 chr7:117650011-117652129 CTTATTCATGGCGGTGCAGGCTGCTCGGAAAGGGAGTCTG 
REV_667 chr7:117652130-117653051 CTTCTTCTTCAAAAAATTTAAAAGTTACTTGTTTTGATGT 
REV_668 chr7:117653052-117659168 CTTAGTACTGGTTTCTAGGTTTTCAGGCTAACCGATGAGT 
REV_680 chr7:117698217-117708237 CTTCTATTTGATCAGCTTTCCTGCAGATAGCTATAAACAT 
REV_687 chr7:117729698-117733947 CTTATTTGTATAACTATAAATTTAGAATGAACTAACTTTC 
REV_695 chr7:117759926-117763481 CTTAACCCAAAGGAATGAATTTATAACAAAAGAAATCCAG 
REV_700 chr7:117787224-117795088 CTTTTTAATAAATCTGGATTTAACCAACTACCACTTAGGT 
REV_711 chr7:117817379-117817857 CTTGTCATTATATTCTCAAGTTTCTGGGTAAAGGCCATAT 
REV_719 chr7:117851062-117856726 CTTGGCAGCAAGAACAATTTTAAGATGACCCTGGGGTCTC 
REV_730 chr7:117883040-117883764 CTTACTTATAAGATTCAAAACCCATATTGTAATCAACTTT 
REV_738 chr7:117913179-117914159 CTTAAACAAGTAATGCTCATTTATTGTATGTAAATAGATT 
REV_750 chr7:117942852-117943861 CTTGGAAGCATCTACAGCAGCCTTAGCAGTCCGTAACAAC 
REV_761 chr7:117965131-117973387 CTTTACAGTAAGGTTAATGTGTAAATGTGCTAAATTAAAG 
REV_769 chr7:117997060-118009420 CTTCTAAACTTCCTGTAATCCAGGCCACACCGGTTTTGTT 
REV_777 chr7:118023307-118032256 CTTGGCACAGCAATAGAAACAATCAAATGAGTGAAAAGGG 
REV_782 chr7:118057843-118065171 CTTAGGCAGATCAGCATGCTGTCAGGATGCACCTGTACTA 
REV_792 chr7:118094746-118096542 CTTTGTTCTCCAAGAATCTTTTTTCTATACATATTTTAGA 
REV_800 chr7:118123466-118123895 CTTAAGACATCTTTTGCTGGAAAGTAAAAAAGTGCCCAAG 
REV_808 chr7:118145508-118153940 CTTTGGAAATTAGTGCATAGAACGACAAAGCTGAAAAGGT 
REV_816 chr7:118182448-118185015 CTTTCAAAATAACAGTTTCATTCAGCTTTCTGATAGGTCA 
REV_825 chr7:118212782-118215208 CTTATTTCTTAGTAAATGGCACCCATTAATTACTTAATGT 
REV_840 chr7:118246300-118256171 CTTTGTTACTGCAGATAGAGATAGGTAATGGCTTTCCCTG 
REV_847 chr7:118268800-118275080 CTTCAAGAAGGAAGCCTTCATATAAGGAAAAATGATGTTA 
263 
 
REV_863 chr7:118303374-118305249 CTTTTTTCTAAGACCTTGAAATCAAAAGCAATTCACTATA 
REV_876 chr7:118335356-118336292 CTTATACTACTGAGAGACAAGATTGTTTAATTTTCAAATG 
REV_892 chr7:118356081-118360339 CTTAGACAAGGCATTTTCCAAGAACTCGATGTATTAAGCC 
REV_898 chr7:118385397-118394195 CTTGGAGGTTTTTCTAGGCTAGAAAAAAAGAGAAATGCTC 
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